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ABSTRACT
The goal of the research presented in this dissertation is to develop laser-induced
fluorescence anisotropy (LIFA) detection for detecting and characterizing amyloid beta (Aβ)
peptide aggregates separated by capillary electrophoresis (CE). Senile plaques composed
primarily of aggregated Aβ (1-40) and Aβ (1-42) peptides have been found in the brains of
Alzheimer’s disease patients. These peptides are thought to be responsible for the disease
pathology. A CE method using UV absorbance detection was developed for the quantification of
Aβ (1-40) monomer and testing of Aβ monomer preparations for undesired aggregates (Chapter
2). Analyses of both Aβ (1-40) and Aβ (1-42) monomer and aggregate samples were performed
by CE-UV (Chapter 3). The CE-UV experiments demonstrated that the CE method can separate
Aβ monomers from aggregated Aβ. A lab-constructed CE-LIFA instrument was built to separate
and detect individual Aβ fibrils using Thioflavin T (ThT) in the separation buffer as a fluorescent
probe (Chapter 4). Separating and detecting individual Aβ aggregates opens the door to a better
understanding of amyloid aggregation, which is normally studied with bulk methods, i.e. all
aggregates measured at once. Individual Aβ aggregates detected by the CE-LIFA instrument
were shown to exhibit fluorescence anisotropy, but all of the aggregate peaks exhibited similar
anisotropy values using ThT as a fluorescent probe. Plots of fluorescence anisotropy vs. time did
not produce peaks as expected. A data treatment method to facilitate visualization of peaks in
CE-LIFA data was developed (Chapter 5). Thioflavin T spectroscopy in the presence of
polystyrene spheres was studied to address potential false positives observed in preliminary
experiments from Chapter 4 using ThT as a fluorescence probe for Aβ aggregate detection
(Chapter 6). It was found that polystyrene spheres can enhance ThT fluorescence similar to Aβ.
A CE-LIFA study of Aβ peptides covalently labeled with a fluorophore was performed to
vii

overcome the apparent limitations of ThT. Aggregation of two different preparations of Aβ was
studied as a function of time. Different forms of Aβ were separated and detected using CE-LIFA,
and peaks resulting from different forms of Aβ exhibited different fluorescence anisotropy
values.

viii

CHAPTER 1
INTRODUCTION
1.1 Amyloid Proteins and Amyloidogenesis
There are over 20 amyloid-forming proteins that are known to be associated with human
diseases [1]. Several amyloid proteins and their associated diseases are listed by Rambaran et al.,
Rochet et al. and Ecryod et al. [1-3]. Briefly, some diseases and their associated amyloid proteins
include Type II diabetes (IAPP, or amylin), Parkinson’s disease (α-synuclein), Huntington’s
disease (Huntingtin), Creutzfeldt-Jakob disease (prion protein) and Alzheimer’s disease (beta
amyloid (Aβ)).
Amyloid proteins misfold and self-assemble under physiological conditions to form
aggregates. This aggregation process is referred to as amyloidogenesis. Ecroyd et al. have
suggested that all proteins are capable of undergoing amyloidogenesis, but the amino acid
sequence of the protein highly dictates a protein’s predisposition to adopt amyloid aggregate
structures [2]. Amyloid proteins are soluble prior to self-assembly but become more insoluble as
aggregation progresses, eventually leading to mature, fully-formed fibrils. Not all proteins that
self-assemble can be characterized as amyloidogenic. Proteins are characterized as “amyloid” by
the cross β-sheet structure that they form as a result of aggregation. Amyloidogenesis is complex,
and many transient and metastable intermediate aggregates existing between monomers and
fibrils. It is believed that the term “amyloid” was derived from “corpus amygdaloideum”, which
is latin for “amygdale”. Amygdala is the name of neurons located in the brain’s temporal lobe
that have an effect on memory.
The nucleation-dependent polymerization pathway is a theory that explains the
mechanism of amyloid fibril formation [4]. According to this theory, monomers self-assemble in
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solution to form a nucleus, i.e. “nucleation”. Remaining free monomers in solution add to the
nucleus and extend its dimensions, i.e. polymerization. The nucleation-dependent polymerization
reaction follows first-order kinetics, with nucleation being the rate-limiting step followed by the
thermodynamically favored polymerization step [4,5].
Research has shown that the process of monomers aggregating to form fully-formed
fibrils produces several complex intermediate and transient structures that exist between
monomers and fibrils [6-8]. Each intermediate aggregate and fully-formed fibril will potentially
be unique in size, shape and structure. Intermediates can be in the form of oligomers, i.e.
dimmers, trimers, tetramers, etc., or protofibrils, which are structures intermediate in size
between oligomers and fully-formed fibrils. Takahashi et al. schematically illustrated the
aggregation process from monomers to fibrils in a recent article [9]. Aβ species in solution have
been shown to reach a dynamic equilibrium with a reproducible end point of approximately 1
µM unpolymerized monomer [10]. Different amyloid proteins do not have similar primary
sequences or monomer structures, but the aggregates they form have common structural features.
For example, β-sheet secondary structures and rod-shaped 3D structures that can be up to
microns in length and roughly 10 nm in diameter. The overall size and shape between aggregates
formed from the same amyloid protein can vary drastically [11,12].
1.2

Amyloid Beta (Aβ) Peptides and Alzheimer’s Disease
As previously mentioned, amyloid aggregation has been linked to human diseases [1].

The research covered in this dissertation focuses on the Amyloid beta (Aβ) peptide. The Aβ
peptide has been found to be the major protein in the extracellular neuritic plaques of people who
have Alzheimer’s disease (AD) [13,14]. Alzheimer’s disease is a form of senile dementia named
after the German Physiologist Alois Alzheimer who originally described the pathology of AD
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based on analyzing slices of neuronal tissue using microscopy in 1906. Alzheimer’s disease is
the most common form of dementia [15]. There are no biological markers to diagnose a living
person with AD, and the greatest risk factor is age [15]. The main symptoms of AD are loss of
memory and cognitive skills [15]. Diagnoses of AD can be accomplished through eliminating
other potential sources of AD-like symptoms [15]. It is not clear if genetics plays a role in
predisposing a person to AD, but genetics does appear to play a role in the timing of the disease
onset [15].
The Aβ peptide is cleaved from the Amyloid precursor protein (APP) by the proteases α,
β and γ secretases [16]. The APP found in neurons is a type 1 transmembrane glycoprotein that
contains 695 amino acids and is abundantly expressed in neuronal tissues [17,18]. α secretase
cleaves APP between amino acids 16 and 17, and produces a nontoxic soluble form of Aβ [16]. β
secretase first cleaves off the extracellular domain of APP. The remaining transmembrane
domain APP is then cleaved by γ secretases, which produces the form of Aβ that becomes
neurotoxic [15,16,18].
Proteolysis of APP can produce different length Aβ peptides from 39 to 43 amino acids
in length. The primary sequence of Aβ is shown below as the Aβ (1-43) amino acid isoform.
Shorter isoforms of Aβ have the same primary sequence minus amino acids from the C-terminus
of the peptide chain. The molecular weight of Aβ is about 4 kDa, depending on the isoform.
1
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The Aβ (1-40) and (1-42) peptides are the most abundant isoforms produced from APP
cleavage. The cleaved Aβ segments from APP are released into the extracellular matrix and exist
in human plasma and cerebrospinal fluid even in normal subjects [15,17]. The concentration of
3

Aβ in the cerebrospinal fluid is estimated to be in the low nanomolar range [19]. The secreted
concentration of Aβ (1-42) is about 5 – 15% of Aβ (1-40) [20]. Interestingly, Aβ (1-42) is the
most abundant form found in senile plaques of AD patients [21-24]. Aβ (1-42) is more
neurotoxic relative to Aβ (1-40) [25]. Aβ (1-40) is found in association with blood vessels [21].
Under physiological conditions, the Aβ peptide accumulates in the brain, and, through
aggregation, deposits as amyloid plaques [17]. The accumulation of Aβ plaques can be observed
decades before the AD symptoms [20]. The amyloid hypothesis describes the accumulation of
Aβ in the brain, the imbalance of Aβ production and clearance from neuronal tissue and how
these events could be critical in AD pathology [13]. Aβ is protease-resistant due in part to
racemization of aspartyl and seryl residues and cyclization of N-terminal glutamyl resides [24].
Additionally, racemization from the L-amino acids to D-amino acids could have an impact on
the aggregation rate of Aβ peptide [26].
Fully formed Aβ fibrils have been found during autopsies performed on the brains of
people who were diagnosed with AD. This is likely the reason that researchers initially targeted
Aβ fibrils to prevent or treat AD. Small molecules and small designer-peptides that can
potentially dismantle Aβ aggregates or inhibit their formation have been tested [16,27,28]. For
example, Curcumin (Yang 2005), phenol-related compounds [29] and pixantrone and
mitoxantrone [30] have been shown to inhibit Aβ aggregation in vitro. An effective disruptor of
Aβ aggregates for clinical use must be necessarily small in order to cross the blood-brain barrier
while still being specific enough to bind only neurotoxic Aβ. Small molecular inhibitors satisfy
the former but can suffer from non-specific binding [28]. Designer-peptide inhibitors have the
advantage of increased binding specificity, relative to small molecules [28,31]. Peptide-based
inhibitors can be designed with specific chirality and level of hydrophobicity, both of which can
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contribute to preventative and disruptive aggregation [28,31]. The central hydrophobic core of
Aβ, amino acids 16 – 20, is known to play a critical role in Aβ oligomer production and is
therefore a popular target for developing agonist of aggregation [32,33]. Other than small
molecules and peptide inhibitors that target the Aβ peptide for prevention or disassembly of the
aggregation, some researchers have investigated ways to treat AD by more indirect methods.
One such method is the regulation of the proteolytic secretases that are responsible for cleaving
APP and producing Aβ [34].
The previous paragraph discussed ways to treat, manage or prevent AD by dismantling or
inhibiting Aβ aggregation. Arguably, the biggest challenge in developing methods to treat,
manage or prevent AD is that there is no clearly defined neurotoxic Aβ aggregate. One
hypothesis is that AD neurotoxicity is related to Aβ aggregate size, but this does not imply that
there is a direct relationship between size and neurotoxicity. Large fibrils were initially suspected
to be the toxic species of AD [32]. More recently, researchers have shown that smaller Aβ
oligomers are also toxic and could be more toxic than larger Aβ aggregates [13,27,35,36]. One
method to determine the cytotoxic potency of Aβ peptides is to monitor the cellular
concentration of 3-(4,5-dimethyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as a function of
Aβ peptide exposure [37]. Normal cells reduce MTT and peptide-treated cells do not reduce
MTT. By monitoring the concentration of MTT using absorbance spectroscopy at 570 nm,
cytotoxic potency can be ascertained [37]. MTT assays have also been used to test inhibitors of
aggregation [38]. It is possible that if smaller Aβ aggregates, such as oligomers are more
neurotoxic relative to larger aggregates, disrupting or dismantling fully-formed aggregates in
vivo could produce oligomers thus leading to enhanced AD neurotoxicity.
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1.3

Preparation of Synthetic Aβ Peptides
The lack of analytical tools to characterize the plethora of sizes, shapes and structures of

Aβ, from monomers to fully-formed fibrils, makes designing treatments for AD a major
challenge. While synthetic Aβ monomer peptides are commercially available as lyophilized
powders, no analytical standards for aggregates exist that can be used to develop analytical
methods to characterize and quantify Aβ aggregates. Because no analytical standards of Aβ
aggregates exist, developing methods to characterize Aβ aggregates relies heavily on the ability
to reproducibly prepare high quality synthetic Aβ samples [39]. Reproducibility of Aβ samples is
a major challenge because the final product is extremely sensitive to small preparation variations.
Chapter 2 demonstrates this clearly. Several Aβ monomer samples were prepared by the same
scientist using the same method, and some samples were found to contain unwanted Aβ
aggregates while others were found to contain only Aβ monomers. There are several potential
sources of Aβ preparation variability [40]. Briefly, some of these include the commercial source
of the peptide, initial aggregation state and aggregation conditions including solvent polarity, pH,
ionic strength and incubation temperature [40,41]. Moreover, errors associated with solid phase
peptide synthesis of Aβ can be a potential source of irreproducible Aβ aggregation [42].
Methods have been developed that can provide reproducible Aβ preparations [42-44].
The first step in preparing synthetic Aβ samples from the lyophilized monomer is treating the
lyophilized monomer with a solvent that will disaggregate any preformed aggregates that could
act as seeds. Seeds are known to accelerate aggregation and increase polydispersity [11,44]. Preformed aggregates could be a result of synthetic impurities or improper storage conditions. An
effective solvent to dismantle preformed aggregates should break down H-bonding between
aggregates and be easily removable. Solvent removal can be performed under a stream of
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oxygen-free and inert gas. Oxygen-free gas is important so that amino acids are not oxidized.
Trifluoroacetic acid (TFA), hexafluorpisopropanol (HFIP), or a combination of the two, are
common solvents used to initially treat the lyophilized monomer to dismantle pre-formed
aggregates. For aggregation studies, incubation temperature is critical because the velocity of
amyloid formation is highly dependent on temperature [4]. The velocity of amyloid formation at
25° C is reported to be only 10% of that at 37° C [4]. High ionic strength buffers and pH between
4 and 7 promote aggregation [40].
1.4

Analytical Methods for Studying Aβ Monomers and Aggregates
An ideal method for studying Aβ aggregation could monitor Aβ monomers, fibrils and all

aggregates in between with a single technique that would provide size, structure and
concentration information of each species detected in real time during aggregation. No single
method is capable of this; however, several methods are routinely used that provide some of this
information. Quantifying Aβ monomer has been achieved by UV absorbance spectroscopy
[17,45]. The peptide bonds between the amino acids absorb in the low UV radiation range (~190
– 254 nm). To accurately quantify Aβ monomer in solution using UV absorbance, a linear
concentration curve should be developed that has been calibrated to the exact protein
concentration by amino acid analysis (AAA). The procedure of AAA involves hydrolysis of the
peptide bonds followed by separation, detection and quantitation of the amino acids. A benefit to
AAA is that any preexisting aggregates are also broken down to monomers and subsequently
amino acids. This means that all of the peptide is accounted for, which results in a more accurate
determination of the peptide concentration. Amino acid analysis can also provide relative amino
acid composition of a protein to help verify the identity of the protein.
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It is not clear that UV absorbance spectroscopy can accurately determine the
concentration of Aβ aggregates. Because aggregates are made up of Aβ monomer subunits, one
might expect that an aggregate’s absorbance would scale with n monomer units. No literature
was found to support or dispute this. It is unknown how molar absorptivity scales with
aggregation. Moreover, unlike monomers, large aggregates will significantly scatter light in
addition to absorbing it. A UV detector would not differentiate between scattered light and
absorbed light, so this could obviously lead to unreliable concentration results. Further
complicating quantification of aggregates by UV absorbance is that, unlike a solution of
monomers, a solution of aggregates is polydispersed, i.e. each aggregate is potentially unique.
UV absorbance spectroscopy is a powerful tool, but it can suffer from if the sample is not pure
since many unwanted analytes can potentially absorb at the same wavelengths being used to
quantify Aβ monomers.
Circular dichroism (CD) is a qualitative spectroscopic method that can detect secondary
structures of proteins. The method relies on the differential absorption of left and right circularly
polarized radiation. The conversion of Aβ monomers to aggregates in solution is accompanied by
a conversion of random coil and α-helix structures to β-sheet structures [40]. This conversion can
therefore be monitored be CD. Circular dichroism is particularly useful in kinetic studies of Aβ
aggregation and screening inhibitors and disruptors of Aβ aggregates. Because CD is based on an
absorbance measurement it can suffer from light scattering from larger aggregates similar to UV
absorbance spectroscopy [44].
As mentioned above, light scattering from aggregates is a potential source of interference
in absorbance-based measurements, but if aggregates are of interest, light scattering (LS)
detection is a useful tool. Aggregated Aβ has been suggested to be a more reliable target for AD
8

diagnoses compared to soluble Aβ monomers [23]. The power of light scattering detection is that
the diffusion coefficients, D, of particles in solution undergoing Brownian motion can be
determined [46,47]. Light scattering detection works well to study Aβ aggregates in solution
because they behave similarly to particles in solution. Lomakin et al. describe in detail how a
particle’s diffusion coefficient can be used to determine that particle’s size, i.e. its hydrodynamic
radius, Rh, using the Stokes-Einstein equation [47]. While the aggregate’s shape has to be
assumed to relate the D to Rh, no other method was found that can determine an aggregate’s Rh.
Rh is most accurately related to D when (1) the solution is dilute so that local viscosity does not
affect D and (2) when the aggregate’s length is not greater than 150 nm [46,47]. Light scattering
detection may not work well for determining Rh of fully-formed fibrils because they are greater
than the approximate 150 nm length threshold. The hydrodynamic radius of low molecular
weight Aβ, however, has been determined to be 1.5 – 2.0 nm based on quasielastic light
scattering measurements [48]. Furthermore, LS detection is not a useful method for monitoring
Aβ monomer because monomers do not scatter light.
Mass spectrometry (MS) is another valuable tool for quantifying Aβ monomer in
solution. Mass spectrometry can identify different monomeric isoforms of Aβ, e.g. 1-40, 1-42, 143, based on their mass differences. Thompson et al. demonstrated that electrospray ionization
(ESI) MS could be used to identify different Aβ monomeric forms based on their m/z values
after being chromatographically separated [49]. Using matrix-assisted laser desorption ionization
(MALDI) with MS imaging (MSI), Stoeckli et al. were able to map different isoforms of Aβ in
post-mortem mouse brain tissue, which demonstrates the power of MS analysis [50]. Mass
spectrometry, however, cannot be used to analyze Aβ aggregates directly because they are too
large to get into the gas phase [51]. Typically, if aggregates are to be analyzed by MS, the
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aggregates are first disaggregated to monomers and then analyzed. A report by Teplow and
coworkers discusses that when monomers build on each other, the m/z remains constant, which
means that normal MS would not be able to differentiate between a monomer and any higher
order oligomer [42]. The authors discuss that ion mobility mass spectrometry (IM-MS) can
differentiate between monomers and higher order oligomers because the technique can resolve
ions of different masses even if the m/z values are the same [42]. For a recent review on IM-MS,
see Uetrecht et al. [52].
For structural information of aggregates, imaging methods, such as transmission electron
microscopy (TEM) have been used [39]. Transmission electron microscopy can quantify
dimensions of a single Aβ aggregate and is commonly used to identify the presence of
aggregates in a solution of Aβ. Non-imaging techniques, such as solid-state nuclear magnetic
resonance (SSNMR) and hydrogen-deuterium exchange mass spectrometry (HDXMS), do not
provide images attainable by imaging techniques. TEM requires that the sample be removed
from solution, spotted onto a surface and dried prior to analysis. It is likely that the dried
aggregate is not in the exact confirmation as it was in solution. Also, only aggregates large
enough to interact with the beam of the electrons from the TEM source will be imaged.
Monomers and low molecular weight oligomers are too small to be resolved by TEM [53].
Atomic force microscopy (AFM) is another imaging technique that has been used to obtain
structural information of Aβ aggregates, but like TEM, the sample is spotted on a surface and
dried [54,55]. One advantage of AFM over TEM is that TEM provides 2 dimensional images and
AFM provides 3 dimensional information.
Ryu et al. have also demonstrated the use of surface plasmon resonance (SPR)
spectrometry to study Aβ peptide [56]. Like TEM and AFM, SPR measurements are made with
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the analyte on a surface. The surface in SPR is a dielectric material that resonates with an
incident beam of radiation at a specific angle, called the SPR angle. As the mass on the surface
increases due to Aβ accumulation, i.e. aggregation, the SPR angle shifts. The shift in SPR angle
is therefore indicative of aggregation. A limitation to SPR is that the monomeric Aβ is bound to
the dielectric surface prior initiating aggregation [56]. While this provides an anchor on which
aggregation can proceed, it is not known how anchoring the peptide affects polymerization. SPR
is a non-quantitative method. Moreover, like AFM and TEM, SPR can be used to determine if
aggregation has occurred. Unlike AFM and TEM; however, SPR is incapable of providing an
image of the aggregates.
Solution-based methods that are capable of providing structural information of proteins
are:

X-ray crystallography, MS and nuclear magnetic resonance (NMR) spectroscopy.

Unfortunately, Aβ fibrils do not form crystals or ordered repeat structures, which limits the use
of X-ray crystallography for structural analysis of larger aggregates [57]. Mass spectrometry
coupled with hydrogen/deuterium exchange (HDX) has been used to probe structural
information of aggregates [58]. HDX is the process of exchanging amide hydrogens on the
peptide for deuterons in solution. Structural information can be obtained using HDX based on
the idea that hydrogens involved in hydrogen bonding and those embedded more deeply in the
aggregate’s core will exchange for deuterium more slowly relative to hydrogens on the surface of
an aggregate [51,58]. After the HDX process, the back exchange of deuterium for hydrogens is
quenched, the aggregates are dismantled and the number of deuterons acquired by an aggregate
can be measured by MS based on the increase in mass [51,58]. It is critical to perform the MS
analysis quickly to minimize loss of HDX information due to back exchange of hydrogens for
deuteriums [58]. Using HDX-LC-MS, Kheterpal et al. were able to demonstrate that about 50%
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of the amide hydrogens of Aβ are protected from exchange after Aβ has aggregated [59].
Another challenge of studying Aβ aggregates is that aggregates become increasing
insoluble as they get larger. This limits the size of Aβ aggregates that are analyzable by solutionbased NMR because the aggregates precipitate out of solution. Smaller oligomers are more
soluble relative to larger aggregates. Moreover, oligomers are short lived relative to larger
aggregates. This means that oligomers are likely to change structure and size before, after or
during the measurements. NMR is limited to proteins approximately 30 kDa [60], which is
approximately equal to 6- or 7-mer oligomers. NMR also requires approximately 1 – 10 mM of
protein, which is a concentration that would certainly promote aggregation and precipitation
[61].
Fluorescence spectroscopy is a very common method for studying and assaying Aβ
aggregation. For a protein to be intrinsically fluorescent, it must contain aromatic amino acids.
Tryptophan (abbreviated Trp or W), Tyrosine (abbreviated Tyr or Y) and Phenylalanine
(abbreviated Phe or F) are the three fluorescent aromatic amino acids of the 22 amino acids.
Tryptophan is by far the most fluorescent amino acid with a molar absorptivity (ε) of 5600 M1

cm-1 and a quantum yield (Ф) of 0.20 [61]. This is compared to Tyr (ε = 1400 M-1cm-1 and Ф =

0.14) and Phe (ε = 200 M-1cm-1 and Ф = 0.04) [61]. Of these aromatic amino acids, Aβ contains
0 Trp, 1 Tyr and 3 Phe. Aβ does not have strong native fluorescence in part because it lacks Trp
and only contains 1 Tyr.
While Aβ does not exhibit strong native fluorescence, researchers have used covalent and
noncovalent fluorescent labeling techniques to study Aβ. Fluorescently labeled Aβ monomeric
isoforms are commercially available. One example is carboxyfluorescein (FAM) labeled Aβ,
which is used in Chapter 7 to fluorescently probe Aβ aggregation. Another labeling technique
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involves using Aβ aggregate antibodies that are covalently bound to fluorescent dyes. Funke et
al. used fluorescent labeled antibodies (6E10-Alexafluor-488 and 19H11-Alexafluor-633) to
fluorescently detect single aggregates by fluorescence correlation spectroscopy [23].
Other fluorescence probes for Aβ aggregates are amyloid dyes. The most widely used
amyloid dyes are Congo Red and Thioflavin T (ThT); although, derivatives of these dyes have
been used. Thioflavin T is perhaps more widely used compared to Congo Red. Amyloid dyes are
fluorogenic according to IUPAC’s definition because their fluorescence is enhanced in the
presence of Aβ aggregates. The research presented in Chapters 2 and 4 of this dissertation
employed ThT as an amyloid dye to study aggregation of Aβ. Chapter 6 covers research on
studying the spectral properties of ThT in the presence of polystyrene beads. Because ThT was a
used in several areas of research for this dissertation, the next section is devoted to covering
background information of ThT.
1.4.1

Thioflavin T
Thioflavin T (ThT) is a water soluble benzothiazole dye that binds to the β-sheet

architecture formed by amyloid aggregates. Molecules of ThT align parallel to the long axis of
the Aβ fibrils [62]. Upon binding to Aβ aggregates, ThT undergoes a excitation:emission spectral
shift from 385:445 nm to 450:482 nm [12,63]. Moreover, ThT fluorescence can increase by
several orders of magnitude when bound to Aβ fibrils compared to unbound ThT [12]. By
monitoring the ThT fluorescence near 450:482 nm, the presence of Aβ aggregates can be
detected. The spectroscopy of ThT in the presence of Aβ has been characterized in detail by
LeVine and Naiki [63-65]. An EEM of ThT in the presence and absence of Aβ (1-40) aggregates
is presented in Chapter 6.
Thioflavin T assays are well-documented and easy to use to determine amyloid
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aggregation kinetics, especially for Aβ (1-40). For kinetic studies of Aβ aggregation with ThT as
the fluorescent marker, an initial lag phase is observed where the ThT fluorescence is weak for a
period of time. This lag phase is presumably during the formation of the Aβ nucleus according to
the nucleation/polymerization theory. The lag phase is followed by a rapid increase in the ThT
fluorescence, which eventually plateaus at a maximum ThT fluorescence. Chapter 2 illustrates
bulk ThT measurements of an aggregating mixture of Aβ (1-40). The rate and extent of Aβ
aggregation is dependent on the starting Aβ monomer concentration. It is interesting that there
are cases where the ThT signal, after reaching its maximum value, begins to decrease as a
function of time. Nilsson et al. have suggested that this is due to the formation of mat-like
assemblies of Aβ fibrils, which could lack ThT binding sites [39].
The structure of ThT is shown below. Researchers have suggested that the free rotation of
the benzylamine and benzothiole rings around their shared carbon-carbon bond quenches the
excited state of ThT, which reduces the Ф of free ThT [12].

Figure 1.1. Structure of Thioflavin T
It has been suggested that the binding of ThT to the β-sheet of Aβ immobilizes the free
rotation about this carbon-carbon axis, which enhances the Ф of ThT relative to free ThT [12].
This means that the rotation of the ring structure of ThT could be the source of the fluorogenic
property of ThT. Stsiapura et al. investigated the rotation about the shared carbon-carbon bond of
the benzylamine and benzothiole rings and how the angle between the rings relates to the
observed Ф enhancement observed in ThT measurements [66]. At a torsional angle, ψ, of 90°
and 270°, the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular
14

orbital (LUMO) overlap the least [66]. This means that when the benzylamine and benzothiole
rings of ThT are perpendicular to each other, ThT is nonfluorescent because there is little to no
charge transfer from the ground electronic state to the excited state. On the other hand, ψ = 0° or
180° could provide the most overlap of the HOMO and LUMO, hence, the largest Ф. When the
two ring structures are in the same plane, the fluorescence is greatest. Stsiapura et al.
demonstrated that increasing the viscosity of the ThT microenvironment lead to an increase in Ф,
presumably due to preventing the ThT rings from adopting the perpendicular configuration [66].
It was not described by Stsiapura et al. and it is not clear why a viscose solution would prevent
only the perpendicular configuration and not the parallel configuration.
Another interesting property of ThT is that it forms micelles [67]. Some data suggest that
ThT micelles bind to Aβ fibrils rather than free ThT [67]. The critical micelle concentration is
debatable but has been suggested to be between 4 – 30 µM [67,68].
1.4.2

Fluorescence Anisotropy
Fluorescence anisotropy is a focal point of the research presented in this dissertation.

Chapter 4 demonstrates a novel use of ThT for fluorescence anisotropy measurements of Aβ
aggregates. Chapter 5 presents a data treatment method that was developed to extract
fluorescence anisotropy peaks from separations of Aβ aggregates. In Chapter 7, fluorescence
anisotropy measurements of FAM-labeled Aβ monomers, intermediate aggregates and fibrils are
presented. This section will cover background information of fluorescence anisotropy.
Fluorescence anisotropy (FA) is based on the photoselective excitation of a fluorophore
using a polarized source. A polarized source means that the electric field vector oscillations have
a particular orientation, i.e. they are not randomly oriented. Photoselective excitation means that
only those fluorescent species whose absorption dipoles are oriented with the polarization of the
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excitation source are excited. The probability of a fluorophore absorbing a photon whose electric
field vector lies in the z-axis is proportional to the cos2θ, where θ is the angle between the z-axis
and the absorption dipole of the fluorophore [69].
For simplicity, ignoring the fundamental anisotropy, which will be discussed below, the
fluorescence emission of a fluorescent species, excited by a polarized source, will have the same
polarization as that of the polarized source. If the emission polarization is altered relative to that
of the excitation polarization, e.g. through rotational diffusion of the fluorescent species, this can
be measured as the fluorescence anisotropy.
The fluorescence anisotropy, then, is a measure of the degree of fluorescence
depolarization. A major source of fluorescence depolarization is rotational diffusion [69].
According to anisotropy theory, slower rotational diffusion rates result in larger fluorescence
anisotropy values and larger rotation diffusion rates result in smaller fluorescence anisotropy
values. This relationship is described by the Perrin Equation, which is discussed in Chapter 4
(Equation 4.2). A fluorescent species’s rotational diffusion rate, hence its fluorescence
anisotropy, will be affected by its shape and size. For Aβ species, size and shape can change
drastically as a function of aggregation.
Fluorescence anisotropy is a calculated value based on measurements of the parallel and
perpendicular fluorescence intensities relative to the excitation source (see Chapter 4 Equation
4.1). The fluorescence anisotropy is independent of the total fluorescence emitted by the
fluorophore because the difference between the parallel and perpendicular intensities is
normalized to the total fluorescence intensity. It is worth noting that fluorescence anisotropy was
preceded by fluorescence polarization, which does not normalize the difference between the
parallel and perpendicular fluorescence intensities to the total fluorescence [69].

16

Each fluorophore has an intrinsic fundamental anisotropy, r0. The fundamental anisotropy
is the anisotropy in the absence of any depolarization. The fundamental anisotropy is described
in Equation 1.1, where β is the angle between the absorption and emission dipoles. For collinear
dipoles, β = 0° and r0 = 0.4. This means that the maximum anisotropy is 0.4. When β > 54.7°, r0
becomes negative reaching a maximum negative value of -0.2 for β = 90° (Lakowicz 3rd Ed).
 =
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(1.1)

Methods for Separating Various Forms of Aβ Peptides
Section 1.4 highlighted some of the more common analytical approaches for studying Aβ

with a focus on fluorescence and fluorescence anisotropy. It is clear that no one method can
detect, quantify and characterize the range of Aβ species between monomers and fibrils. Many
detection methods for studying Aβ rely on bulk-based measurements, i.e. the results are
population averages. The difficulty with bulk-based measurements is that the larger species tend
to dominate the signal. As mentioned, there is growing consensus that smaller Aβ aggregated
species may be more cytotoxic compared to very large fibrillar aggregates. There is an obvious
need for detecting and characterizing smaller aggregates independent of monomers and fibrils.
To accomplish this, separation methods are needed to effectively characterize Aβ monomers and
aggregates.
Several liquid-based separation methods have been used to study Aβ. Separation methods
like high performance liquid chromatography (HPLC) and size-exclusion chromatography (SEC)
use columns that are packed with small particles that serve as a stationary phase. Stationary
phases have the potential to disrupt amyloid aggregates due to shear force as the aggregates are
forced through the stationary phase at high pressures. The mechanism of separation is based how
much time the analytes spend in the mobile phase versus the stationary phase. Analytes that
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spend more time in the mobile phase pass through the column faster than those that spend more
time in the stationary phase. For HPLC, the affinity of an analyte for the stationary phase versus
the mobile phase determines how much time the analyte will spend on the column. For SEC, the
analyte does not interact chemically with the stationary phase like HPLC. Instead, the stationary
phase particles are porous, and the analytes that can physically fit into the particles’ pores have
more volume of solvent to pass through compared to an analyte that is too large to fit into the
pore volume. Size exclusion chromatography thus separates analytes based on size. For amyloid
aggregates, it is assumed that shape also affects how the aggregate passes through an SEC
column. HPLC is typically only used to separate monomers of various isoforms of Aβ [49].
Researchers have successfully separated Aβ oligomers from monomers using SEC [70].
Gel-based separations are another approach used for Aβ separations. Klafki et al.
optimized an SDS-PAGE separation method to separate synthetic Aβ (17-40), Aβ (1-40) and Aβ
(1-42) monomers [71]. Gel electrophoresis has also been used successfully for separating smaller
oligomeric forms of Aβ [25,72]. Gel-based separations certainly offer the advantage of simplicity
over HPLC and SEC while still achieving separations of monomer and oligomers. A
disadvantage of gels is that large fibrillar aggregates may not be able to traverse the gel because
they are too large to enter the pore-sizes of the gel material. This means that fibrillar aggregates
may not be easily analyzable by gel-based separation methods. Hartley et al. were able to use
SDS-PAGE with western blotting employing the Aβ antibody R1282 to analyze monomers,
protofibrils and fibrils, but the fibrils showed little to no movement through the gel [53]. Agarose
gels can provide large intrinsic pore sizes relative to sodium dodecyl sulfate gels and may be
more suitable for analyzing larger fibrils [73].
While HPLC, SEC and gels are popular separation platforms for amyloid studies,
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stationary phases have the potential to disrupt amyloid aggregates on-column. Alternative to
stationary phase-based separations, field-flow fractionation (FFF) and capillary electrophoresis
offer stationary-free separations. The analytes are separated based on their diffusion coefficient
and hydrodynamic size [74]. Field-flow fractionation can separate macromolecular complexes
ranging from 1 nm to 100 µm [74]. Rambaldi et al. demonstrated the use of FFF with UV/Vis
absorbance detection and multiangle light scattering (MALS) detection for the size
characterization of soluble and insoluble Aβ (1-42) aggregates [75]. While FFF has not gained
significant attention for Aβ separations, Silveira et al. demonstrated the utility of FFF to separate
aggregates of another aggregate-forming peptide, PrP-res [74].
1.5.1

Capillary Electrophoresis (CE)
Open tubular capillary electrophoresis, also known as capillary zone electrophoresis

(CZE), has been shown to be a powerful separation method to study Aβ monomers and
aggregates [76,77]. Capillary electrophoresis was extensively used in this research, and CE
theory and applications will be discussed in this section. Some features of CE that are
advantageous for Aβ studies are (1) no stationary phase that can potentially disrupt aggregates on
column, (2) small volumes (nL) of sample can be analyzed, (3) the ability to separate individual
particle-like structures and (4) many types of on-column detection methods are possible.
Moreover, commercial CE instruments are available. Additionally, laboratory-constructed CE
instruments are simple in design and can be easily constructed. For the work presented in this
dissertation, a commercial CE instrument and a laboratory-constructed CE instrument were used.
Figure 1.2 illustrates the basic components of a CE instrument.
Capillary dimensions, i.e. length, inner diameter (i.d.) and outer diameter (o.d.), will vary
depending on the application. For the work in this dissertation, typical dimensions were
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approximately 60 cm in length with i.d. and o.d. of 50 µm and 360 µm, respectively. The silanol
groups of the fused silica capillary are ionizable, and at pH values above 3, they become
negatively charged. When the capillary is filled with buffer, the negatively charged silanol
surface attracts positively charged ions from the buffer, and an ionic double layer is formed at
capillary wall. Under an applied voltage, cations in the double layer migrate to the cathode.
Because these cations are hydrated, they pull bulk solvent toward the cathode. This phenomenon
is called electroosmotic flow (EOF), which will be discussed below.

Figure 1.2. Schematic diagram of a capillary electrophoresis instrument.
The EOF is extremely important in CE separations because it is the pumping mechanism
of CE [78]. Having control of the EOF is equivalent to having control of the pump in HPLC.
Two main factors to consider with EOF are direction and velocity. The direction of the EOF will
depend on whether electrophoresis is performed in negative or positive polarity. For example, in
the Figure 1.2, applying a positive voltage (positive polarity) causes the electrode on right to
become negatively charged, i.e. the cathode. As a result, the EOF would flow from left to right.
The direction of the EOF can be reversed by applying a negative polarity, which would cause the
electrode on the left to become the cathode, and the EOF would flow from right to left.
The velocity of the EOF should be fast enough to drag all analytes past the detector, even
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anions. The general order of elution in normal CE is cations, neutrals and anions. The EOF
velocity can be controlled based on the buffer ionic strength and pH. Buffer cations are attracted
to the negatively charged silanol groups of the capillary surface, which forms an electric double
layer at the capillary surface. The double layer thickness (δ), is dependent on the molar
concentration of the buffer (c), dielectric constant of the eluent (εr), the permittivity of a vacuum
(ε0), the universal gas constant (R), temperature (T) and the Faraday constant (F) according to
Equation 1.2 [78]. The formation of the double layer produces a potential called the zeta
potential, ζ. The ζ is highest at the capillary surface and falls off exponentially moving away
from the surface toward the center of the capillary [79]. Equation 1.3 relates the ζ to the δ, where
σ is the surface charge density [78]. Equation 1.4 shows the Smoluchowski equation, which
relates the linear velocity of the EOF, ueo, to ζ, where E is the electric field and η is the solvent
viscosity [78].
  
=
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Increasing the ionic strength of the buffer, i.e. c, results in a decreased δ (see Equation
 =

1.2). This results in a decrease in ζ (see Equation 1.3), which results in a decrease ueo (see
Equation 1.4). For high pH values, more silanol groups on the capillary surface are ionized,
which increases the surface charge density, σ. This results in an increase in the ζ (see Equation
1.3) and an increase in ueo.
Ionic strength also plays a considerable role in Joule heating, which increases peak
broadening [78]. This has a negative impact on peak resolution. Joule heating is generated from
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the resistance of the current flowing through the ions of the buffer. Joule heating can be reduced
by reducing the ionic strength of the buffer and/or reducing the applied voltage. Thermostatting
the capillary and/or using a capillary with higher surface to volume ratios, i.e. capillaries with
smaller inner diameters, are other ways to effectively remove heat from the capillary. Joule
heating has the potential to alter Aβ and is known to have an effect on the spectroscopy of ThT
[66]; therefore, measures were taken in this work to reduce Joule heating by using low ionic
strength buffers (10 mM Tris), small i.d. capillaries (50 µm) and capillary thermostatting when
available.
To perform a CE separation, analytes are injected into a buffer filled capillary by
positioning the inlet end of the capillary into the sample vial, and a voltage is applied across the
capillary for a short time. This type of injection is called electrokinetic injection. The injection
time and voltage applied depend on the application. Hydrodynamic injection and gravity
injections are other injection techniques that use pressure and gravity, respectively, instead of
voltage to transfer the analytes into the capillary. After the analytes have been injected into the
inlet of the capillary, the inlet is positioned into the inlet buffer reservoir. A voltage is then
applied across the capillary via a high voltage power supply, which induces the EOF.
During electrophoresis, analytes separate according to their electrophoretic mobilities.
Chapter 2 describes equations that govern electrophoretic mobility (Equations 2.1 and 2.2). For
protein separations, the net charge on the protein will be a function of the solution pH. The
isoelectric point, pI, is the pH at which the net charge on the protein is zero. For example,
monomeric Aβ (1-40) has a pI of 5.1, therefore, in buffers of pH < 5.1, Aβ has a net positive
charge and in buffers of pH > 5.1, Aβ has a net negative charge.
For CE separations, analytes migrate at different rates based on their electrophoretic
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mobilities. For example, using a positive polarity, cations will pass the detector at a faster rate
than anions. This is unlike liquid chromatography, where analytes pass the detector at a constant
velocity dictated by the mobile-phase flow rate. This point is discussed here because in Chapter
2, the CE-UV peak areas are divided by the corresponding migration times of the peaks [80].
This was done to normalize the peaks’ areas for varying migration rates. Slower migration rates
produce wider peaks, and faster migration rates produce narrower peaks for analyte zones of the
same physical dimensions migrating at different rates. This is not to be confused with band
broadening. Band broadening is the longitudinal diffusion of a zone of analyte and should not
have a major impact on peak area. In other words, as a zone broadens, the peak gets wider and
the peak height reduces, so the peak area is not changed.
Another benefit of CE for Aβ separations is that CE can separate particles based on size
without the need for a stationary phase. This is ideal for Aβ fibrils, which will migrate similarly
to particles in solution. Chapter 4 demonstrates the separation and detection of individual Aβ
aggregates by CE and discusses how peak widths of aggregates are defined and how it differs
from how peak widths of monomers are defined. The electrophoretic migration of particles is
covered in great detail by Radko and coworkers [81]; however, because of the complexity of
particle separations by CE and the similarities of particles to Aβ fibrils, in terms of size, a brief
discussion explaining how particles separate by CE will be covered next.
A particle in an electrolyte solution will develop an electric double layer that forms due
to the electrostatic interaction of counterions in the buffer with charges on the particle’s surface.
The thickness of a particle’s double layer, κ-1 is a function of the ionic strength of the solution, I
(κ ~ I1/2) [81]. In CE experiments, when a voltage is applied, a particle’s motion is dependent on
the magnitude of the charge of the particle, the magnitude of the charge of the counterions in the
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double layer (which moves opposite to that of the particle) and the viscous drag of the double
layer [81]. Adding to the complexity of translational motion of a particle in CE is the effect of
double layer distortion, which is called the relaxation effect. The relaxation effect describes how
when a particle is displaced in solution, its double layer lags behind, which has been shown to
decrease particle mobility [81].
Spherical particles of the same size with very narrow size distributions have been shown
to have slightly different electrophoretic mobilities, referred to as electrophoretic heterogeneity
[82]. Electrophoretic heterogeneity could be a result of ζ heterogeneity [81]. As discussed above,
ζ is the potential that arises due to the formation of an electric double layer. Recall that peak
widths of particles passing a detection zone are defined by their electrophoretic mobilities. This
means that electrophoretic heterogeneity can result in various peak widths for particles of the
same size due to differences in the particles’ ζ potentials. Another factor to consider is that nonspherical particles, such as Aβ fibrils, can be oriented in an electric field, which can affect their
electrophoretic mobilities [81].
1.6

Goals of This Research
Amyloid beta (Aβ) proteins have been linked to Alzheimer’s disease (AD). Some of the

challenges studying Aβ are discussed above. To reiterate a few of these challenges, (1)
aggregating mixtures of Aβ are heterogeneous with various Aβ species ranging in size from
monomers to micron-sized aggregates, (2) detection methods that work well for smaller Aβ
species tend to not work well for larger Aβ species and vice versa and (3) most detection
methods are based on bulk measurements that do not provide information regarding individual
Aβ aggregates. The overall goal of this research is to develop analytical methods for studying
and characterizing Aβ species from monomers to fully-formed fibrils.
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Chapter 2. A CE-UV method is developed to analyze Aβ (1-40) peptide samples.
Chapter 2 demonstrates that CE-UV can be used to quantify monomeric Aβ (1-40) and can
separate monomeric and aggregated Aβ (1-40). The CE conditions established in Chapter 2 lay
the foundation for the CE conditions in later chapters were fluorescence detection is used.
Chapter 3. One of the goals in Chapter 3 was to confirm that the additional nonmonomeric peaks observed in the electropherograms from Chapter 2 were due to aggregated Aβ.
Samples of Aβ (1-40) monomers, fibril and seed and Aβ (1-42) monomers and fibrils were
prepared for this study. These samples were carefully prepared at nearly equal monomericequivalent concentrations to minimize difference between the electrophoretic profiles that could
be a result from differences in Aβ concentration. The results of Chapter 3 confirmed that the two
main electrophoretic peaks observed in Chapter 2 were due to monomer and aggregate. Chapter
3 also demonstrates some additional sharp electrophoretic UV peaks in samples that were
prepared to contained fibrils. These peaks were thought to be due to individual Aβ fibrils and
were further investigated in Chapter 4.
Chapter 4. In Chapters 2 and 3, the UV detector on the commercial-based instrument
was not fast enough to detect individual Aβ aggregates. For detecting and characterizing
individual aggregates, a CE instrument with laser-induced fluorescence anisotropy (LIFA)
detection was constructed. The CE-LIFA instrument is shown in Chapter 4 to separate and detect
individual aggregates from Aβ (1-40) and Aβ (1-42) samples. The dye thioflavin T was used in
the separation buffer to fluorescently label the Aβ aggregates online during the separation. The
fluorescence part of the method was validated based on bulk measurements of the same samples
using a microplate reader. The anisotropy of the individual aggregates was calculated in an
attempt to differentiate one individual aggregate from another, but no clear anisotropy
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differences between individual aggregates were observed.
Chapter 5. In Chapter 4, the anisotropy values calculated from the individual Aβ
fluorescence peaks were indistinguishable from the anisotropy calculated from the background
ThT fluorescence. A data treatment method was developed to extract anisotropy peaks from the
anisotropy background. The method is mathematically described using data from experiments in
Chapter 4. The benefits and limitations of the method are discussed in the chapter.
Chapter 6. Thioflavin T is a powerful tool for detecting amyloid aggregates. It is widely
used in the literature and was used in this dissertation for Aβ detection. While ThT is branded as
an amyloid specific dye, preliminary CE-LIF data using ThT in the electrophoresis buffer to
label and detect Aβ aggregates suggested that ThT was binding to non-amyloid species and
producing false-positives. This observation initiated a spectroscopic investigation of ThT in the
presence of non-amyloid particles, polystyrene spheres. Chapter 6 confirms that polystyrene
spheres can enhance ThT spectroscopy similar to that of Aβ. Several concentrations and sizes of
polystyrene spheres are analyzed to demonstrate the enhancement.
Chapter 7. In Chapter 7, we investigated if Aβ monomers, intermediate aggregates and
fibrils could be differentiated based on their fluorescence anisotropy values using a FAMlabelled Aβ instead of ThT as in Chapter 4. By using a covalently labeled fluorescent Aβ
monomer to perform the study, all forms of Aβ could be detected independent of size. Unlike
other Aβ analysis by CE in this dissertation, the Aβ samples were analyzed at different time
points during the aggregation process. The main reason for this was to attempt to detect any
transient intermediate Aβ species. Additionally, Arctic Aβ was mixed with normal Aβ, which
has been shown to stabilize oligomeric/protofibril structures [83].
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CHAPTER 2
ANALYSIS OF MONOMERIC Aβ (1-40) PEPTIDE BY CAPILLARY
ELECTROPHORESIS*
2.1 Introduction
Protein aggregation to form amyloid fibrils is closely linked to many diseases
including Parkinson’s disease, type II diabetes, Huntington’s disease, prion diseases and
Alzheimer’s disease [1,84-86]. Peptides that are seemingly unrelated in terms of size and
sequence aggregate to form structures that are very similar in size and shape – amyloid
fibrils. A major component of senile plaques found in the brains of patients suffering from
Alzheimer’s disease is the β-amyloid (Aβ) peptide, and this peptide is thought to be
responsible for the disease pathology [1,84,86]. The amyloid core of these plaques contains
interwoven fibrils that are composed of 40 and 42 amino acid residue peptides denoted as Aβ
(1-40) and Aβ (1-42), respectively. Figure 2.1 shows a transmission electron microscopy
(TEM) image of Aβ (1-40) fibrils produced in vitro for this work. These fibrils typically are
10 – 12 nm in diameter and can be 102 – 103 nm long.

Figure 2.1. TEM of Aβ (1-40) fibrils. The monomer equivalent concentration of this sample
was 31 µM. Scale bar is 1 µm. Data for this sample are also presented in Figures 2.2b and
2.4b.
*

Reproduced by permission of The Royal Society of Chemistry
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Due to the link between Aβ aggregation and Alzheimer’s disease, the aggregation
mechanism and kinetics of Aβ aggregation are the focus of intense study [86,87]. In vitro
studies of Aβ fibril formation have demonstrated that this process occurs via a complex
multi-step

nucleated

polymerization

mechanism

[4,41,86,88].

Preparing

consistent

monomeric Aβ samples, free from aggregates and at known concentrations, is critical for
kinetic and mechanistic studies of Aβ aggregation, and it is a significant technical challenge.
Complex protocols are used in an attempt to prepare Aβ monomer solutions free of
aggregates that might influence both aggregation kinetics and the aggregation mechanism
[40,42-44]. Studies have shown that sample preparation significantly influences aggregation
kinetics and the aggregate structures formed [40-42,44,89,90].
In this work, we present a capillary electrophoresis (CE) method with UV absorbance
detection for characterizing Aβ preparations and quantifying Aβ monomer. Capillary
electrophoresis has been used to separate and detect Aβ peptides and aggregates, and most of
this work has been qualitative [77,91-93]. Alper et al. showed a calibration curve for Aβ (140) monomer based on CE-UV peak areas in the Supplementary Material of a recent
publication [17]. Our initial goal for this work was to develop an alternative method to HPLC
for quantifying Aβ monomer solutions prior to using them for aggregation studies [17,43,44].
During the development of this method, Aβ peaks in addition to the major monomeric Aβ
peak were observed. We investigated differences in aggregation kinetics relative to the
presence and absence of these additional aggregate peaks in monomer preparations.
2.2 Experimental
2.2.1

Chemicals
Tris (hydroxymethyl) aminomethane hydrochloride (Tris-HCl), sodium phosphate
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monobasic, trifluoroacetic acid (TFA), thioflavin T (ThT) and hexafluoroisopropanol (HFIP)
were purchased from Sigma (St. Louis, MO). Sodium hydroxide was purchased from Fisher
(Pittsburgh, PA). All solutions were prepared in 18 MΩ water obtained from a Modulab water
purification system (United States Filter Corp.; Palm Desert, CA). Chemically synthesized Aβ
(1-40) peptide was purchased from Biosource International, Inc (Camarillo, CA).
2.2.2

Aβ Monomer and Fibril Preparation
Monomer samples were prepared as described previously [43]. Briefly, Aβ peptide

was treated with TFA/HFIP to remove any pre-existing aggregates. The solvent was
evaporated off, and the peptides were dissolved stepwise in equal volumes of 2.0 mM NaOH
and 2× phosphate buffered saline (PBS) at pH 7.4, containing 0.1% sodium azide. The PBS
was prepared with sodium chloride. Alternate to the PBS preparation, a fraction of the
sample was dissolved in 10.00 mM Tris buffer at pH 7.8. Centrifugation (~50,000 g) for a
minimum of 10 hr at 4 °C was carried out to remove any aggregates. The supernatant
monomer concentration was determined using CE as described below, and the quantification
of the peptide monomer was confirmed by amino acid analysis. Fibril samples were prepared
by incubating the Aβ samples in 1× PBS without agitation at 37 °C for approximately 7 days.
Thioflavin T fluorescence was used to monitor fibril growth.
2.2.3

Capillary Electrophoresis
All CE separations were performed using a Beckmann Coulter P/ACETM MDQ CE

system. The instrument was equipped with a photodiode array (PDA) detector. Fused-silica
capillaries (50 µm i.d., 353 µm o.d.; 60 cm total length, 50 cm to detector) were used
(Polymicro Technologies, Phoenix, AZ). A new capillary was pretreated by flushing with 1.0
M NaOH for 30 min followed by rinsing with water for 20 min and the separation buffer
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(10.00 mM Tris buffer, pH 7.8). Between runs, the capillary was flushed with water (20 psi,
2.0 min) and separation buffer (20 psi, 2.0 min). Hydrodynamic injections were used (1.0 psi,
5.0 s), and the applied separation potential was 30.0 kV (500 V/cm) for 6 min. The
instrument was thermostatted at 20.0 °C. Data were acquired using 32 Karat™ Software
Version 5.0 from Beckman Coulter at a scan rate of 4 Hz. Quantification was based on
integrated peak areas corrected for the migration time for each individual CE run as
discussed by Hjerten et al [94].
The electropherograms were plotted as as a function of electrophoretic mobility rather
than migration time due to variablility in migration times between runs. This is commonly
observed in CE separations of peptides and biological samples due to changes in
electroosmotic flow (EOF) caused by adsorption of sample components to the capillary
surface. For the CE experiments presented in this work, the RSD for migration times
(intraday) ranged from 1-5 % although it was below 2% for all but one day. The changes in
EOF can be corrected by using a neutral marker peak to measure the average EOF rate [95].
In these experiments, there was a reproducible neutral system peak in the electropherograms
at about 150 s. This peak was confirmed to be neutral by adding mesityl oxide to the sample,
which co-migrated with this peak. The electrophoretic mobilities, µep, of the peaks were
calculated by subtracting the electroosmotic mobility, µeo, from the apparent mobilities, µapp,
of the peaks (Equation 2.1). Equation 2.2 shows how µeo can be calculated based on
experimental data where Ld is the length of capillary from the inlet to the detection window
(cm), Lt is the total length of the capillary (cm), V is the applied voltage (V) across the
capillary, tm is the migration time of the analyte peak (s) and teo is the migration time of the
neutral marker peak (s).
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Thioflavin T Fluorescence
The aggregation progress, or fibril formation, of Aβ samples was monitored using

ThT fluorescence. The change in fluorescence is linear with an increase in protein
concentration of the amyloid fibrils [57]. Samples were incubated at 37 °C in PBS, and
representative aliquots were taken daily to measure the ThT fluorescence. Each aliquot was
transferred to a well of a 96-well plate, containing 200 µL PBS and 2 µL of 1.5 mM ThT
([ThT]final = 15 µM). The sample volumes were adjusted to give a final peptide mass of 1.00
– 1.25 µg per well. Fluorescence excitation was at 450 nm, and the emission was measured at
482 nm using a BMG Lab Technologies FLUOstar 430 microplate reader (Offenburg,
Germany).
2.2.5

Amino Acid Analysis
A Dionex Direct Amino Acid Analysis System (Sunnyvale, CA) was used to perform

the amino acid analysis (AAA) with an internal standard correction to determine the Aβ
monomeric concentration of each sample. The technique involved hydrolyzing the peptide,
separating the amino acids on an anion-exchange column by a stepwise salt and pH gradient,
detecting the amino acids by integrated pulsed amperometric detection and calculating the
amino acids’ peak areas, which allow the determination of each amino acid’s concentration
and the original peptide concentration. The concentration of each Aβ sample determined by
AAA was used as the starting concentration of the stock solution to quantify the Aβ
monomer by CE-UV.
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2.2.6 Transmission Electron Microscopy
Transmission electron microscopy images of the aggregated Aβ samples were
obtained with a JEOL 100CX (Tokyo, Japan). TEM analyses are routinely performed by
spotting the sample on a carbon coated mesh grid, allowing the sample to rest for several
minutes, wicking the excess solvent from the grid, applying 2% uranyl acetate to the grid,
wicking off excess solvent and imaging.
2.3
2.3.1

Results and Discussion
Separations of Aβ Monomer Samples
The initial goal of this research was to develop a method based on capillary

electrophoresis with UV absorbance detection for quantifying Aβ peptide in preparations of
monomeric peptide for studies of Aβ fibril formation. This analysis is commonly carried out
by HPLC [17,43,44,89]. Determining the initial concentration of Aβ peptide in a preparation
at the start of an experiment is critical in order to obtain reproducible kinetic data or even
reproducible aggregate structures [40-42,44,90]. Some loss of peptide during preparation to
remove aggregates before the start of an experiment is inevitable and will vary substantially
between different experiments or different experimentalists. While satisfactory quantification
of Aβ peptide can be obtained by HPLC, CE offers several potential advantages. Very rapid
separations consuming only a few nL of sample per injection are possible with CE.
Laboratory-constructed CE instruments with UV detectors are common, inexpensive and
simple to operate, and more sophisticated commercial instruments with autosamplers are
available.
Figure 2.2 presents a typical electropherogram of monomeric Aβ peptide with UV
absorbance detection at 200 nm. The monomer peak, M, has an electrophoretic mobility of 32

1.20 × 10-4 cm2V-1s-1 (migration time of 183 s) in this separation. Just after the main
monomer peak there are two small peaks that are consistently present in sequential
separations of the same sample and for different Aβ monomer preparations. It is suspected
that these peaks are produced by impurities from Aβ synthesis [42,96]. If these peaks were
due to Aβ aggregates or impurities from sample preparation, more variability in magnitude
would be expected between different preparations.

Figure 2.2. Electropherograms of (a) Aβ monomer, M, and (b) Aβ monomer, M, with aggregate,
A. The injections were 5.0 s long at 1.0 psi, and the separation potential was 30.0 kV (500 V/cm).
The Aβ peptide monomeric-equivalent concentrations for (a) and (b) were determined by AAA
to be 26 and 31 µM, respectively. The Aβ preparation used in (b) is the same as that used in
Figure 2.1. The same electropherograms plotted vs time are presented in Appendix A Figure A.1.
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2.3.2 Quantification of Aβ
β Monomer
Peptide samples are difficult to prepare at accurate concentrations due to the difficulty
of removing water, salts and other impurities from the peptides so that standard solutions can
be generated. Quantitative sample preparation is particularly challenging for Aβ peptide due
to the extensive procedures used to prepare a monomer solution initially free of aggregates.
Amino acid analysis was used to quantify the Aβ monomeric peptide in each stock solution
prepared for this work as described in the Experimental section. Analysis with this technique
provides the absolute concentration of the peptide as prepared in the sample solution without
using a standard of the same peptide at known concetration. After the monomeric equivalent
concentrations were determined by AAA, CE-UV was performed on the same stock
solutions. The Aβ stock solutions were then serially diluted to generate calibration plots
using CE peak areas.
Two plots of peak areas measured by CE with UV absorbance detection vs. Aβ
monomer concentration (based on AAA analysis and serial dilution) are shown in Figure 2.3.
A linear response is obtained for the range of concentrations studied. Table 2.1 presents
linear regression data for calibration curves measured using four different preparations of Aβ
monomer (including the two shown in Figure 2.3). The lowest concentration of Aβ monomer
injected was 5 µM, resulting in a peak with a S/N of 28. For Aβ monomer, the estimated
detection limit (S/N = 3) is 0.5 µM, and the estimated limit of quantitation (S/N = 10) is 1.8
µM. The calculated sample injection volume is 8.8 nL, and the mass LOD and LOQ are 19.1
pg and 68.6 pg, respectively. The LOD for a method used to quantify Aβ in our laboratory
based on HPLC with UV absorbance detection is 0.2 µM (5 ng) (unpublished results). It is
not unexpected that the plots for the 4 samples are not perfectly superimposable. One source
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of error is AAA since each of the fours Aβ monomer samples were prepared seperately, and
their concentrations were determined by AAA separately [97]. Another source of error is CE,
since different capillaries were used for analysis of different preparations. Any difference in
capillary inner diameter (nominally 50 µm) will lead to a different pathlength for absorbance
detection.

Figure 2.3. Calibration curves for two Aβ monomer preparations. The starting concentration
of Aβ monomer for each preparation was determined by AAA to be 35 µM (open circles/plot
(A)) and 26 µM (closed circles/plot (B)). Serial dilutions were performed to generate the
standards at lower concentrations. All samples were run in triplicate and the error bars are
presented in the figure. Linear regression data for these plots are presented in Table 2.1. The
Aβ preparation used to generate plot (B) is the same as that used in Figure 2.2a.
Table 2.1. Concentrations of Aβ monomer and linear regression values from peak areas
measured for serial dilutions of 4 Aβ preparations.
Linear Regression

Sample ID

Starting Monomer
Concentration by
AAA (µM)

Slope
(mAU min µM-1)

Y-intercept
(mAU min)

R2

(A)a

35

0.476

0.69

0.97

(B)b

26

0.386

-0.47

1.00

(C)

18

0.302

0.69

0.93

(D)

11

0.271

-0.48

0.89

a,b

Data shown in Figure 2.3 (A) and (B)
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2.3.3

Aggregate Peaks and Fibril Formation
Figure 2.2b shows an electropherogram that contains an additional peak with an

electrophoretic mobility of -2.43 × 10-4 cm2V-1s-1 (migration time = 247 s). This peak was
present in the electropherograms for some, but not all of the Aβ monomer samples prepared
for this study. One hypothesis is that this peak is due to an aggregated form of Aβ present in
those preparations. Unpublished studies in our laboratory showed that Aβ samples containing
fibrils or protofibrils result in electropherograms with additional peaks at more negative
electrophoretic mobilities compared to monomer peaks. Other studies in the literature also
indicate that Aβ aggregates migrate with more negative electrophoretic mobilities (relative to
monomer peaks) although those published studies were carried out in different buffers at
different pH’s [91].
Aggregation studies were carried out using both Aβ monomer samples that contained
the putative aggregate peak and samples for which this peak was absent. Fibril formation for
these two different types of monomer samples was monitored using Thioflavin T (ThT)
fluroescence with excitation at 450 nm and detection of emission at 482 nm. Thioflavin T
fluorescence

is

routinely

used

to

follow

the

progression

of

Aβ

aggregation

[4,41,57,63,89,90]. Thioflavin T fluorescence increases in intensity and shifts spectrally
when it selectively binds to amyloid fibrils [4,57,63].
Figure 2.4 presents representative plots of ThT fluorescence from these aggregation
studies. The plot in Figure 2.4a is typical for Aβ aggregation from monomer to form fibrils.
The fluorescence is relatively low and constant through about Day 5, and then it increases
rapidly to a higher values at Day 6 and 7. This lag phase followed by rapid aggregation is
typical of Aβ aggregation [41,44,86,89]. The lag phase is reduced for peptides that aggregate
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more rapidly to form amyloid fibrils [41,89].
Figure 2.4b shows a representative plot of ThT fluorescence for aggregation studies
using a sample with the additional peak present in the CE separation at -2.43 × 10-4 cm2V-1s1

. The ThT fluorescence is relatively high at the initial measurement and remains relatively

constant throughout the aggregation study. This indicates that the fibril formation was
extremely rapid, and a lag phase was not apparent.
We hypothesize that the presence of aggregates as indicated by the peak with an
electrophoretic mobility of -2.43 × 10-4 cm2V-1s-1 is the cause of the abnormally rapid
aggregation kinetics shown in Figure 2.4b (no lag phase). We studied the aggregation by ThT
fluorescence of six Aβ preparations. Of the six preparations, four contained preexisting
aggregates, and the ThT data indicated no lag phase or sustained ThT fluorescence increase
over 6-7 days. The other two preparations did not contain aggregates, and they demonstrated
typical lag phases and subsequent increases in ThT fluorescence over time as expected.
These results are consistent with the hypothesis that monomer preparations that contain
preexisting aggregates eliminate the lag phase indicated by ThT fluorescence, and CE with
UV absorbance detection is capable of detecting these aggregates in monomer preparations.
We do not believe that the presence of these putative aggregate peaks indicates a
limitation of the sample preparation method used in this work [43]. This basic CE method
has been used previously in our laboratory to analyze Aβ monomer samples prepared by
scientists with more experience using this preparation technique, and the aggregate peaks
were never observed (unpublished data). The scientist who prepared Aβ monomer samples
for this publication was eventually able to routinely prepare monomer samples without the
aggregate peak. It is not known what improvements in technique led to the elimination of the
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aggregate peaks in CE, but based on our experience this method can be used to routinely
prepare aggregate free monomer preparations.

Figure 2.4. Plots of ThT fluorescence of (a) Aβ monomer (26 µM) and (b) Aβ monomer with
aggregate (31 µM) vs. time. [ThT] = 15 µM. The Aβ preparation used for (a) is the same as that
used for Figure 2.2a (no peak at -2.43 × 10-4 cm2V-1s-1 . The Aβ preparation used for (b) is the
same as that used for Figures 2.1 and 2.2b (has a peak at -2.43 × 10-4 cm2V-1s-1).
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2.4

Conclusions
These results demonstrate that CE with UV absorbance detection is an effective

technique for characterizing and quantifying Aβ peptide monomer preparations for studies of
amyloid fibril formation. Compared to HPLC methods, CE offers rapid analysis times and
reduced sample consumption. Importantly, this study shows that aggregate peaks in CE analysis
of Aβ monomer preparations can be used to indicate whether a preparation will exhibit normal or
accelerated aggregation kinetics.
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CHAPTER 3
ANALYSIS OF Aβ (1-40) AND Aβ (1-42) MONOMER AND FIBRILS BY CAPILLARY
ELECTROPHORESIS†
3.1

Introduction
Amyloid beta (Aβ) peptides have been identified as the primary peptide component of the

neuritic plaques of Alzheimer’s disease (AD) patients [13,15,21]. This has led to the hypothesis
that Aβ peptide aggregates are the cause of the development and progression of AD.
Biologically, monomeric Aβ is formed through the enzymatic cleavage of the transmembrane
amyloid precursor protein (APP) [98]. Different length Aβ peptide monomers can be formed
from APP through additional enzyme processing [98]. The characteristic plaques of AD patients
are composed of both Aβ (1-40) and Aβ (1-42), but Aβ (1-42) is the dominant species [70].
Under physiological conditions, soluble Aβ monomers that have been released into the
extracellular fluid can self-assemble to form Aβ aggregates, reaching 10 – 12 nm in diameter and
102 – 103 µm in length for mature Aβ fibrils. The toxicity of Aβ is thought to be related to
aggregate size and structure, and the most toxic species may be an intermediate species between
monomer and fibrils [15,36,53,99].
Both Aβ (1-40) and Aβ (1-42) peptides have been the focus of intense research because
of their relevance to AD and their potential as therapeutic targets for AD treatment. The
characterization of Aβ aggregation is complex and challenging, even when synthetic peptides of
only one length (e.g. Aβ (1-40) or Aβ (1-42)) are studied. Preparations of aggregated, synthetic
Aβ peptides result in heterogeneous mixtures containing numerous aggregated structures and
unaggregated monomer. In order to understand the aggregation process and determine which Aβ
aggregate species are toxic, it is necessary to characterize and quantify the different aggregate
†

Reproduced by permission of Journal of Chromatography B
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species present in a sample. Few analytical techniques are capable of analyzing Aβ monomer and
aggregates with a single experiment. Thioflavin T (ThT) fluorescence, transmission electron
microscopy (TEM) and light scattering, for example, are powerful tools for analyzing large Aβ
aggregates but are not well suited for studying small oligomeric structures and monomer [44].
Separation techniques such as HPLC, size-exclusion chromatography and gel electrophoresis
have been applied to Aβ analysis [44,70]; however, these methods are able to separate Aβ
structures only over a limited size range. Their stationary phases have the potential to disrupt
aggregates during the separation [100]. An ideal separation method for Aβ analysis would
provide rapid and gentle separations of structures ranging in size from monomeric Aβ to mature
Aβ fibrils.
Capillary electrophoresis (CE) has been used to analyze species ranging in size from
small cations like Na+ and K+ to whole cells [101-103]. Capillary electrophoresis with UV
absorbance detection (CE-UV) is emerging as a valuable tool for studying Aβ peptides
[17,30,45,77,91,93]. In 1993, Sweeney et al. first applied CE-UV to analyze Aβ peptides [77].
Over a decade later, Verpillot et al. produced similar CE-UV results and additionally analyzed
Aβ (1-40) peptide from cerebrospinal fluid of an AD patient [93]. De Lorenzi and coworkers
analyzed Aβ (1-40) and Aβ (1-42) peptides by CE-UV after performing ultracentrifugation using
different molecular weight cut-off filters to determine the sizes of aggregates producing peaks
attributed to Aβ aggregates [91]. The antifibrillogenic effectiveness of small molecules on Aβ (142) peptides by CE-UV was also studied using a similar approach [30]. Picou et al. recently
reported a CE-UV method to characterize and quantify Aβ (1-40) monomer samples and predict
whether an Aβ preparation will exhibit normal or accelerated aggregation kinetics [45]. While
previous papers have shown that CE-UV has the potential to serve as a powerful tool for
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studying Aβ aggregation, such studies are challenging. Small changes in sample preparation can
result in large variations in aggregation kinetics and aggregate structures [45,70,90]. In this
paper, stringent preparation procedures were used to prepare high quality Aβ monomer and
aggregated samples at low concentrations (≤ 25 µM). The Aβ concentrations were determined
independently by HPLC with UV absorbance detection (calibration based on amino acid analysis
(AAA)), and the aggregated samples were characterized by TEM. This study assesses the
potential of CE-UV to distinguish the aggregate types present in different Aβ samples.
3.2

Experimental

3.2.1

Chemicals
All solutions were prepared in 18 MΩ water obtained from a Modulab water purification

system

(United

States

Filter

Corp.;

Palm

Desert,

CA)

unless

otherwise

noted.

Tris(hydroxymethyl)aminomethane (Tris) and methanol (99.8%) were purchased from Fisher
Scientific (Fair Lawn, NJ). Tris buffer was prepared at 10.00 mM, and the pH was adjusted to
7.79 with 1.0 M HCl and filtered through a 0.2 µm filter (Whatman; Hillsboro, OR). This Tris
buffer was used for all experiments as the electrophoresis buffer unless otherwise noted. Mesityl
oxide (MO) was purchased from Alfa Aesar (Ward Hill, MA), and solutions of MO were
prepared in Tris buffer at a concentration of 0.2 % (v/v) MO. Formic acid was obtained from
Acros Organics; (Geel, Belgium). α-Cyano-4-hydroxycinnamic acid (CHCA) was prepared in
acetonitrile/H2O (50:50, v/v) containing 1.0 % trifluoroacetic acid (TFA) with a final
concentration of 10 mg/mL.
3.2.2

Aβ Peptide Sample Preparation
Aβ (1-40) was purchased from the W.M Keck Foundation Biotechnology Research

Laboratory (Yale University; New Haven CT), and Aβ (1-42) peptides were purchased from
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rPeptide (Bogart, GA). The Aβ (1-42) sequence is shown below, and the Aβ (1-40) sequence is
identical except the two amino acids at the C terminus, isoleucine (I) and alanine (A), are not
present.
Aβ (1-42)
1

5

10

15

20

D A E FR H DSG Y E V H H Q K L V F F A
25

30

35

40

E DVGSN KG A IIG LM VG G V V IA

Five sample types were prepared for this work: Aβ (1-40) monomer, Aβ (1-40) mature
fibrils, Aβ (1-40) seed prepared by ultrasonicating mature fibrils, Aβ (1-42) monomer and Aβ (142) mature fibrils. The samples were prepared as described previously by O’Nuallian et al. and
Picou et al. [44,45]. Briefly, Aβ peptides were treated with TFA/hexafluoroisopropanol (HFIP)
to remove any preexisting aggregates. For Aβ monomer samples, the solvent was evaporated off,
and the peptides were dissolved in 10.00 mM Tris at pH 7.79. For Aβ (1-40) aggregate samples,
the TFA/HFIP was evaporated off, and the peptides were dissolved stepwise in equal volumes of
2.0 mM NaOH and 2× phosphate buffered saline (PBS) containing 22.8 mM phosphate, 274 mM
NaCl, 5.4 mM KCl and 0.1% NaN3 at pH 7.4. The samples were centrifuged at 50,000 g for a
minimum of 10 hr at 4 °C. The supernatant was incubated at 37 °C for 7 d. Fibril formation was
monitored using HPLC-UV and ThT fluorescence as described previously [44]. The seed sample
was prepared by ultrasonicating a mature fibril sample for 30 s with a Branson Digital Sonifier
Microtip (Model 450) and then placed on ice for 1 min. The ultrasonication process was repeated
5×. Prior to CE analysis, the fibril and seed samples were buffer exchanged from PBS to
electrophoresis buffer, 10.00 mM Tris at pH 7.79 as described previously [59].
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The Aβ (1-42) monomer and fibril samples were prepared using the same procedure with
the following exceptions: (1) the Aβ (1-42) monomer sample was centrifuged for 30 min at
20,000 g and 4 °C instead of 10 hr at 50,000 g and 4 °C, and (2) the Aβ (1-42) fibril sample was
incubated for 2 days to form mature fibrils. These method changes were due to the faster
aggregation kinetics for Aβ (1-42) peptide compared to Aβ (1-40) peptide.
3.2.3

Characterization and Quantification of Aβ Samples
The Aβ concentration for each sample was determined with a Shimadzu HPLC-UV

instrument with detection at 215 nm. The concentration of Aβ standards for calibration was
determined independently by AAA, as described previously [10]. For aggregate-free samples, the
monomer concentration was determined using peak areas and the standard curve for Aβ. For
aggregate-containing samples, the Aβ monomer-equivalent concentration was determined by (1)
disassembling the aggregates to form monomers by treatment with 70% formic acid and (2)
determining the resulting monomer concentration by HPLC-UV. The monomer-equivalent
concentrations of the samples used in this work are reported in Table 3.1. Mature fibrils and seed
were characterized by TEM and ThT fluorescence assays [4].

Table 3.1. Monomeric-equivalent concentrations determined by HPLC-UV
Monomeric Equivalent
Peptide Type

Sample ID

Concentrations by HPLC-UV
(µM)

(1-40)

(1-42)

Monomer

20

Fibril

25

Seed

20

Monomer

22

Fibril

22
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3.2.4

Aβ Analysis by MALDI-MS
Mass spectrometry experiments were performed on an Applied Biosystems Voyager DE-

PROTM MALDI-TOF MS, equipped with a 20 Hz repetition rate nitrogen laser (337 nm). The
instrument was controlled by Voyager Version 5.0 Software with Data ExplorerTM and was
operated in linear mode. The CHCA matrix was prepared as described in Section 3.2.1. The CE
separation buffer for these experiments was 10 mM Tris-HCl at pH 8.0, and a Beckman Coulter
CE-MDQ was used for CE experiments. Fractions were collected from 30 consecutive CE
separations and combined with an equal volume of matrix. This sample was spotted on a 100
well stainless steel MALDI sample plate for MS analysis. The laser power was adjusted for each
sample spot with 200 shots acquired per spectrum.
3.2.5

Aβ Analysis by CE-UV
Capillary electrophoresis with UV absorbance detection was performed with a Beckman

Coulter P/ACE MDQ CE system equipped with a diode array detector (DAD) (Brea, CA) [45].
All electropherograms were plotted at 190 nm. The instrument and data collection were
controlled with Beckman Coulter 32 KaratTM Software Version 5.0. Fused-silica capillaries were
purchased from Polymicro Technologies (Phoenix, AZ). The capillary (ID = 50 µm, OD = 366
µm) was cut to 63.0 cm total length with a window created 53.0 cm from the inlet end using a
window maker (MicroSolv Technology Corp.; Eatontown, NJ). The capillary was conditioned by
flushing with 1.0 M NaOH (20.0 psi for 1.0 h), 18 MΩ water (20.0 psi for 1.0 h) and Tris buffer
(20.0 psi for 30 min).
All samples were dissolved or buffer exchanged (see Section 3.2.2.) into electrophoresis
buffer prior to CE in order to eliminate conductivity and composition differences between the
sample buffer and electrophoresis buffer. The Tris electrophoresis buffer has a low ionic strength
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compared to PBS, and the high conductivity of PBS results in a high electrophoretic current and
poor results due to excessive Joule heating. Samples (50 µL) were placed in 200 µL thermowell
polypropylene vials (Corning Incorporated; Corning, NY). Prior to each run, the sample was
removed from the MDQ and vortexed briefly to resuspend any aggregates that settled to the
bottom of the sample vial. For each run, MO was injected for 2.0 s at 0.3 psi prior to the Aβ
sample injection. The Aβ sample was then injected for 5.0 s at 0.5 psi. The calculated Aβ
injection volume was 4.2 nL. Because MO migrated faster than all forms of Aβ, injection of MO
first minimized potential on-column interaction between MO and Aβ. The capillary was
thermostatted at 20 °C. The applied separation voltage was 25.0 kV (397 V/cm), and the current
was 5.0 µA. The detection scan rate was 32 Hz (maximum allowed), and the run time was 10
min.
All electropherograms were plotted as a function of electrophoretic mobility, µep, instead
of migration time to correct for any electroosmotic flow (EOF) variations, which is a common
problem for CE [45,95].
3.3 Results and Discussion
The goal of the studies presented here was to determine if CE-UV could be used to
separate and characterize monomeric and aggregated samples of Aβ (1-40) and Aβ (1-42)
peptides for carefully prepared and well-characterized samples. In this study, samples of Aβ (140) monomer, mature fibrils and seed (ultrasonicated fibrils) and Aβ (1-42) monomer and fibrils
were analyzed using CE-UV. The equivalent monomer concentrations of all samples, as
measured by HPLC-UV, were kept at low concentrations between 20 and 25 µM Aβ, to
minimize structural differences resulting from Aβ concentration differences [104]. Each sample
was quantified independently by HPLC-UV and characterized by TEM. Mass spectrometry was
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used to confirm that selected peaks in the electropherograms were due to Aβ peptide.
3.3.1

Aβ (1-40) Monomer, Fibril and Seed Analysis by CE-UV
A representative electropherogram with UV absorbance detection (plotted at 190 nm) of

an Aβ (1-40) monomer sample is presented in Figure 3.1a. Monomeric Aβ (1-40) was dissolved
directly in electrophoresis buffer (10.00 mM Tris at pH 7.79) and analyzed by CE-UV. The CE
conditions are summarized in Table 3.2. All electropherograms are plotted as absorbance vs.
electrophoretic mobility, where the neutral marker (NM) has µep = 0 cm2/Vs. The principal peak
at a mobility of -1.082 × 10-4 cm2/Vs in Figure 3.1a is Aβ (1-40) monomer (M). The
electrophoretic mobility of the main monomer peak is consistent with that from our previous
studies (-1.2 × 10-4 cm2/Vs) [45]. Figure 3.1a does not indicate the presence of aggregates, which
is expected for unaggregated samples. Furthermore, the electrophoretic peak pattern of the Aβ
(1-40) monomer sample is similar to that observed by Sabella et al. for Aβ (1-40) at a higher Aβ
concentration (100 µM) dissolved in 20 mM phosphate at pH 7.4 and electrophoretically
separated using 80 mM phosphate buffer at pH 7.4 [91]. The small peaks near the principal
monomer peak are thought to be minor impurities from the peptide synthesis [45]; however,
other researchers have hypothesized that peaks with similar mobilities could be due to different
oligomerization states of Aβ monomers ranging from 3000 to 50000 Da [91]. Attempts to
identify these minor peaks by dilution-based experiments provided inconclusive results (data not
shown).
In related experiments, Aβ (1-40) monomer was analyzed by MALDI-TOF MS to
confirm the identity of the main monomer peak based on its measured molecular mass. Figure
3.2 shows a mass spectrum for the Aβ (1-40) monomer peak. Fractions at the migration time of
the monomer peak were collected from 30 CE runs (see Figure 3.2 inset) and spotted on a
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MALDI target for MS analysis. The main MS peak corresponds to the molecular ion, [M+H]+, of
the Aβ (1-40) monomer (m/z of 4330.5 Da), and this supports the identification of the main peak
in Figure 3.1a as Aβ (1-40) monomer. The weak MALDI MS signal is not surprising since the
sample volume injected for each CE run was only a few nanoliters.
An electropherogram of the Aβ (1-40) fibril sample is presented in Figure 3.1b. This
sample was prepared to contain mature fibrils by allowing an aliquot of Aβ (1-40) monomer to
aggregate for 7 days. Incubation for 7 – 10 d is common to produce mature fibrils [44,45,105].
Figure 3.1b shows two main peaks at -1.071 × 10-4 cm2/Vs and -2.39 × 10-4 cm2/Vs in addition to
the neutral marker peak. The peak at -1.071 × 10-4 cm2/Vs is identified as monomer based on its
electrophoretic mobility. Detecting a small monomer peak is not surprising since 0.7 – 1.0 µM
residual monomer remains unaggregated at equilibrium with fibrils [10]. While the monomer
equivalent concentrations of the Aβ (1-40) monomer and fibril samples are similar (20 and 25
µM, respectively, Table 3.1), the monomer peak area in Figure 3.1b is reduced relative to that in
Figure 3.1a, 2.2 mAU·s and 15.2 mAU·s, respectively. This is expected because Aβ monomer is
aggregating to form fibrils, which migrate at different times relative to monomer. The monomer
concentration in the Aβ (1-40) fibril sample is estimated to be 3.5 µM based on its peak area (2.2
mAU·s). This is four to five-fold greater than the residual monomer concentration reported by
O’Nuallian, et al. by HPLC [10].
Table 3.2. Summary of Capillary Electrophoresis Conditions
Capillary Dimensions (LT, LD, i.d.)
Separation Buffer (concentration, pH)
Aβ Injections (tinj, pressure)
Applied Electric Field
Electrophoretic Current
Electroosmotic Flow Velocity (n = 5)*
Thermostated Capillary Temperature

63.0 cm, 53 cm, 50 µm
10.00 mM, 7.79
5 s, 0.5 psi
397 V/cm
5.0 µA
0.25 ± 0.01 cm/s
20 °C

*The EOF is averaged from the 5 electropherograms shown in Figures 3.1 and 3.3.
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Figure 3.1. Electropherograms of Aβ (1-40) samples. Absorbance plotted at 190 nm. (a) Aβ (140) monomer, (b) Aβ (1-40) fibril and (c) Aβ (1-40) seed. The neutral marker, NM, has an
electrophoretic mobility of 0 cm2/Vs. A monomer peak, M, was detected in all Aβ (1-40)
samples at µep = -1.077 (± 0.006) × 10-4 cm2/Vs (n = 9). An aggregate peak, A, was detected in
the fibril and seed samples at µep = -2.37 (± 0.02) × 10-4 cm2/Vs (n = 6). The TEM insets confirm
the presence of aggregates observed in the electropherograms (scale bar = 1 µm).
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Figure 3.2. MALDI-TOF mass spectrum of collected CE fractions of Aβ (1-40) monomer, M.
The Aβ was mixed 1:1 (v/v) with α-cyano-4-cinnamic acid matrix prior to MS. MS data were
collected in linear mode. Inset: CE-UV (λ = 200 nm) electropherogram of Aβ (1-40) monomer
sample in 10.0 mM Tris-HCl at pH 8.00. The main electrophoretic peak at µep = -1.2 × 10-4
cm2/Vs is monomer, M. Fractions were pooled from 30 consecutive CE runs to obtain the mass
spectrum.
The broad peak (FWHM = 18.70 s) at -2.39 × 10-4 cm2/Vs in Figure 3.1b is attributed to
Aβ (1-40) aggregates (A). In previous work, we analyzed several Aβ (1-40) monomer
preparations by CE-UV absorbance [45]. In that work, some preparations produced only a
monomer peak in the CE-UV electropherogram; however, other samples contained an additional
broad peak at -2.4 × 10-4 cm2/Vs. These samples also exhibited accelerated aggregation kinetics
based on ThT fluorescence studies, suggesting that the additional peak was due to Aβ (1-40)
aggregates [45]. Analyses of the Aβ (1-40) aggregate peak by CE-UV and MALDI-TOF MS
confirmed that the electrophoretic peak at µep = -2.4 × 10-4 cm2/Vs in mature fibril preparations
produced a MS peak at m/z of 4330 Da (data not shown), similar to that shown in Figure 3.2.
This confirms that the CE peak at -2.4 × 10-4 cm2/Vs contained Aβ (1-40) peptide. The presence
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of full-length, mature fibrils in the sample studied in Figure 3.1b was verified by TEM (Inset,
Figure 3.1b).
An interesting observation in Figure 3.1b is the detection of several sharp peaks (FWHM
~0.25 s) with electrophoretic mobilities between those of the monomer and aggregate peaks.
These peaks were consistently observed for injections of the Aβ (1-40) fibril sample, but they
were not observed for injections of the Aβ (1-40) monomer sample (Figure 3.1a). The exact
electrophoretic mobilities of these peaks and the number of peaks were quite variable for
consecutive injections of the Aβ (1-40) fibril sample compared to the mobility and appearance of
the monomer peak and peak A. We hypothesize that these peaks are due to individually detected,
large Aβ aggregates. They are similar in appearance to the sharp peaks detected in previous
reports for Aβ (1-43) and Aβ (1-42) analyses by CE-UV [30,77,91]. If these sharp peaks are due
to individually detected aggregates, then the peak widths will be defined by the migration rate of
the aggregate through the detection zone [82]. The optical aperture used in the capillary cartridge
defines the detection zone for this work, which is 0.08 cm. The calculated migration rate of the
sharp peak in Figure 3.1b at -1.7 × 10-4 cm2/Vs is 0.179 cm/s, which was determined by dividing
the length of the capillary to the detection window (53.0 cm) by the peak’s migration time
(295.50 s). The predicted peak width, calculated by dividing the detection zone length by the
migration rate of the peak, is 0.5 s. This value is consistent with the measured baseline peak
width of 0.45 s. To put this into context, the FWHM and baseline width for the monomer peak in
Figure 3.1b are 2.25 s and 3.81 s, respectively. For the work in this paper, the instrument’s
maximum data sampling scan rate was 32 Hz, which means that the 0.45 s peak was represented
by about 14 points. Therefore, a scan rate much less than 32 Hz would be insufficient to
accurately represent peaks from individual aggregates migrating at the rate described above,
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based on a minimum of 10 points to define a peak [82,106].
The results in Figure 3.1a and 3.1b clearly show that the electrophoretic mobility of Aβ
peptide changes as it aggregates from monomer to mature fibrils. Both the broad aggregate peak
and the sharp peaks have more negative electrophoretic mobilities (i.e. slower migration times)
relative to that of the monomer peak. Ideally, the relative sizes of aggregates could be
determined by their relative electrophoretic mobilities. Based on the relative migration of the
monomer peak and peak A, one might expect that Aβ monomer would be detected first (smaller
negative electrophoretic mobility), followed by the broad aggregate peak labeled A (intermediate
negative electrophoretic mobility) and finally the sharp peaks due to mature fibrils (largest
negative electrophoretic mobility). However, the sharp peaks migrate between monomer and
peak A. For molecules, it is known that electrophoretic mobility is proportional to the ratio of an
analyte’s charge, z, to hydrodynamic radius, Rh, but it is not known how the ratio z/Rh scales as
Aβ aggregates. Additionally, the electrophoretic mobilities of larger Aβ aggregates will depend
on more than just their size. Aggregate shape, counter ion double layer and surface zeta potential
have been shown to be important for electrophoresis of polystyrene spheres of dimensions
similar to mature Aβ fibrils [107]. Because standards for Aβ aggregates do not exist, interpreting
separations of Aβ aggregates based on CE and other techniques (e.g. size-exclusion
chromatography and field flow fractionation) is quite challenging [42,75].
Seeds are aggregated amyloid peptides that can be added to an unaggregated peptide
solution, e.g. a solution of Aβ monomer, to accelerate aggregation to form amyloid fibrils [108].
Seeds reduce the lag phase of Aβ aggregation in a concentration-dependent manner [10,89,108].
An Aβ seed sample was prepared by ultrasonicating mature fibrils as described in the Section
3.2.2. Ultrasonication breaks apart mature fibrils into smaller pieces. The TEM inset of Figure
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3.1c confirms the presence of aggregates after ultrasonication. The Aβ (1-40) seed sample was
analyzed by CE-UV, and the electropherogram is shown in Figure 3.1c. The electrophoretic
profile of the Aβ (1-40) seed closely resembles that of Aβ (1-40) fibril (Figure 3.1b) with two
peaks at -1.072 × 10-4 cm2/Vs and -2.34 × 10-4 cm2/Vs for monomer and aggregates,
respectively. The monomer and aggregate peak areas from the Aβ fibril and seed samples are
similar, which is consistent with the samples having similar equivalent monomer concentrations
of 25 µM and 20 µM, respectively. For the Aβ (1-40) fibril sample (Figure 3.1b), the average
monomer and peak A areas are 2.3 ± 0.1 mAU·s (n = 3) and 20.6 ± 0.5 mAU·s (n = 3),
respectively. The sum of the sharp peak areas in Figure 3.1b is 0.6 mAU·s for six peaks. For the
Aβ (1-40) seed sample (Figure 3.1c), the average monomer and peak A areas are 1.7 ± 0.1
mAU·s (n = 3) and 18.9 ± 0.7 mAU·s (n = 3), respectively.
Although the electropherograms for Aβ (1-40) fibril and seed are quite similar in most
respects, it is interesting to note that the seed sample produced fewer sharp peaks between the
mobilities of the monomer and aggregate peaks relative to fibril samples. We hypothesized that
the sharp peaks observed in the electropherogram for the Aβ (1-40) fibril sample are due to
individually detected mature fibrils. If ultrasonication broke up the mature Aβ fibrils producing
the sharp peaks, fewer sharp peaks would be observed.
3.3.2

Aβ (1-42) Peptide Analysis by CE-UV Absorbance
Figure 3.3 presents electropherograms for Aβ (1-42) samples. Like Aβ (1-40), Aβ (1-42)

is present in neuritic plaques associated with AD, but it is thought to be more neurotoxic
compared to Aβ (1-40). It is well known that Aβ (1-42) peptide aggregates much faster than Aβ
(1-40) peptide. The Aβ (1-42) monomer sample (Figure 3.3a) was prepared as described in the
experimental section. The sample was analyzed by CE-UV within 6 hr of its initial preparation,
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and during that time, the sample was on ice or refrigerated at 4 °C to minimize aggregation
before analysis. A large Aβ (1-42) monomer peak at -1.072 × 10-4 cm2/Vs and a small aggregate
peak at -2.29 × 10-4 cm2/Vs were observed in the electropherogram (Figure 3.3a). The TEM in
Figure 3.3a (inset) confirmed that aggregates were present in the Aβ (1-42) monomer sample
despite careful sample preparation and low peptide concentration (22 µM).
Other reports of Aβ (1-42) monomer analysis using CE-UV have shown the presence of
aggregate peaks but not a monomer peak in contrast to the data shown in Figure 3.3a [30,91].
Several factors may explain these differences: sample concentration, peptide source, sample
preparation and handling and buffers. De Lorenzi and coworkers used 100 µM Aβ (1-42), about
5 times the concentration used in this work. Their sample was prepared in 20 mM phosphate
buffer at pH 7.4, and 80 mM phosphate buffer at pH 7.4 was used as the electrophoresis buffer.
In the work presented here, the sample and electrophoresis buffers were 10.00 mM tris at pH
7.79. Consistent with the electropherogram for Aβ (1-42) monomer in Figure 3.3a, De Lorenzi
and coworkers did report a broad peak at a more negative electrophoretic mobility (longer
migration time) compared to the peaks they attributed to small (< 50000 Da) Aβ oligomers. The
electropherogram in Figure 3.3a indicates that it is possible to prepare and analyze a sample of
Aβ (1-42) that contains primarily monomer as indicated by the peak at -1.072 × 10-4 cm2/Vs, in
contrast to the work of De Lorenzi et al.
The electrophoretic mobility of the Aβ (1-42) monomer peak in Figure 3.3a is almost
identical to that for the Aβ (1-40) sample presented in Figure 3.1, suggesting that the two
additional amino acids in the Aβ (1-42) peptide did not result in a significant mobility shift. The
CE method described in this work was not optimized to separate Aβ (1-40) monomer from Aβ
(1-42) monomer. Rather, it was designed to separate monomeric Aβ from aggregated Aβ, and it
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is successful for both Aβ (1-40) and Aβ (1-42) peptides. Other reports have demonstrated that
CE is capable of separating a mixture of different length Aβ peptides, including Aβ (1-40) and
Aβ (1-42) [77,93].

Figure 3.3
Figure 3.3. Electropherograms of Aβ (1-42) samples. Absorbance plotted at 190 nm. (a) Aβ (142) monomer sample produced a monomer peak, M at µep = -1.074 (± 0.003) × 10-4 cm2/Vs (n =
3) and an aggregate peak at µep = -2.294 (± 0.002) × 10-4 cm2/Vs (n = 3). (b) Aβ (1-42) fibril
sample produced many peaks in the mobility range of aggregates. The neutral marker, NM, has
an electrophoretic mobility of 0 cm2/Vs. The TEM insets confirm the presence of aggregates
observed in the electropherograms (scale bar = 1 µm).
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Figure 3.3b shows an electropherogram for an Aβ (1-42) mature fibril sample. To
produce fibrillar Aβ (1-42), this sample was incubated at 37 °C for 2 days in PBS. After
incubation, the sample was buffer exchanged to 10.00 mM tris at pH 7.79 as described in Section
3.2.2. Unlike all of the other electropherograms in this work, there is no monomer peak apparent
near -1.1 × 10-4 cm2/Vs. The equilibrium concentration of Aβ (1-42) monomer has been reported
as approximately four to five-fold less than Aβ (1-40), which may be below the detection limit
for Aβ (1-42) monomer using this method [109]. The TEM for the fibril sample (inset in Figure
3.3b) indicates the presence of fibrils. Unlike the Aβ (1-40) fibril and seed samples, no broad
peak is detected at an electrophoretic mobility near -2.4 × 10-4 cm2/Vs. Instead, there are 17
peaks between -1.4 × 10-4 and -2.9 × 10-4 cm2/Vs (253–314 s). These peaks all have a FWHM of
~ 0.30 s. Based on these peaks’ electrophoretic mobilities and appearance; it is believed that they
are due to mature Aβ (1-42) fibrils. Other researchers have reported detecting sharp peaks when
analyzing Aβ (1-42) peptide [30]. Colombo et al. analyzed 100 µM Aβ (1-42) peptide in 20 mM
phosphate buffer at pH 7.4. In that work, after 24 hr of incubation at room temperature, two main
oligomer peaks and a few sharp peaks attributed to micro-precipitation and fibril deposition were
observed [30]. No other reports examining Aβ (1-42) by CE-UV have shown a separation similar
to that in Figure 3.3b. As discussed in Section 3.3.1 for Aβ (1-40) fibril samples, the length of
the detection zone and data sampling rate are critical when detecting peaks due to individual
fibrils passing through the detector.
3.4

Conclusions
In this chapter, five distinct monomeric and aggregated samples of Aβ (1-40) and Aβ (1-

42) peptides were analyzed by CE with UV absorbance detection. The results showed that the
CE-UV method can separate monomeric and aggregated forms of Aβ based on differences in
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electrophoretic mobilities. Samples that contained Aβ aggregates, confirmed by TEM, produced
a single broad peak, several sharp peaks or both in CE-UV separations. The broad peak is
attributed to smaller oligomeric Aβ aggregates, and the sharp peaks are due to larger mature
fibrils. Detecting these sharp fibril peaks requires fast data sampling, and faster data collection
combined with a narrower detection window should improve the detection of the individual
fibrils. Capillary electrophoresis with UV detection is a powerful tool to examine the contents of
aggregating Aβ samples containing aggregates ranging from monomers to fibrils, and the method
and results described here help lay the foundation for future amyloid analysis by CE.

58

CHAPTER 4
SEPARATION AND DETECTION OF INDIVIDUAL Aβ AGGREGATES BY
CAPILLARY ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE
DETECTION
4.1

Introduction
Senile plaques composed of neurofibrillary tangles and polymorphic amyloid beta (Aβ)

fibrils are hypothesized to be responsible for the neurological degeneration associated with
Alzheimer’s disease (AD) [36,110]. Aggressive research efforts have focused on developing
methods to prevent the formation of or cause the dissociation of amyloid fibrils [9,110].
Effective development of such treatments requires a thorough understanding of the formation
and composition of Aβ plaques. Amyloid β peptides (1-40) and (1-42) readily form amyloid
fibrils in vitro. The aggregation reaction from soluble monomeric peptide to insoluble fibrils is a
complex, multistep process including heterogeneous populations of dynamic polymorphic
intermediates [110]. These intermediates have been implicated to be cytotoxic; however, the
identity and structure of the cytotoxic species are unknown. These multiple potential therapeutic
targets make developing a treatment for AD extremely challenging.
An ideal technique to analyze Aβ peptide aggregation would provide concentration and
structural information as a function of time for the entire reaction landscape from monomer to
fully-formed fibrils, where all forms of Aβ would be distinguishable. Current analytical
techniques are far from this ideal. A variety of techniques has been employed to study static Aβ
structures, mainly monomers or fully-formed fibrils. These include imaging techniques such as
transmission electron microscopy (TEM), atomic force microscopy and total internal reflection
fluorescence microscopy [54,111]. In addition, spectroscopic and spectrometric techniques such
as circular dichroism, ThT and Congo red fluorescence, fluorescence correlation spectroscopy,
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light scattering techniques, surface plasmon resonance, nuclear magnetic resonance and mass
spectrometry have been applied to study Aβ structures [4,23,46,51,56,63,112].
Detecting and distinguishing monomeric Aβ peptides, intermediate oligomeric
aggregates and fully-formed fibrils within a sample mixture using one technique is an important
challenge that has not been met. Most of the aforementioned techniques can detect larger peptide
aggregates, or fibrils, but are incapable of simultaneously detecting smaller aggregated peptide
structures. Imaging techniques, for example, have a size threshold, below which the peptide is
not detectable. This size threshold also exists for light scattering detection. Thioflavin T (ThT)
fluorescence measurements allow the detection of peptide aggregates that have folded into a βsheet conformation, which is more pronounced as a function of increasing aggregate size. The
signal measured by bulk fluorescence is also dominated by larger Aβ aggregates, which mask the
signal produced from smaller aggregates. Larger aggregates also dominate bulk light scattering
measurements. Although there is no one technique to monitor all forms of Aβ, all of the current
techniques are very informative and important within their limitations.
Characterizing the structural pathway from monomeric peptides to fibrillar aggregates
involves measuring and characterizing the intermediate oligomeric structures between monomers
and fibrils for which little information is available. Separations of Aβ aggregates based on size
have been performed using several techniques, including ultracentrifugation, sedimentation
velocity analysis, gel electrophoresis, size-exclusion chromatography (SEC) and capillary
electrophoresis (CE) [22,26,53,70,71,77,91,92,113-115]. Capillary electrophoresis was first
applied to the analysis of Aβ monomer in 1993 by Sweeney et al. [77]. Since this early paper,
only a few reports regarding the application of CE to Aβ analysis have been published
[26,45,91,92,113,116-118]. Capillary electrophoresis offers fast separations with higher peak
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capacities and lower mass detection limits relative to other separation methods applied to study
Aβ aggregation. Speed is especially important since some aggregate species will presumably
disaggregate when they are physically separated from an aggregating mixture. Another
advantage of CE relative to gel electrophoresis and SEC is that it does not require a gel or
stationary phase that can disrupt or otherwise alter aggregates due to shear and adsorption.
Clodfelter et al. demonstrated that CE is a more gentle technique relative to SEC for separating
protein aggregates for another aggregate-forming peptide (C8GLIP) [100].
Laser-induced fluorescence (LIF) is a common on-column detection technique for CE,
and CE-LIF has been used to study Aβ peptides [113]. Laser-induced fluorescence anisotropy
(LIFA) is a less common detection method for CE, which has been applied to study proteinprotein and protein-nucleic acid interactions [119-122]. Fluorescence anisotropy (FA) is a
fluorescence phenomenon that is dependent on the size of the fluorescent entity being
investigated. Sabaté et al. demonstrated the use of bulk ThT anisotropy to monitor aggregation
kinetics of the fungal prion protein HET-s(218-289) [68]. Allsop et al. demonstrated that bulk
time-resolved fluorescence anisotropy can be used for monitoring early stages of Aβ aggregation
using a fluorescein-labeled Aβ peptide [123]. Capillary electrophoresis with LIFA detection has
the potential to be developed into a powerful tool for studying Aβ aggregation. Capillary
electrophoresis is capable of resolving different Aβ aggregate species, and LIFA could provide a
sensitive on-line detection method that also could provide information about the sizes of the
separated species. To the best of our knowledge, there are no reports of the application of CELIFA to study aggregation of amyloid forming peptides.
The goal of this work was to separate and detect individual Aβ aggregates labeled with
ThT using capillary electrophoresis with laser-induced fluorescence detection. Furthermore, the
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potential of laser-induced fluorescence anisotropy to characterize individual Aβ aggregates
labeled with ThT was explored.
4.2
4.2.1

Experimental
Chemicals
All solutions were prepared in 18 MΩ water obtained from a Modulab water purification

system (United States Filter Corp.; Palm Desert, CA) unless otherwise noted. Tris
(hydroxymethyl) aminomethane (Tris) and methanol (99.8%) were purchased from Fisher
Scientific (Fair Lawn, NJ). Tris buffer was prepared at 10.00 mM, and the pH was adjusted to
7.79 with HCl. This Tris buffer was used for all experiments unless otherwise noted. The buffer
was filtered through a 0.02 µm filter (Whatman; Hillsboro, OR). Mesityl oxide (MO) was
purchased from Alfa Aesar (Ward Hill, MA), and working solutions of MO were prepared in
Tris buffer at a concentration of 0.2% (v/v). Coumarin 334 was purchased from Acros Organics
(Morris Plains, NJ), and a stock solution was prepared at 1.00 µM in methanol. Working
solutions of coumarin 334 were prepared at 50 nM in Tris buffer. Thioflavin T was purchased
from Sigma (St. Louis, MO). A stock solution of 289 µM ThT solution was prepared in Tris
buffer, and working solutions of ThT were prepared at 15.0 µM in Tris buffer.
4.2.2

Aβ Peptide Sample Preparation and Characterization
Aβ (1-40) peptide was purchased from the W.M. Keck Foundation Biotechnology

Research Laboratory (Yale University, New Haven, CT), and Aβ (1-42) peptide was purchased
from rPeptide (Bogart, GA). Four Aβ sample preparations were studied in this work: Aβ (1-40)
monomer, Aβ (1-40) fibril, Aβ (1-42) monomer and Aβ (1-42) fibril. All Aβ samples were
prepared as previously described [44,45,118]. Aβ peptides were treated with trifluoroacetic acid
(TFA)/hexafluoroisopropanol (HFIP) to remove any preexisting aggregates. For Aβ monomer
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samples, the solvent was evaporated off, and the peptide was dissolved in 10.00 mM Tris at pH
7.79. For the Aβ (1-40) fibril sample, the TFA/HFIP was evaporated off, and the peptides were
dissolved stepwise in equal volumes of 2.0 mM NaOH and 2× phosphate buffered saline (PBS)
containing 22.8 mM phosphate, 274 mM NaCl, 5.4 mM KCl and 0.1% NaN3 at pH 7.4. The
samples were centrifuged at 50,000 g for a minimum of 10 h at 4 °C. The supernatant was
incubated at 37 °C for 7 d. The Aβ (1-42) monomer and fibril samples were prepared using the
same procedure with the following exceptions: the Aβ (1-42) monomer sample was centrifuged
for 30 min at 20,000 g and 4 °C, and the Aβ (1-42) fibril sample was incubated for 2 d to form
mature fibrils. These changes were due to the faster aggregation kinetics of Aβ (1-42) peptide
compared to that of the Aβ (1-40) peptide.
Fibril growth was monitored using ThT fluorescence and transmission electron
microscopy as described previously [4,118]. Depletion of Aβ monomer during fibril formation
was monitored using a Shimadzu HPLC-UV instrument with detection at 215 nm as described
previously [44,45,118]. Samples were characterized by CE-UV. The CE-UV analysis was
performed using a Beckman Coulter P/ACE MDQ equipped with a diode array detector, and the
absorbance was monitored at 190 nm as previously described [118]. The capillary (ID = 50 µm,
OD = 366 µm) used for CE-UV was cut to 63.0 cm total length with a window created 53.0 cm
from the inlet end using The Window MakerTM (MicroSolv Technology Corp.; Eatontown, NJ).
The Aβ samples were vortexed prior to every injection to resuspend any aggregates that settled
to the bottom of the sample vial.
Prior to CE analysis, fibril samples were buffer exchanged from PBS to 10.00 mM Tris
electrophoresis buffer at pH 7.79 [51]. This step eliminated conductivity and composition
differences between the sample buffer (PBS, higher conductivity) and electrophoresis buffer
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(Tris, lower conductivity). The higher conductivity of PBS would result in high electrophoretic
current and poor results due to excessive Joule heating if it were used for electrophoresis. The
monomer-equivalent concentrations of all samples were determined by HPLC-UV as previously
described [44] and were: Aβ (1-40) monomer, 15.7 µM; Aβ (1-40) fibril, 5.1 µM; Aβ (1-42)
monomer, 19.9 µM; Aβ (1-42) fibril, 29.5 µM. For CE analysis, the total sample volume was
50.0 µL, and it was placed in a 200 µL thermowell polypropylene tube (Corning Incorporated;
Corning, NY).
4.2.3

Capillary Electrophoresis with Laser-Induced Fluorescence Anisotropy Detection
The Aβ samples were characterized first by CE-UV and then analyzed with the CE-LIFA

system on the same day. The samples were not transferred to different vials when switching from
the CE-UV instrument to the CE-LIFA instrument. A laboratory-constructed instrument was
used for all CE-LIFA experiments. The CE part of the instrument was similar to an instrument
described previously [124].
Capillary electrophoresis was performed in an open-tubular capillary (ID = 50 µm, OD
366 µm) cut to 60.0 cm total length. A detection window was created at 23.0 cm from the inlet
end. A new capillary was initially conditioned with a manual syringe pump using the following
sequence: 400 µL of 1.00 M NaOH, 400 µL of 18 MΩ water and 2 × 400 µL of Tris buffer. The
total rinse time was approximately 60 min. The capillary was rinsed twice between sample types
with 400 µL of Tris electrophoresis buffer using a manual syringe pump. The fluorescent neutral
marker (coumarin 334) was injected for 1.0 s at 25.0 kV prior to the Aβ sample injection for 5.0
s at 25.0 kV. This injection order minimized potential interactions between Aβ and the neutral
marker because all forms of Aβ detected migrated slower than the neutral marker. The Aβ
samples were vortexed prior to every injection. The electrophoretic potential was applied using a
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Spellman CZE1000R high-voltage power supply (Hauppauge, NY) at 25.0 kV (417 V/cm). The
electrophoretic current was 5-6 µA. This system was not temperature controlled, unlike the
commercial CE-UV system.
Figure 4.1 presents a schematic of the detection system for the CE-LIFA instrument. The
light source was a 445 nm diode laser (Model No. LDCU12/7532, Power Technology, Inc;
Alexander, AR). The laser produced a continuous beam of polarized radiation, and the measured
power was 30.0 mW. The beam was attenuated with a neutral density filter to 3.0 mW and
focused onto the capillary window with a plano-convex lens (focal length = 25.4 mm). The
fluorescence emission was collected with a 20× microscope objective lens (Numerical Aperture
= 0.4) at 90° relative to the excitation beam. The emission was directed through a 441.6 ± 10 nm
notch filter (MK Photonics, Inc; Albuquerque, NM) to remove Rayleigh scattered light from the
laser and a 490 ± 10 nm bandpass filter (Omega Optical; Brattleboro, VT) to selectively detect
amyloid-bound ThT fluorescence. After being spectrally filtered, the emission was spatially
filtered with a 1000 µm pinhole. The emission was then separated into its parallel and
perpendicular polarized components (relative to the excitation source) with a broadband
polarizing cube beamsplitter (10FC16PB.3, Newport Corporation; Irvine, CA). Both emission
components were detected simultaneously and equidistant from the capillary by two identical
photomultiplier tubes (PMT) (H9306-04, Hamamatsu; Bridgewater, NJ). The PMT collecting
parallel emission (PMT║) was at 1000 V, while the PMT collecting perpendicular emissions
(PMT┴) was at 935 V. The outputs of the PMTs were filtered by 500 Hz low pass RC filters and
collected by a National Instrument PCI-6024E DAQ board at a scan rate of 1000 Hz. The CELIFA data collection was controlled by a program written with LabView Version 5.0, and the
data were analyzed using Origin Pro 7.5, Synaptosoft Minianalysis Programs version 6.0.7 and
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Microsoft Excel 2007.
Equation 4.1 was used to calculate the fluorescence anisotropy, r, where I║, and I┴, are
the measured parallel and perpendicular fluorescence intensities relative to the polarization of the
excitation source. The factor G corrects the anisotropy for the differences in sensitivities of the
two PMTs. For this work, G was empirically adjusted to 1 by optimizing the potentials applied to
both PMTs so that the responses and sensitivities were equal for a small fluorescent molecule,
Lucifer Yellow (Molecular Probes; Eugene, OR), from 250 nM to 1 µM (data not shown).
r=

.∥ − 0.1
.∥ 2 20.1

(4.1)

Figure 4.1. Schematic of the fluorescence anisotropy detection system for CE. Components are
(a) polarized laser (445 nm), (b) neutral density filter, (c) focusing lens, (d) capillary, (e)
microscope objective lens (20×), (f) 440 ± 10 nm notch filter, (g) 490 ± 10 nm bandpass filter,
(h) 1000 µm pinhole, (i) polarizing beam splitter cube, (j) PMT║, (k) PMT┴.
4.2.4

Microplate Reader Fluorescence
The same samples analyzed by CE-UV and CE-LIF were also analyzed by bulk ThT

fluorescence using a BMG Lab Technologies FLUOStar 430 microplate reader (Offenbur,
Germany). The instrument and data acquisition were controlled by FLUOstar Software Version
3.02-0. Forty microliters of each sample were transferred from the 200 µL polypropylene tubes
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used for CE to separate wells of 96-well Corning, Inc. 3650 black nontransparent microplates.
Consistent with the CE experiments, ThT was added at 15 µM to each sample well. The
excitation was set to 440 ± 12 nm with a bandpass filter, and the emission was collected at 485 ±
12 with a bandpass filter.
4.3

Results and Discussion
The primary goal of this work was to separate and detect individual Aβ peptide

aggregates by CE-LIF using thioflavin T as an amyloid-selective fluorescent label. Thioflavin T
(ThT) is a common fluorescence probe used to study Aβ aggregation because it is selective for
amyloid aggregates, and its excitation/emission maxima shift from 330/440 nm to 440/490 nm
when it noncovalently binds to amyloid aggregates [4,12,63]. Thioflavin T was added to the
electrophoresis running buffer to bind to the Aβ aggregates on-column [113]. This approach
eliminates the potential for ThT to alter the Aβ aggregates’ sizes and shapes during the
aggregation process while still being used as an effective fluorescent label for their on-column
detection. At the excitation and emission wavelengths used in this work, fluorescence
interference from unbound ThT is minimal [63]. The concentration of ThT (15 µM) was chosen
based on earlier publications which used 10 and 20 µM ThT for Aβ aggregate detection [45,63].
This is above the critical micelle concentration of free ThT reported by Khurana et al. (3.8 ± 0.5
µM) [67].
The work presented here is distinct from the earlier study by Kato et al. [113] because the
instrument used here was designed to detect peaks resulting from individual aggregated Aβ
species, which required the use of sufficiently fast data sampling and electronic filters [82,106].
In addition, the ThT fluorescence measured after CE separation was validated by measuring bulk
ThT fluorescence for the same samples.
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4.3.1

Detection of Individual Aggregates by CE-LIF
The detection system was designed as a two channel (polarization) fluorescence detector

in order to evaluate the potential of fluorescence anisotropy to size-characterize individual
aggregates (see Experimental for details); however, for the purpose of separating and detecting
individual ThT-labeled Aβ aggregates by CE-LIF, two channel fluorescence detection is not
required. Data from one fluorescence channel has been plotted in Figures 4.3-4.6 for clarity. The
two channel data will be discussed in Section 4.3.3.
Four different Aβ sample types were prepared and used for this work:

Aβ (1-40)

monomer, Aβ (1-40) fibril, Aβ (1-42) monomer and Aβ (1-42) fibril. The two fibril samples
were prepared to contain large mature fibrils that would bind to ThT to produce fluorescence
peaks. The Aβ (1-40) monomer and Aβ (1-42) monomer samples were prepared to be free of
aggregates and serve as negative controls. A TEM of each sample type is shown in Figure 4.2.
The Aβ fibril samples (Figures 4.2B and 4.2D) show clear evidence of fibrillar aggregates and
were expected to bind ThT and produce fluorescence peaks. The Aβ monomer samples did not
show fibrillar aggregates by TEM (Figures 4.2A and 4.2C). These samples were not expected to
produce fluorescence peaks with ThT. Amyloid monomers, unlike amyloid fibrils, do not cause
the ThT enhancement [4,12,63].
Figures 4.3A and 4.3B show electropherograms with LIF detection for the Aβ (1-40)
monomer sample without and with ThT in the running buffer, respectively. As expected, no
peaks were observed in the absence of ThT (Figure 4.3A). In contrast, with ThT a few small,
sharp peaks were present (Figure 4.3B). The migration times of these peaks appear to be random
for consecutive injections, and approximately the same numbers of peaks were observed in
electropherograms of the electrophoresis buffer with thioflavin T for which no Aβ was injected
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(data not shown). These peaks are hypothesized to be a result of unfiltered particulate matter
(non Aβ particles) in the running buffer that can enhance ThT fluorescence similar to amyloid
fibrils. We are currently investigating ThT fluorescence in the presence of synthetic
nanoparticles due to their potential to produce false positives in amyloid fibril assays. The Aβ (140) monomer sample also was analyzed by a CE-UV method previously developed by Picou et
al. [45]. A representative CE-UV electropherogram of the Aβ (1-40) monomer sample is
available in Appendix A Figure A.2. This experiment confirmed that the Aβ (1-40) monomer
sample does contain Aβ monomer, and it does not indicate that Aβ aggregates are present.

Figure 4.2. TEM images of (A) Aβ (1-40) monomer; (B) Aβ (1-40) fibril; (C) Aβ (1-42)
monomer; (D) Aβ (1-42) fibril. Samples were buffer exchanged into 10.00 mM Tris buffer at pH
7.79 prior to imaging (scale bar = 500 nm).
The large, relatively broad peaks at approximately 60 s in Figures 4.3A and 4.3B are the
fluorescent dye, coumarin 334, which was used as a neutral marker to determine the
electroosmotic flow. The coumarin 334 and Aβ samples were injected consecutively
(electrokinetic injection) from separate vials to minimize potential interaction of the neutral
marker and Aβ. For these experimental conditions, Aβ has a negative electrophoretic mobility.
The coumarin 334 and Aβ sample buffers did not contain ThT. As a result, when they were
injected into a capillary filled with ThT, a vacancy zone was created, which caused the
fluorescence to decrease as observed at 47 s in Figure 4.3B. No ThT vacancy zone is present in
Figure 4.3A because ThT was not included in the running buffer. The vacancy peak in Figure
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4.3B gives an indication of the magnitude of the background fluorescence due to unbound ThT
and is consistent with reports of ThT background fluorescence in the literature [4,12,63].

Figure 4.3. Electropherograms with LIF detection for Aβ (1-40) monomer without (A) and with
(B) 15 µM ThT in the electrophoresis buffer (10.00 mM Tris at pH 7.79). The peak at 59 s in
each electropherogram is the neutral marker (NM), coumarin 334. Coumarin 334 was injected
for 1.0 s at 25.0 kV prior to the Aβ sample injection for 5.0 s at 25.0 kV. The separation potential
was 25.0 kV (417 V/cm). The dip in the baseline at 47 s in (B) is due to a ThT vacancy zone.
Figures 4.4A and 4.4B show representative electropherograms with LIF detection for the
Aβ (1-40) fibril sample without and with ThT in the running buffer, respectively. The Aβ (1-40)
fibril sample was prepared by allowing Aβ (1-40) monomer to aggregate for 7 d to produce
mature Aβ (1-40) fibrils. Many sharp peaks are observed near 110 s in both Figures 4.4A and
4.4B. Table 4.1 shows that the electropherograms for the Aβ (1-40) fibril sample with ThT in the
separation buffer contain approximately 100 of these peaks compared to 10 peaks for the Aβ (140) monomer sample (Figure 4.3B). The peaks in Figures 4.4A and 4.4B are hypothesized to be
due to individual Aβ (1-40) aggregates passing through the LIF detection zone. The inset of
Figure 4.4B is an expanded view showing two individual aggregate peaks in the Aβ (1-40) fibril
sample, illustrating their narrow peak widths.
It is extremely challenging to show definitively that these sharp peaks are due to
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individual amyloid fibrils. The fundamental limitation is the lack of an analytical standard or
surrogate standard for Aβ fibrils. Our laboratory has extensive experience with single particle
detection [82,125] and Aβ fibril preparation and analysis [45,51,118]. The peak widths observed
are consistent with peaks due to single polymer particles of comparable size observed with a
similar CE detector [82]. The expected FWHM of an aggregate passing through a focused laser
beam can be estimated by dividing the calculated diameter of the focused laser spot by the
measured migration rate of the aggregate [82]. In this case, the calculated diameter of the
focused laser beam is 5.7 µm, and the migration rate for species detected at 105.03 s is 0.22 cm/s,
which gives a theoretical FWHM for a single aggregate peak of 3 ms. In the inset in Figure 4.4B,
the peak at 105.03 s has a measured FWHM of 11 ms, and the peak widths for peaks attributed to
individual aggregates ranged from 3–15 ms. The width for the peak in Figure 4.4B is greater than
the predicted FWHM of 3 ms, but this is expected due to refraction of the excitation beam at the
curved capillary surfaces, which causes the actual spot size to be significantly larger than the
calculated spot size [82]. An actual spot size of 24.2 µm would produce the observed peak width
of 11 ms. The measured FWHM for coumarin 334 is 1.2 s, which is typical for a CE peak due to
large numbers of identical fluorescent molecules.
The presence of large Aβ aggregates in the Aβ (1-40) fibril sample was confirmed by
CE-UV, TEM and bulk ThT fluorescence measurements. In the CE-UV electropherogram
(Figure 4.4C), the broad peak at 313 s and the sharp peaks from 300-400 s are typical for Aβ
samples containing mature fibrils [118]. Bulk ThT fluorescence was higher for the Aβ (1-40)
fibril sample compared to the Aβ (1-40) monomer sample (Table 4.2), which is consistent with
the presence of large Aβ aggregates in the fibril sample [4,12,63]. Finally, the TEM of this
sample (Figure 4.2B) shows that mature Aβ fibrils were present in this sample.
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Table 4.1. Number of CE peaks detected with and without ThT. All data are presented as
averages with standard deviations from 3 experiments. All peaks with S/N > 3 were included.
Peaks Detected
Sample
with ThT

without ThT

Aβ (1-40) Monomer

10 ± 3

1±1

Aβ (1-40) Fibril

99 ± 23

13 ± 4

Aβ (1-42) Monomer

176 ± 27

5±2

Aβ (1-42) Fibril

300 ± 46

300 ± 30

Table 4.2. Comparison of the total signal measured for each sample by CE and bulk
fluorescence with a plate reader. All data are presented as averages with standard deviations
from 3 trials. Data are normalized to the values for the Aβ (1-42) fibril sample. The CE values
were calculated by summing the integration of the peaks detected in the electropherogram.
Capillary Electrophoresis (CE)
Plate Reader
Sample

with ThT (RFU)

without ThT
(RFU)

with ThT (RFU)

without ThT
(RFU)

Aβ (1-40)
Monomer

0.1 ± 0.1

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

Aβ (1-40) Fibril

3.8 ± 0.1

0.9 ± 0.5

8.8 ± 0.1

2.1 ± 0.1

Aβ (1-42)
Monomer

5.9 ± 0.6

0.2 ± 0.0

3.2 ± 0.1

0.2 ± 0.0

Aβ (1-42) Fibril

100.0 ± 26.3

12.3 ± 3.0

100.0 ± 0.5

18.9 ± 0.1
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Figure 4.4. Electropherograms with LIF detection of Aβ (1-40) fibril without (A) and with (B)
15 µM ThT in the electrophoresis buffer. The experimental conditions for (A) and (B) are the
same as in Figure 3. The inset in (B) is an expanded view (0.2 s) of Aβ (1-40) aggregate peaks.
The same sample analyzed by CE with UV absorbance (190 nm) is shown in (C). In (C), the NM
was injected for 2.0 s at 0.3 psi followed by the Aβ injection for 5.0 s at 0.5 psi. The separation
potential in (C) was 25.0 kV (397 V/cm). The peaks at 200 s and 243 s are due to the neutral
marker (NM) and Aβ monomer (M), respectively.
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The peaks in Figure 4.4A (Aβ (1-40) fibril without ThT) are hypothesized to be due to
scattered light from individual aggregates and are not unexpected. We have previously shown
that polystyrene spheres as small as 110 nm diameter can be detected individually by light
scattering after CE separation [82], and Aβ fibril samples produce similar peaks in instruments
designed to detect scattered light with CE (unpublished results). The peaks in Figure 4.4A were
detected despite the use of a 440 nm notch filter and a 490 nm bandpass filter to minimize
detection of scattered light and isolate ThT fluorescence. The peaks in Figure 4.4A suggest that
aggregates in the mature Aβ (1-40) fibril sample produced a non-negligible light scattering signal
in the absence of ThT that will contribute to the apparent fluorescence signal in the presence of
ThT. Comparing Figure 4.4A and 4.4B, it is clear that most of the observed signal in Figure 4.4B
is due to enhanced ThT fluorescence. The data in Table 4.2 for microplate fluorescence
measurements of this sample (without ThT) also produce a higher signal than microplate
measurements of Aβ monomer samples both with and without ThT added.
It is important to recognize that the migration times and electrophoretic mobilities for the
aggregate peaks in the three electropherograms in Figure 4.4 cannot be directly compared. The
differences between the migration times of the aggregate peaks in the CE-LIF and CE-UV
electropherograms are mainly due to the difference in capillary length from the inlet to the
detection window, LD, for the two instruments (23.0 cm, Figure 4.4A and 4.4B; 53.0 cm, Figure
4.4C). This will not affect electrophoretic mobilities of the Aβ aggregate peaks, but ThT added
to the running buffer in Figure 4.4B can potentially alter the electrophoretic mobilities of Aβ
aggregates compared to Figure 4.4A and 4.4C. Finally, the laboratory-constructed CE-LIF
instrument used for Figure 4.4A and 4.4B was not thermostatted, but the commercial CE
instrument used for Figure 4.4C does control the capillary temperature. Even though the
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separation buffers used for all separations were identical, changes in capillary temperature will
affect the electrophoretic mobilities of the Aβ species.
Aβ (1-42) peptide samples also were prepared and investigated by CE-LIF. Preparing an
Aβ (1-42) monomer sample to be completely aggregate-free is extremely challenging owing to
the fast aggregation kinetics of Aβ (1-42) peptide relative to that of the Aβ (1-40) peptide [70].
Figures 4.5A and 4.5B show representative electropherograms of the Aβ (1-42) monomer sample
without and with ThT in the running buffer, respectively. Figure 4.5A shows that other than the
coumarin 334 peak at 58 s, few peaks (<10) are detected in the Aβ (1-42) monomer sample when
no ThT is included in the running buffer (Table 4.1). In contrast, Figure 4.5B shows an
electropherogram of the same Aβ (1-42) monomer sample injected with 15 µM ThT in the
electrophoresis buffer, and over 150 peaks were detected (Table 4.1). These peaks have FHWMs
ranging from 3–15 ms like those attributed to individual aggregates for the Aβ (1-40) fibril
sample. Characterization of this sample by CE-UV also indicated that the sample contained
aggregates based on the presence of the broad peak at 343 s (Figure 4.5C) [45,118]. The large
UV peak at 259 s also demonstrates that this sample contains unaggregated Aβ (1-42) monomer
[118].
In the presence of ThT, the Aβ (1-42) monomer sample produced a broad peak (FWHM
= 9 s) at 98 s that is separated from most of the peaks attributed to individual aggregates (Figure
4.5B). The Aβ (1-40) fibril sample (with ThT) also produced a broad peak that co-migrated with
most of the peaks attributed to individual aggregates (Figure 4.4B). These broad peaks in Figures
4.4B and 4.5B could be due to oligomeric structures, which are too small to produce large
distinct peaks for individual aggregates but are large enough to bind ThT and enhance its
fluorescence. Biancalana et al. discuss minimal β-sheet requirements for binding and
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fluorescence enhancement of ThT using a peptide self-assembly mimic [12], but it is not certain
exactly what size Aβ aggregates meet the minimum β-sheet requirements.

Figure 4.5. Electropherograms with LIF detection of Aβ (1-42) monomer analyzed without (A)
and with (B) 15 µM ThT in the electrophoresis buffer. (C) shows the same sample analyzed by
CE-UV at 190 nm. The peaks at 213 s and 259 s are due to neutral marker (NM) and Aβ
monomer (M), respectively. The experimental conditions for (A–C) are the same as in Figure
4.4(A–C).
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A sample containing Aβ (1-42) fibrils also was prepared and analyzed by CE-LIF (Figure
4.6) and CE-UV. The CE-UV electropherogram (Appendix A Figure A.3), bulk ThT
fluorescence (Table 4.2) and TEM data (Figure 4.2D) from the Aβ (1-42) fibril sample clearly
indicate that large aggregates were present in this sample. Unlike the Aβ (1-40) fibril sample
studied in this work (Figure 4.4), the CE-UV data of the Aβ (1-42) fibril sample showed no signs
of Aβ monomer (Appendix A Figure A.3). The absence of a monomer peak in the Aβ (1-42)
fibril is presumably due to the fast aggregation kinetics and the smaller monomer equilibrium
concentration of the Aβ (1-42) peptide relative to that of the Aβ (1-40) peptide [70].
Figures 4.6A and 4.6B are electropherograms of the Aβ (1-42) fibril sample without and
with ThT in the running buffer, respectively. Figure 4.6A shows that the Aβ (1-42) fibril sample
produced many sharp peaks in the absence of ThT that are believed to be due to scattered light
from individual aggregates, similar to the scattering observed in the Aβ (1-40) fibril sample
(Figure 4.4A). Table 4.1 shows that an average of 300 peaks were detected for the Aβ (1-42)
fibril sample in the absence of ThT, and the peaks were much larger than those observed for Aβ
(1-40) fibrils. This is consistent with the microplate measurements for the samples without ThT
(Table 4.2). The large peak heights for the Aβ (1-42) fibrils relative to the Aβ (1-40) fibrils,
without ThT, suggest that the Aβ (1-42) fibrils are larger.
Adding ThT to the running buffer resulted in an increase in the intensity of the peaks
detected for the Aβ (1-42) fibril sample. Most of the peaks were off scale initially, and a neutral
density (ND) filter (10.7% transmission) was used to attenuate the emission for the
electropherogram shown in Figure 4.6B. The inset of Figure 4.6B highlights a few of the Aβ (142) aggregate peaks, which shows that the most peaks are well-resolved from each other. The
average values for total peaks presented in Table 4.1 are the same for the Aβ (1-42) fibril sample
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with or without ThT, but the peaks are much larger with ThT in the running buffer. The total
signal from the Aβ (1-42) fibril sample does increase by a factor of 8 when analyzed in the
presence of ThT (Table 4.2).

Figure 4.6. Electropherograms with LIF detection of Aβ (1-42) fibrils analyzed without (A) and
with (B) ThT in the electrophoresis buffer. A neutral density filter was used in (B) to attenuate
the emission (10.7% transmission), and the y-axis in (B) was adjusted to account for this. The
inset in (B) shows a 0.2 s segment of the electropherogram showing several of the Aβ (1-42)
aggregate peaks. The experimental conditions for (A) and (B) are the same as in Figure 4.3.
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4.3.2

Validating CE-LIF Results by Bulk Measurements
Bulk ThT fluorescence measurements are widely used for studying amyloid aggregation

[4,10,12,45,63,70]. While the studies presented in Section 4.3.1 and by Kato et al. [113] show
that ThT can be used as a label for LIF detection of Aβ aggregates with CE, it is not known if the
fluorescence detected as peaks by CE is equivalent to the increase in bulk ThT experiments
commonly used to indicate increased Aβ aggregation and to study Aβ aggregation kinetics. To
validate the CE results, the total fluorescence detected in electropherograms (summed area of all
peaks) has been compared to bulk fluorescence measurements obtained with a microplate
fluorometer using the same Aβ samples.
The data for these experiments are presented in Table 4.2. All microplate fluorometer
data were normalized to the fluorescence for the Aβ (1-42) fibril sample with ThT, and all of the
CE-LIF data were normalized to the total fluorescence for the Aβ (1-42) fibril sample with ThT
for CE experiments. The data presented in Table 4.2 demonstrate that the results from the two
methods are equivalent. Both methods show almost no signal for Aβ (1-40) monomer both with
and without ThT added. Relative to Aβ (1-40) monomer, both techniques indicate a significant
increase in signal for the Aβ (1-40) fibril sample without the addition of ThT, suggesting that
signal due to scattered light for CE experiments (Figure 4.4A) is also detected by the microplate
reader. Upon binding to ThT, the fluorescence signal for Aβ (1-40) fibrils increased by a factor
of 4.2 using both techniques. Similarly, both Aβ (1-42) monomer and Aβ (1-42) fibrils show
similar signal intensities using both techniques in the presence and absence of ThT.
Overall, the data in Table 4.2 show that the CE-LIF data are consistent with standard bulk
fluorescence measurements. The advantage of the CE-LIF technique is that it separates the
aggregates in the sample, providing a profile of mobility and intensity data for the Aβ aggregate
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population.
4.3.3

Fluorescence Anisotropy of Individual Aβ Aggregates
The results presented in Sections 4.3.1 and 4.3.2 demonstrate that this CE-LIF method

can separate Aβ aggregates, providing information about their numbers, electrophoretic
mobilities and fluorescence intensity with ThT labeling. While this approach provides a wealth
of information about the Aβ aggregate population compared to bulk measurements of ThT
fluorescence, it does not allow us to determine the size and shape of an individual aggregate
based on CE-LIF peaks. For particles of the size scale of Aβ fibrils, electrophoretic mobility is
not a simple function of aggregate size and shape [81,82]. Standards or suitable surrogate
standards representative of amyloid fibrils to determine these relationships do not exist. The
relationship between aggregate size, shape and structure and ThT fluorescence also is not well
understood. This section investigates the potential of characterizing individual aggregates by
fluorescence anisotropy with ThT fluorescence.
Fluorescence anisotropy (FA) is a technique capable of providing size-related
information about fluorescent analytes. Equation (4.2) shows how fluorescence anisotropy is
related to the rotational diffusion coefficient, D, through the Perrin equation, where r0 is the
fundamental anisotropy and τ is the fluorescence lifetime. The fundamental anisotropy is
dependent on the angle between the absorption and emission transition dipoles of the fluorophore
[69]. It was hypothesized that the differences in size and structure of Aβ aggregates detected by
CE would result in differences in fluorescence anisotropy, according to Equation (4.2).
=


1 2 645

(4.2)

For this work, the fluorescence anisotropy detector used two PMTs that simultaneously
collected perpendicular and parallel emission relative to the polarization of the excitation source
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(Figure 4.1). A pair of data points was collected at each time point, and the emission intensities
were used as described in Equation (4.1) to calculate the fluorescence anisotropy, r, as described
in Section 4.2.3.
Figures 4.7A–C show three representative 100 ms time segments of the parallel and
perpendicular fluorescence signals from the electropherograms of the Aβ (1-42) monomer
sample. This sample was chosen to test the potential of fluorescence anisotropy to characterize
Aβ aggregates because it produced on-scale peaks in the presence of ThT and no significant
signal in the absence of ThT, i.e. minimal scattering signals. These are important attributes for
this assessment because peak intensities, which are used in the calculation of fluorescence
anisotropy (See Equation 4.1), cannot be determined from off-scale peaks. Moreover, it is known
that scattered light from a polarized source is highly polarized and could have a significant
impact on the fluorescence anisotropy results [69].
In Figure 4.7A–C, the parallel channel data are plotted as solid lines, and the
perpendicular channel data are plotted as dashed lines. Note that the parallel channel data in
Figure 4.7A–C are from the same electropherogram shown in Figure 4.5B. It is clear from
Figures 4.7A–C that the signal detected in the parallel channel is higher than that detected in the
perpendicular channel, indicating fluorescence anisotropy. Coumarin 334, which was used as a
neutral marker to measure the electroosmotic flow for these studies, was also used to as a control
to assess the performance of the fluorescence anisotropy detection system. The fluorescence
anisotropy of coumarin 334 is expected to be near zero because it has a low MW (283.32 g/mol)
[69]. The fluorescence anisotropy of coumarin 334 that was injected with the Aβ (1-42)
monomer sample in Figure 4.7 was calculated to be 0.007 (coumarin 334 data not shown). This
verifies that the detection system was performing properly.
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Figure 4.7. Electropherograms of Aβ (1-42) monomer for LIFA detection. Figures A–C are
three 0.1 s segments of the electropherogram shown in Figure 4.5B. The parallel and
perpendicular fluorescence emissions are shown as solid and dashed lines, respectively. Figures
D–F show fluorescence anisotropy electropherograms corresponding to A–C, respectively. The
anisotropy data in D–F were calculated using Equation 4.1.
Figures 4.7D–F show fluorescence anisotropy vs. time calculated from the LIF data in
Figures 4.7A–C. Figures 4.7D–F show that individual aggregate peaks have non-zero
anisotropies, but these anisotropy values are indistinguishable from the anisotropy calculated
from the background signal, i.e. no fluorescence anisotropy peaks were observed in Figures
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4.7D-F. It was hypothesized that plots of fluorescence anisotropy vs. time for an Aβ aggregate
sample would result in distinguishable fluorescence anisotropy peaks and that the intensity of
these peaks might provide information about the relative sizes of the aggregates. Protein-protein
affinity interaction studies by CE-LIFA included plots of fluorescence anisotropy vs. time with
distinct peaks [121]. Sabate and Saupe reported an increase in ThT fluorescence anisotropy due
to aggregation of a fungal prion protein (HET-s(218-289) [68]. A study by Khurana et al.
reported anisotropy values near 0.3 for ThT without any protein aggregates present in the
solution [67]. While ThT clearly produced enahanced fluorescence for Aβ aggregates in this
study, fluorescence anisotropy did not appear to increase significantly relative to background
levels. In order to effectively use CE with fluorescence anisotropy detection to characterize
individual aggregates, the fluorescence anisotropy of Aβ aggregates must be distinct from that of
the background anisotropy.
4.4

Conclusions
This work shows that CE with LIF detection can be used to analyze samples of

aggregated Aβ (1-40) and Aβ (1-42) using ThT, a dye that fluoresces upon binding to the
amyloid fibrils, in the running buffer. This study distinguishes itself from an earlier study [113]
by demonstrating the ability to separate and detect individual aggregates and by validating the
CE-LIF data using direct comparison with bulk thioflavin T fluorescence measurements, which
are widely used to study aggregation kinetics of amyloidogenic peptides. Compared to bulk ThT
fluorescence measurements, CE-LIF provides a profile of the aggregate population based on
electrophoretic mobilities, fluorescence intensities and numbers of individual aggregate peaks.
The studies presented here focus on analysis of Aβ aggregates, but they should be applicable to
studies of other amyloidogenic peptides.
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Initial studies of CE-LIFA to characterize individual Aβ aggregates yielded encouraging
results, but significant improvements must be made to effectively apply this to study Aβ
aggregation.
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CHAPTER 5
A DATA TREATMENT METHOD FOR DETECTING FLUORESCENCE
ANISOTROPY PEAKS IN CAPILLARY ELECTROPHEROGRAMS
5.1 Introduction
Fluorescence anisotropy (FA) is a measure of the degree of emission depolarization of a
fluorescent molecule after being excited with a polarized excitation source [69]. A major cause
of emission depolarization is molecular rotational diffusion during the excited state lifetime of
the fluorophore. In general, molecules with smaller rotational diffusion rates, i.e. slower rotation
in solution, exhibit larger fluorescence anisotropy. Similarly, molecules that have large rotational
diffusion rates exhibit smaller fluorescence anisotropy.
Laser-induced fluorescence anisotropy (LIFA) has been demonstrated as an on-column
detection technique for capillary electrophoresis (CE) for studies of biomolecular interactions,
e.g. protein-protein or oligonucleotide-protein interactions [119-122,126,127]. Chapter 4
demonstrates the separation and detection of individual Aβ peptide aggregates by CE-LIF using
ThT in the running buffer as the fluorescent probe. It was hypothesized that fluorescence
anisotropy differences between aggregates could indicate relative size differences between
separated aggregates (see Chapter 4). Plots of fluorescence anisotropy vs. time showed that
fluorescence anisotropy due to aggregates and the ThT background [67] were indistinguishable;
i.e. no fluorescence anisotropy peaks were observed although there were obvious peaks in plots
of fluorescence vs. time. In order to evaluate if CE-LIFA can be used to differentiate individually
detected Aβ aggregates, it is important that the fluorescence anisotropy of the aggregates be
easily distinguishable from the background anisotropy.
A close examination of the few CE-LIFA papers available indicated that most papers did
not include plots of fluorescence anisotropy vs. time [119,121,122,126]. This hinted that other
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researchers using fluorescence anisotropy for separation detection may have faced the same
issues that we encountered when plotting fluorescence anisotropy vs. time, i.e. clear fluorescent
peaks, low background fluorescence, high fluorescence anisotropy background and no observed
fluorescence anisotropy peaks. We then set out to understand why our anisotropy plots did not
produce peaks like some examples in the literature [120,127] and how we could better visualize
the peaks in plots of fluorescence anisotropy vs. time that are evident in the raw fluorescence
data.
A simple data treatment method is described here that enables differentiation of
anisotropies due to fluorescent peaks (peptide aggregates here) and background signals. This
data treatment method effectively extracts anisotropy peaks from fluorescence anisotropy
electropherograms that were originally embedded in the background fluorescence anisotropy
noise. This method allows simple visualization of anisotropy peaks vs. time.
5.2
5.2.1

Experimental
Chemicals and Peptide Samples
The chemicals, solutions and sample preparations used in this study have been described

in detail in Chapter 4. Tris (hydroxymethyl) aminomethane (Tris) was purchased from Fisher
Scientific (Fair Lawn, NJ). Thioflavin T (ThT) was purchased from Sigma (St. Louis, MO).
The electropherograms presented in this work were performed using 10.00 mM Tris
buffer at pH 7.79. Thioflavin T (15 µM) was included in the running buffer to detect Aβ (1-42)
aggregates [113]. The Aβ (1-42) peptide sample was prepared as previously described [45,118].
The monomer-equivalent concentration of the Aβ (1-42) was measured to be 5.1 µM by HPLCUV [44]. Analysis of the sample by TEM, CE-UV and CE-LIF confirmed that the sample
contained Aβ (1-42) aggregates (see Chapter 4).
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5.2.2

Capillary Electrophoresis
Capillary electrophoresis was performed in a fused-silica capillary (ID = 50 µm, OD 366

µm; Polymicro Technologies, Phoenix, AZ) cut to 60.0 cm total length with a window created at
23.0 cm from the inlet. The electrophoretic potential was applied across the capillary using a
Spellman CZE1000R high-voltage power supply (Hauppauge, NY) at 25.0 kV (417 V/cm),
which produced an electrophoretic current of 5-6 µA. Sample injections were performed for 5 s
at 25.0 kV. Prior to each injection, the sample was vortexed to suspend any aggregates that could
have settled to the bottom of the sample vial.
5.2.3

Laser-Induced Fluorescence Anisotropy Detection System
The fluorescence anisotropy detection system used here has been described in detail

previously (see Chapter 4 Figure 4.1). This detector is based on the design reported by Whelan et
al. [120] and has been modified for the detection of narrow peaks (3-15 ms) due to individual
aggregates. The beamsplitter cube (10FC16PB.3, Newport Corporation; Irvine, CA) separates
the fluorescence emission into parallel and perpendicular components relative to the polarization
of the 445 nm diode laser excitation source (Model No. LDCU12/7532, Power Technology, Inc;
Alexander, AR). Both emission components were spectrally filtered by a 490 nm bandpass filter
and 440 nm notch filter. Then the emissions were detected simultaneously and equidistant from
the capillary by two identical photomultiplier tubes (PMT) (H9306-04, Hamamatsu;
Bridgewater, NJ). The outputs of the PMTs were filtered by 500 Hz low pass RC filters and
collected by a National Instrument PCI-6024E DAQ board at a scan rate of 1000 Hz. The CELIFA data collection was controlled by a program written in LabView 5.0, and the data were
analyzed using Origin Pro 7.5 and Microsoft Excel 2007.
Equation 5.1 was used to calculate the fluorescence anisotropy, r, where I║, and I┴, are
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the measured parallel and perpendicular fluorescence intensities relative to the polarization of the
excitation source. The factor G corrects the anisotropy for the differences in sensitivities of the
two PMTs. For this work, G was empirically adjusted to 1 by optimizing the potentials applied to
both PMTs so that the responses and sensitivities were equal for a small fluorescent molecule,
Lucifer Yellow (Molecular Probes, Eugene, OR) over range of concentrations (data not shown).
The applied potentials for PMT║ and PMT┴ were 1000 and 935 V, respectively.
r=
5.3

I∥ − GI1
I∥ 2 2GI1

(5.1)

Results and Discussion
The aggregation of Aβ peptides has been linked to Alzheimer’s disease. The data presented

here are from a capillary electrophoretic separation of a mixture of Aβ (1-42) peptide aggregates.
The peptides are non-covalently labeled with the amyloid dye, Thioflavin T (ThT). The peaks in
the electropherograms presented here are due to individual Aβ (1-42) aggregates.
Figure 5.1 presents parts of three electropherograms for a sample containing Aβ (1-42)
aggregates. The individual parallel and perpendicular fluorescence signals are plotted in the
lower part of the figure (left y-axis), and the fluorescence anisotropy calculated from these
signals (Equation 5.1) is plotted in the top part of the figure (right y-axis). The fluorescence peak
in Figure 5.1 is due to an individual Aβ (1-42) aggregate with ThT noncovalently bound to it
(refer to Chapter 4 for more details). The binding of ThT to Aβ causes an excitation and emission
spectral shift and enhancement at the wavelengths being using for excitation and detection (440
and 490 nm) [12,63]. Figure 5.1 shows only 1 of the 178 aggregate peaks that were detected for
this injection of Aβ (1-42) aggregates. Figure 5.1 shows that the anisotropies of the fluorescence
due to Aβ aggregates and due to background fluorescence of ThT [67] are indistinguishable, i.e.
no fluorescence anisotropy peaks are apparent in the plot of fluorescence anisotropy vs. time
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although fluorescence peaks for I║, and I┴ and their different heights are obvious. The slight
difference in the background fluorescence signals for ThT is also apparent in Figure 5.1.

Figure 5.1. Bottom two plots are electropherograms with LIF detection showing an individual
Aβ (1-42) aggregate peak at 120.65 s (left axis). The dashed plot and dark solid plot are the
parallel and perpendicular fluorescence emissions, respectively. The lighter solid plot is the
fluorescence anisotropy, r, calculated from the parallel and perpendicular emissions using
Equation 5.1 (right axis).
Based on reports in the literature, we expected that fluorescence peaks resulting from the
Aβ (1-42) aggregates would produce distinguishable peaks in a plot of fluorescence anisotropy
vs. time [120]. Whelan et al. demonstrated the use of CE-LIFA for affinity assays to monitor the
fluorescence anisotropy of Gαi1 protein complex formation with BODIPY-GTPγS (BGTPγS)
[120]. In that work, the fluorescent probe, BODIPY, was included in the electrophoresis buffer,
similar to ThT in this paper [120]. As shown in Figure 4 of Whelan et al. [120], the parallel and
perpendicular fluorescence signals of the Gαi1/GTPγS complex were approximately 40 and 25
RFU above background signals of 35 RFU for both the parallel and perpendicular channels
[120]. A fluorescence anisotropy peak was clearly observed in plots of fluorescence anisotropy
vs. time for the Gαi1/GTPγS complex with an intensity of approximately 0.08 above a
background fluorescence anisotropy of approximately 0.00 [120].
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An important difference between the data reported by Whelan et al. and that presented
here is the heights of the analyte peaks relative to the fluorescence background signal. In Figure
5.1 of this manuscript for example, the ratios of the Aβ aggregate peak heights to the intensity of
the background signals for the parallel and perpendicular channels are 11.2 and 10.3,
respectively. The equivalent ratios observed by Whelan et al. for the Gαi1/GTPγS complex were
about 1.1 and 0.7 [120].
It was hypothesized that uniformly adding an artificial background signal to the data for
both fluorescence channels, I║, and I┴, prior to calculating the anisotropy might enable
differentiation of the anisotropies of the aggregate peaks and background, resulting in the
visualization of anisotropy peaks. This would greatly facilitate visualizing and interpreting
differences between fluorescence anisotropy of Aβ aggregates and that of the background.
Adding an artificial signal to all fluorescence data points would have the same effect on the data
as if ThT were producing a high fluorescence background signal similar to the BODIPY
background signal observed in the work of Whelan et al. [120].
Figure 5.2A shows plots of the original fluorescence data (bottom two traces) and the
fluorescence data after adding an artificial signal, z, of 0.5 to the original data (top two traces). In
Figure 2, the ratio of the fluorescence intensity of the Aβ aggregate peak at 121.8 s to that of the
background for the parallel and perpendicular channels are 7.0 and 8.4, respectively. The added
value of 0.5 RFU produced a ratio of Aβ peak height:background signal of 1.1 and 0.7, which are
the same ratios of analyte signal:background signal observed by Whelan et al. [120].
Figure 5.2B shows the fluorescence anisotropy before and after the addition of the 0.5
RFU background signal. In Figure 5.2B, the upper trace is the anisotropy calculated from the
original fluorescence data, and the lower trace is the anisotropy calculated from the modified
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fluorescence data. As hypothesized, the addition of the artificial background signal results in a
relative enhancement of the anisotropy of the aggregate peaks relative to the background
anisotropy. It is clear that the fluorescence anisotropy peaks correspond in time to the
fluorescence peaks in Figure 5.2A.

Figure 5.2. (A) Electropherograms with LIF detection showing peaks due to two individual Aβ
(1-42) aggregates at 121.84 s and 122.02 s. The dashed plot and solid plot are the parallel and
perpendicular fluorescence emissions, respectively. The bottom two plots are LIF emissions
without any addition of z, and the top two traces are the LIF emissions after the additions of z =
0.5. (B) Anisotropy calculated from (A) using Equation 5.1. The lighter solid plot was calculated
from the unadjusted parallel and perpendicular LIF emissions (lower two traces in (A)). The
lower darker solid plot was calculated from the parallel and perpendicular LIF emissions after
the addition of z = 0.5 (upper two traces in (A)).
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This result can be explained mathematically starting with the Equation 5.1, where r is the
original anisotropy, i.e. the anisotropy before the fluorescence signals are artificially adjusted.
Equation 5.1 is used to calculate the anisotropy data plotted in the upper trace of Figure 5.2B.
Recalling that this method adds a constant artificial signal, z, to all the fluorescence data, the
modified anisotropy, rm, can be described by Equation 5.2, which can be reduced to Equation
5.3. Equation 5.3 can be used to calculate the modified anisotropy data, which is plotted vs. time
in the lower plot in Figure 5.2B. Subtracting Equation 5.3 from Equation 5.1 gives Equation 5.4,
which is useful for considering the differences observed between the two plots in Figure 5.2B.
r9 =
r9 =

(I∥ 2 z) − (I1 2 z)
(I∥ 2 z) 2 2(I1 2 z)

I∥ − I1
I∥ 2 2I1 2 3z

I∥ − I1
I∥ − I1
r − r9 = ;
<−;
<
I∥ 2 2I1
I∥ 2 2I1 2 3z

(5.2)
(5.3)
(5.4)

Only the second term on the right side of Equation 5.4 is dependent on z. For lower
fluorescence intensities, the z term is more important, and greater differences will result between
the original and modified anisotropies. Conversely, adding z to higher fluorescence intensities,
e.g. like those produced by aggregates, has less of an impact on the second term of Equation 5.4,
which translates to smaller differences between the original and modified anisotropies.
In general, the anisotropy of the background fluorescence is reduced to a greater extent
relative to the anisotropy of the Aβ aggregate peaks. After addition of an artificial background
signal, our data resembles the data obtained by Whelan et al., and peaks become apparent in a
plot of anisotropy vs. time as shown in Figure 5.2B. The natural background fluorescence in our
data is due to the fluorescence of unbound ThT, and this fluorescence does have a fluorescence
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anisotropy value of about 0.2 at the ThT concentrations used in this work. If the background
fluorescence did not exhibit fluorescence anisotropy, the plot of fluorescence anisotropy vs. time
would be similar to the upper plot in Figure 5.2B, except it would be centered at 0.0 instead of
0.2. The high noise in the plot of fluorescence anisotropy vs. time would still largely mask the
fluorescence anisotropy peaks observed after data modification (bottom plot in Figure 5.2B)
[67]. The modified fluorescence anisotropy values are not equal to the true (original) anisotropy
values. Our goal here was to develop a data treatment method that allows better visualize
fluorescence anisotropy peaks in a plot of fluorescence anisotropy vs. time. Once the peaks of
interest have been identified with the help of this method, the true anisotropy values can be
easily calculated using Equation 5.1 for data points at the migration times of interest.

Figure 5.3. (A) Electropherogram with LIF detection showing an individual Aβ (1-42)
aggregate at 148.35 s. The dashed plot and solid plot are the parallel and perpendicular
fluorescence emissions, respectively. (B) Anisotropy plots at varying levels of z (0, 0.5, 1.5, 3.0
and 5.0) added to the LIF emissions. Note that all the y-axis in Figure 5.3B are the same except
in the plot where z = 0.
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The impact of the magnitude of z on the adjusted fluorescence anisotropy was
investigated. Figure 5.3A shows another time segment of parallel and perpendicular fluorescence
data from the same electropherogram shown in Figures 5.1 and 5.2. Figure 5.3B shows five plots
of fluorescence anisotropy vs. time, which were calculated from the fluorescence data in Figure
5.3A using several values of z (z = 0, 0.5, 1.5, 3.0 and 5.0 RFU). Consistent with Equation 5.3
and the discussion above, larger z values result in lower fluorescence anisotropy values, and
fluorescence anisotropy peaks become apparent in the electropherograms.
The S/N of some of the fluorescence anisotropy peaks were analyzed as a function of the
magnitude of z. Figure 5.4 shows a plot of the fluorescence anisotropy S/N vs. z for selected
peaks from the same electropherogram. The S/N values are also presented in Table 5.1.

Figure 5.4. S/N of four individual Aβ aggregate anisotropy peaks plotted as a function of z. The
anisotropy values were derived from fluorescence peaks with various S/N values. The diamonds,
triangles, circles and squares are are anisotropy S/N values from a fluorescence peaks whose
parallel fluorescence peaks’ S/N values were calculated to be 127, 65, 30 and 15, respectively.
The S/N values plotted here are tabulated in Table 5.1.
The peaks in Figure 5.4 were selected based on the S/N of their corresponding
fluorescence peaks prior to any data treatment (S/N = 15, 30, 65, and 127). In general, the S/N
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values of the anisotropy peaks initially increase as z increases before approaching a limiting
value. For the peaks examined here, the S/N values of the anisotropy peaks plateau at a
maximum S/N when z is approximately 10 RFU. The plots in Figure 5.4 show that the maximum
anisotropy S/N was greater if the corresponding fluorescence peak had a greater S/N. For z = 20
RFU, the anisotropy S/N values are 5.9, 11.0, 28.8, 48.7 and 142.7 for fluorescence peaks that
had S/N values of 15, 30, 65, 127 and 323, respectively. The data treatment method resulted in a
relatively large increase in fluorescence anisotropy S/N.
Table 5.1. S/N of anisotropy peaks as a function of z (z = 0.5, 1, 1.5, 2, 3, 5, 10, 20 and 35). Data
shown for 5 different aggregate peaks, whose fluorescence peaks S/N values varied (15, 30, 65,
127 and 323). All data are plotted in Figure 5.4 with the exception of the data from the
fluorescence peak with a S/N of 323.

S/N of Fluorescence Peaks

z
0.5

1

1.5

2

3

5

10

20

35

15

4.9

5.3

5.5

5.6

5.7

5.8

5.9

5.9

5.9
(1.2)

30

7.6

9.0

9.6

10.0

10.3

10.6

10.8

11.0

11.0
(1.4)

65 14.1

19.1

21.7

23.2

25.0

26.7

28.0

28.8

29.1
(2.1)

127 19.6

28.3

33.1

36.4

40.1

43.7

46.9

48.7

49.4
(2.5)

323 29.0

48.7

63.3

74.3

90.4

109.1

129.4

142.7

149.3
(5.1)

5.4 Conclusions
A simple and effective data treatment method was described for visualizing fluorescence
anisotropy peaks in a plot of fluorescence anisotropy vs. time for capillary electrophoresis
separations of Aβ (1-42) peptide aggregates. The data treatment method revealed fluorescence
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anisotropy peaks that were masked by the high anisotropy noise of the background signal prior to
the data treatment. Although this method did alter the fluorescence anisotropy values in the
peaks, true fluorescence anisotropy values could be easily calculated once peaks of interest had
been identified and considered. While this data treatment method was applied to CE separations
with laser-induced fluorescence anisotropy detection, it is equally applicable to other separation
techniques using fluorescence anisotropy detection.
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CHAPTER 6
FLUORESCENCE ENHANCEMENT OF THIOFLAVIN T
BY POLYSTYRENE BEADS
6.1 Introduction
Thioflavin T is a benzothiozole fluorescent dye that has been used extensively to study
amyloid aggregation. After binding to amyloid aggregates, ThT undergoes a red shift for both the
excitation and emission λmax and an increase in fluorescence signal relative to unbound ThT
[64,65]. These two characteristics of ThT are often referred to in the literature as “ThT
enhancement”. Because ThT enhancement has been observed in the presence of several amyloid
proteins, it is believed that the β-sheet structural motif, which is common to amyloid aggregates,
is the binding site of ThT.
The exact cause of ThT enhancement is not well understood. Related hypotheses have
been that ThT enhancement depends on the torsional angle between the benzylamine and
benzylthiol rings [12,66]. The underlining idea is that when ThT is bound, the torsional angle
between its ring structures is rigid and small, i.e. the rings are more coplanar relative to when
ThT is unbound. This can reduce the HOMO/LUMO gap, resulting in a red shift observed in
ThT enhancement. This is plausible, and if it is accurate, it is also plausible that ThT
enhancement could be observed in the presence of other structures that can bind and stabilize the
coplanar ThT. In fact, bacteria, which can grow readily under the conditions used for Aβ
aggregation, can bind ThT and produce false positives [39].
Thioflavin T was used to label and detect hundreds of individual Aβ (1-40) and (1-42)
aggregates that were separated by capillary electrophoresis (CE) (see Chapter 4). This was
accomplished by including ThT as a component in the electrophoresis buffer. While establishing
a baseline, the buffer (with ThT in it) showed irreproducible sharp peaks that mimicked Aβ/ThT
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peaks. These false-positive peaks could not be deconvoluted from Aβ/ThT. After filtering the
ThT buffer through a 0.02 µm filter, the number of peaks in the buffer reduced to nearly zero and
the few random peaks remaining were far less intense. Because filtering reduced the number of
peaks, it is assumed that the peaks were either due to bacterial growth in the buffer or the
accumulation of dust particles.
Importantly, these peaks were not observed in buffer that did not include ThT even
before filtering. This suggested that whatever was causing the peaks was not itself fluorescent,
but it could have bound ThT and produced a fluorescent signal. Although we nearly eliminated
the false positive peaks by filtering, we wanted to develop a better understanding of ThT
enhancement in the presence of non-amyloid particles because of the potential they have to
produce false-positives in amyloid studies using ThT.
This work is a fluorescence spectroscopic study of ThT enhancement by polystyrene (PS)
beads. Polystyrene beads are ideal analytes for this study because they are uniform in size and
the concentrations are controllable (unlike amyloid aggregates). Moreover, many sizes of PS
beads are commercially available.
6.2 Experimental
6.2.1

Chemicals
Polystyrene (PS) beads of different sizes (1072 ± 19, 771 ± 25, 535 ± 10, 356 ± 14, 202 ±

10, 108 ± 4.5 nm) were purchased from Polysciences (Warrington, PA). Thioflavin T (ThT) was
purchased from Sigma (St. Louis, MO). Tris(hydroxymethyl) aminomethane (Tris) was
purchased from Acros (Geel, Belgium) and hydrochloric acid (HCl) was purchased from Fisher
Scientific (Pittsburgh, PA). 10.00 mM Tris buffer was prepared in ultrapure water (>18 MΩ cm)
from a Modulab water purification system (United States Filter; Palm Desert, CA) and adjusted
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to pH 7.80 with HCl. The solutions of PS beads were prepared by mixing required volume of
stock solution with the 10.00 mM Tris buffer at pH 7.80 filtered twice with a 0.02 µm syringe
filter (Fisher Scientific; Pittsburgh, PA). All stock solutions were homogenized by vortexing
prior to use. Dilutions of bead stock solutions were performed directly in microplate well for
plate reader studies and in cuvette for fluorometer study.
6.2.2

Plate Reader Study
Fluorescence of the samples was measured using a BMG Lab Technologies FLUOstar

430 microplate reader (Offenberg, Germany). Measurements were made from the top of a black
96 well plate (Corning 3650) (Corning incorporated; Corning, NY) with excitation wavelength
440±12 nm and emission wavelengths 485± 12 nm. A 60 s orbital shaking of the plate was
performed prior to the measurement to mix and homogeneous samples.
Measurements were performed in well mode. Each measurement was the average
intensity from 100 flashes. Three measurements were made from each well before moving on the
next well. Each well that contained PS beads with ThT had a corresponding well with the same
concentration of PS beads without ThT. This allowed any scattered light from PS beads to be
subtracted from the fluorescence signal.
6.2.3

Spectrophotometry and Spectrofluorometry
Absorbance spectra (200 - 800 nm) of all samples and blank solutions in 10.00 mM tris

buffer at pH 7.80 were determined with a Cary 50 UV-Vis spectrophotometer (Varian; Palo Alto,
CA) using a 1 cm quartz cuvette. A slit width of 1 nm was used for data collection. Absorbance
spectra were collected at room temperature, and the blank was subtracted from each spectrum.
Excitation-emission spectra and EEMs of the samples were determined using a SPEX
Fluorolog-3 spectrofluorometer (model FL3-22TAU3; HORIBA Jobin Yvon; Edison, NJ)
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equipped with a 450 W Xenon lamp and R928P photomultiplier tube (PMT) detector. Both
excitation-emission spectra and EEMs were performed at room temperature using a 1-cm quartz
cuvette and adjusting both excitation and emission slit widths to 5 nm. For the determination of
EEMs the excitation wavelength was varied from 250 nm to 500 nm in 5 nm intervals, while the
emission spectra were collected from 350 nm to 600 nm in 2 nm intervals. For the determination
of excitation spectrum, the emission wavelength was fixed (at 435 or 490 nm) and excitation was
scanned from 250 nm to 500 nm. Similarly, for the determination of emission spectrum, the
excitation wavelength was fixed (at 332, 405, or 440 nm) and emission was scanned from 350
nm to 600 nm. The scanning was at the interval of 1 nm for both excitation and emission spectra.
For data processing, an inner-filter effect correction was performed on the data for both
PS bead without ThT and PS bead with ThT. This was accomplished using Equation 6.1, where
the Fc is the corrected fluorescence, Fobs is the observed fluorescence, i.e. the raw measured
fluorescence, Abem is the absorbance measured at the emission λ and Abex is the absorbance
measured at the excitation λ. After the inner filter correction, the scattering was subtracted from
the fluorescence. The contour plots of EEM data and excitation-emission spectrum were plotted
using OriginPro 7.5 (Origin Lab; Northapton, MA).
= = >?

(@A, 2 @AB )
2

(6.1)

6.3 Results and Discussion
6.3.1

Effect of Bead Diameter on ThT Fluorescence
The interaction of ThT with PS beads is thought to be dependent on the surface area of

the PS beads similarly to the ThT interaction with the β-sheet motif of the protein aggregates.
The concentration units, therefore, are reported here as PS bead surface area per volume of
solution, i.e. µm2/mL. The data in Table 6.1 and Equations 6.2–6.4 demonstrate how these values
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were determined. The 108 nm PS beads will be used to briefly explain the equations. For the 108
nm PS beads, the surface area per bead, Ab, was calculated using Equation 6.2, where C is the
PS bead diameter. The number of beads per volume, Nv, was determined using Equation 6.3,
where w is the grams of polymer per mL of solution (provided by PS bead manufacturer), ρ is
the density of the polymer (g/mL) (provided by PS bead manufacturer), V is the volume of PS
bead solution prepared. Equation 6.4 is used to convert from number of beads per mL to total
surface area per mL, AT.
Table 6.1. Volume of beads needed to obtain a PS bead concentration of 1.26 × 108 µm2/mL for
each PS bead.
Bead Diameters,

Surface Area per

Number of Beads

Total Surface

Volume of Bead

C (nm)

Bead,

per Volume, NV

Area per Volume,

Solution Used

Ab (µm2)

(N/mL)*

AT (µm2/mL)

(µL) ‡

108

3.67 × 10-2

3.75 × 1013

1.38 × 1012

2.3

202

1.28 × 10

-1

12

11

4.2

356

3.98 × 10-1

1.09 × 1012

4.33 × 1011

7.2

535

9.00× 10

-1

11

11

10.9

771

1.87

1.04 × 1011

1.94 × 1011

16.6

3.61

10

11

23.5

1072

5.78 × 10
3.17 × 10
3.90 × 10

7.41 × 10
2.85 × 10
1.41 × 10

* Based on manufacturer’s percent weights.
‡ This was the volume used of a 100-fold dilution of the manufacturer’s stock solution to obtain
1.26 × 108 µm2/mL in a total of 250 µL for the plate reader study.
E
@> = 4D * 2

(6.2)

@M = @> × FG

(6.4)

6H10J
FG =
KE L D)

(6.3)

Figure 6.1 demonstrates the effect of PS bead diameter on ThT fluorescence for two
different concentrations, 1.26 × 109 µm2/mL (A) and 1.26 × 108 µm2/mL (B). Six PS bead
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diameters were tested, and first column in Table 6.1 lists the bead diameters used.

Figure 6.1. Fluorescence of 15 µM ThT in the presence of PS beads of different sizes. The
fluorescence was measured using a plate reader and a 96-well plate (excitation: 440 nm,
emission: 485 nm). Two graphs are for two different PS bead concentrations (1.26×109 µm2/mL
and 1.26×108 µm2/mL). Concentrations are reported as bead surface area per mL.
A maximum fluorescence is reached that appears to be related to bead diameter and
concentration. For both concentrations, the intensity of the maximum fluorescence is
approximately 3-fold that of the intensity of the smallest bead size tested. The bead diameter at
which the maximum fluorescence is reached is 202 nm for 1.26 × 109 µm2/mL (Figure 6.1A) and
535 nm for the 1.2 × 108 µm2/mL (Figure 6.1B). More smaller beads are needed to attain the
same µm2/mL compared to larger beads. For example, 8.63 × 1010 beads/mL of the 108 nm
beads are needed to attain a surface area per volume of 1.26 × 108 µm2/mL, while 3.46 × 109
beads/mL of the 535 nm beads are needed to attain the same 1.26 × 108 µm2/mL. A higher
number of beads/mL could result in the beads being packed more closely together. Also, the
greater number of beads/mL could cause the beads to aggregate in solution. Either of these
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possibilities could effectively reduce the available surface area of the beads for binding ThT and
would explain the lower ThT fluorescence intensity for the smaller beads relative to larger beads.
Larger beads will not pack so tightly, so more bead surface area is available for binding ThT. A
related effect has been suggested to explain the decrease in ThT intensity in the presence of Aβ
fibril formation that is followed by the initial ThT increase and plateau [39]. It is suggested that
Aβ fibrils can stack on top of each other forming a mat-like motif, which effectively reduces the
binding sites available for ThT binding; hence, a reduction in ThT intensity is observed [39].
6.3.2

Effect of Bead Concentration on ThT Fluorescence
The data in Figure 6.1 show that the overall fluorescence intensity is approximately 1

order of magnitude greater for the 1.26 × 109 µm2/mL concentration versus the 1.2 × 108
µm2/mL concentration. This observation indicates that PS bead concentration has an impact on
the ThT fluorescence intensity. Based on the results in Figure 6.1, two PS bead diameters (108
and 535 nm) were selected to further investigate the effect of PS bead concentration on ThT
fluorescence. The 108 and 535 nm PS beads were selected based on the fact that in Figure 6.1,
they covered the range of minimum and maximum ThT fluorescence for both concentrations.
The concentrations studied are listed in the caption of Figure 6.2.
Figure 6.2 shows that the ThT intensity as a function of concentration is drastically
different for the 535 nm PS beads (A) versus the 108 nm PS beads (B). The data for the 535 nm
PS beads suggest that even for the highest concentration of PS beads tested, a maximum ThT
intensity is not reached. This is in stark contrast to the data for the 108 nm PS beads, which
indicate that a maximum ThT is reached. The data in Figure 6.2 also support the hypothesis that
bead packing may play a role in the amount of bead surface area for ThT to bind as described in
section 6.3.1.
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Figure 6.2. Fluorescence of 15 µM ThT in the presence of 535 nm (●) and 108 nm (■) PS beads
as a function of bead concentration (µm2/mL). Bead concentrations are 1.26 × 105, 1.26 × 106,
1.26 × 107, 1.26 × 108, 6.92 × 108, 1.26 × 109, 4.08 × 109, 6.92 × 109, 9.72 × 109, 1.26 × 1010
µm2/mL. Fluorescence measurements were performed according the procedure described in the
experimental section.
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6.3.3

ThT Enhancement: PS Beads Are Similar to Aβ
All the data described in sections 6.3.1 and 6.3.2 were collected on a fluorescence plate

reader at excitation and emission wavelengths of 440:485 nm. These wavelengths are the
enhanced ThT maximum wavelengths described in the literature for the interaction of ThT with
amyloid fibrils [63].

It is clear from the plate reader data that PS beads do induce ThT

fluorescence at these wavelengths over the range of 108–1072 nm.
Excitation/emission matrix (EEM) data were also collected to determine the enhanced
λmax of ThT in the presence of PS beads. For this study, a spectrofluorometer was used, which
scans the defined wavelengths of interest using monochromators. This is clearly advantageous
over the plate reader, whose wavelengths were rigidly defined by bandpass filters. In addition to
indicating the ex:em λmax, another advantage of EEM measurements is that it can indicate
whether any additional interesting ex:em fluorescence wavelengths result from the interaction of
ThT with PS beads.
Figure 6.3 shows EEMs for unbound 15 µM ThT (A), 15 µM ThT in the presence of Aβ
(1-40) fibrils (B), 15 µM ThT in the presence of 1.26×108 µm2/mL 535 nm PS beads (C) 15 µM
ThT in the presence of 1.26×108 µm2/mL 108 nm PS beads (D). The Aβ (1-40) fibril sample was
confirmed to contain fibrils in another published study [118]. After that study the Aβ sample was
frozen at -80°C until thawed for this study. Figure 6.3A shows only a single peak at for ThT at
ex:em 332:440 nm. In the presence of Aβ fibril, ThT enhancement is observed with a new ThT
peak emerging at ex:em 440:490 nm (Figure 6.3B). These wavelengths are consistent with those
reported by LeVine et. al. for Aβ-bound ThT enhancement [63]. Moreover, unbound ThT can
also be observed in Figure 6.3B, which indicates that not all the ThT is bound to Aβ. Figures
6.3C and 6.3D illustrate that the 535 and 108 nm PS beads exhibit ThT enhancement at ex:em
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405:490 nm. The excitation λmax of ThT in the presence of PS beads (405 nm) is not perfectly
aligned with that for Aβ-bound ThT (440 nm). The emission λmax for ThT in the presence of PS
beads and Aβ are the same. The EEM data presented in Figure 6.3 clearly demonstrate that PS
beads can be a source of interference when studying Aβ aggregates with ThT at ex:em 440:490
nm.

Figure 6.3. Contour plots of EEM of 15 µM ThT (A), 15 µM ThT in the presence of Aβ fibrils
(B), and 15 µM ThT in the presence of 1.26×108 µm2/mL 535 nm beads (C), 15 µM ThT in the
presence of 1.26×108 µm2/mL 108 nm PS beads (D). All samples were in 10.0 mM tris buffer at
pH 7.80. 3.00mL of sample were placed in a in a 1.0 cm quartz cuvette for measurements. Inner
filter correction was performed before plotting the data.
6.3.4

Excitation and Emission Scans of ThT as a Function of Bead Concentration
The goal of this part of study was to evaluate the excitation-emission spectra as a

function of PS bead concentration at selected wavelengths observed in the contour plots of EEMs
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in Figure 6.3. The wavelengths of interested selected from the EEMs where 332 nm, 405 nm, and
440 nm for the excitation and 435 nm and 490 nm for the emission. Emission spectra were
collected with the excitation at 332 nm, 405 nm, and 440 nm. Similarly, excitation spectra were
collected with the emission at 435 nm and 490 nm. Initially, the goal was to analyze a larger
range of concentrations of both 108 nm and 535 nm beads as in microplate reader studies
(1.26×105 µm2/mL to 1.26×1010 µm2/mL). Due to the high inner filter effect at higher
concentrations and insignificant change in the fluorescence of ThT at lower concentrations this
was not possible. After evaluation of several sets of experiments the range of concentrations
studied was between 1.26×107 µm2/mL and 1.26×108 µm2/mL for the 535 nm PS beads and
between 1.26×108 µm2/mL and 1.26×109 µm2/mL for the 108 nm PS beads.
The study of the mixtures of PS beads and 15 µM ThT using a fluorometer showed an
increase in fluorescence signal of ThT with the increase in concentration of beads. The data are
illustrated in Figure 6.4. It is clear in Figure 6.4 that other than intensity the emission spectra are
not affected by concentration, i.e. no additional emission peaks are observed as a function of PS
bead concentration
Figure 6.4A shows emission spectra of mixtures of 15 µM ThT and different
concentrations of 535 nm PS beads between 1.26 ×107 µm2/mL and 1.26×108 µm2/mL with the
excitation at 440 nm. The bead concentration was added in equal steps of 3.88×107 µm2/mL as
discussed in the figure caption. There is an increase in the fluorescence of ThT with the addition
of 535 nm beads. The increase in ThT fluorescence as a function of PS bead concentration is
plotted in the inset of Figure 6.4A, where the fluorescence value is the apex, or λmax of the
emission intensity. An exponential fit provided the highest correlation coefficient (R2 = 0.989)
between the ThT fluorescence and PS bead concentration. A linear fit resulted in an R2 = 0.957.
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Figure 6.4B shows emission spectra of mixtures of 15 µM ThT and different concentrations of
108 nm diameter beads between 1.26×108 µm2/mL to 1.26×109 µm2/mL with the excitation at
440 nm. Note that the concentration of 108 nm PS beads used for the experiment is one order of
magnitude higher than the concentration of 535 nm PS beads. This is because initial experiments
showed only negligible changes in ThT fluorescence with PS bead concentration. The bead
concentration was added in equal steps of 3.88×108 µm2/mL. The inset of Figure 6.4B shows that
the relationship of ThT fluorescence versus PS bead concentration is linear (R2 = 0.998).

(C) Legend for Figure 6.4 (A) and (B).
Concentration of PS Beads (µm2/mL)
Line Style
535 nm PS Bead

108 nm PS Bead

Dash/Dot

1.26×107

1.26×108

Dot

5.03×107

5.03×108

Dash

8.80×107

8.80×108

Solid

1.26×108

1.26×109

Figure 6.4. Fluorescence emission spectra of of 15 µM ThT in the presence of 535 nm PS beads
(A) and 108 nm PS beads (B) over a 1 order magnitude range in concentrations (surface
area/mL). Excitation was performed at 440 nm. Inner filter correction was performed before
plotting the data. For both (A) and (B) the initial mixture of PS beads was prepared in 10 mM tris
buffer at pH 7.8 with 15 µM ThT in a 1 cm quartz cuvette. To increase the concentration of PS
beads in the cuvette, subsequent additions of PS beads were pipetted directly into the cuvette.
For the 535 nm PS beads, equal steps 4.0 µL of 2.91×1010 µm2/mL was added, which equals
3.88×107 µm2/mL step in concentration. Likewise, for the 108 nm PS beads 4.0 µL of 2.91×1011
µm2/mL was added, which equals 3.88×108 µm2/mL step in concentration. A legend is provided
in (C) below figures (A) and (B), which list the PS bead concentrations. The insets in (A) and (B)
plot the intensities of the em λmax versus concentration.
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6.4

Conclusions
This work demonstrated that PS beads can induce Thioflavin T fluorescence

enhancement similarly to Aβ. Polystyrene beads were used as a model system here because their
sizes and concentrations could be carefully controlled. It was shown that the intensity of ThT
increases with increasing PS bead diameter, and a maximum fluorescence was reached over the
PS bead sizes studied. In general, the magnitude of the ThT intensity increased with increasing
concentration of PS beads; however, this relationship is not necessarily linear and depends on
both PS bead diameter and PS bead concentration range.
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CHAPTER 7
ANALYSIS OF Aβ (1-40) PEPTIDE AGGREGATION BY CAPILLARY
ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE ANISOTROPY
DETECTION
7.1 Introduction
The development and

progression of Alzheimer’s disease (AD) and other

neurodegenerative diseases have been linked to aggregation of amyloidogenic peptides. Soluble
monomeric amyloid peptides self-aggregate under physiological conditions to form aggregates
ranging vastly in size and structure. The level of neurodegenerative toxicity has been suggested
to be related to the size and structure of Aβ aggregates, but it is not clear what size/structure is
most toxic. It has also been suggested that the most toxic forms of Aβ are intermediate in size
between monomer and fully-formed fibrils [13,27,35,36].
Developing methods to monitor intermediate species between monomers and fullyformed fibrils is extremely challenging. Methods that are commonly used to study monomers or
fully-formed fibrils do not work well for studying intermediate-sized structures. For example,
mass spectrometry has been used to study monomers, but ionizing aggregates without breaking
apart their structures is a problem. Thioflavin T fluorescence is a powerful analytical tool for
studying fully-formed fibrils and their rates of formation but is less effective at monitoring Aβ
structures that are smaller than fully-formed fibrils, especially monomers. Moreover, a minimum
size or structure of Aβ for ThT binding is not clear. Other examples include TEM imaging and
light scattering which are effective for studying fully-formed fibrils but less effective for
structures smaller than fully-formed fibrils.
An underlying hurdle for Aβ analysis is that multiple methods are needed to study the
vast sizes, structures and numbers of Aβ species present in an aggregating Aβ mixture.
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Complicating matters further is that intermediates Aβ structures are short-lived transient and
dynamic species. Very little is known about these structures because they are unstable relative to
fibrils and monomers making it difficult to sample and study.
Capillary electrophoresis (CE) has been shown to be a powerful tool for Aβ analysis
[45,77,93,118]. Monomeric and aggregated peptides have been separated by CE-UV for both Aβ
(1-40) and Aβ (1-42) isoforms [45,118]. Previous studies in our laboratory [128] and by Kato et
al. [113] demonstrated that capillary electrophoresis with laser-induced fluorescence detection
could be used study the aggregation of Aβ peptides. Both of these studies used thioflavin T in the
separation buffer to label Aβ aggregates. In Chapter 4, it was demonstrated that CE with laserinduced fluorescence (LIF) detection can resolve individual Aβ aggregates using Thioflavin T as
a fluorescence probe. In that same chapter, LIF anisotropy (LIFA) was introduced to size
characterize the individually detected Aβ aggregates; however, no anisotropy differences were
detected for different Aβ aggregates using ThT as a fluorescence probe. Another problem was
that the background ThT anisotropy and Aβ aggregate anisotropy were indistinguishable. It was
hypothesized that the unpredictable binding ratio and unknown binding mechanism of ThT to Aβ
aggregates could have been a partial cause for not observing any anisotropy differences between
aggregates and between aggregates and the background.
In this work, a covalently labeled Aβ (1-40) peptide with carboxyfluorescein (FAM) was
investigated using CE-LIFA to determine whether different forms of Aβ could be differentiated
based on their relative fluorescence anisotropy (FA) values. By using a covalently labeled Aβ
peptide, all forms of Aβ from monomers to fully-formed fibrils will be fluorescently labeled.
This is distinct from the work in Chapter 4 where ThT was used to noncovalently label some of
the Aβ structures in an unpredictable manner. In addition to using covalently labeled Aβ
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peptides, this work is distinct from the previous work in Chapter 4 because the FAM-Aβ peptide
is sampled and analyzed during its incubation while aggregating over several days. The goal of
analyzing the aggregating mixture over time is to attempt to detect transient Aβ species that are
intermediate between monomers and fully-formed aggregates.
7.2
7.2.1

Experimental
Chemicals
All solutions were prepared in 18 MΩ water obtained from a Modulab water purification

system (United States Filter Corp.; Palm Desert, CA) unless otherwise noted. Phosphate buffered
saline (PBS), Tris (hydroxymethyl) aminomethane (Tris) and methanol (99.8%) were purchased
from Fisher Scientific (Fair Lawn, NJ). Phosphate buffered saline contained 22.8 mM phosphate,
274 mM NaCl, 5.4 mM KCl and 0.1% NaN3 at pH 7.4. Tris buffer was prepared at 10.00 mM,
and the pH was adjusted to 7.80 with HCl. This Tris buffer was used for all experiments unless
otherwise noted. The buffer was filtered through a 0.02 µm filter (Whatman; Hillsboro, OR).
Mesityl oxide (MO) was purchased from Alfa Aesar (Ward Hill, MA), and working solutions of
MO were prepared in Tris buffer at a concentration of 0.2% (v/v). Coumarin 334 was purchased
from Acros Organics (Morris Plains, NJ), and a stock solution was prepared at 1.00 µM in
methanol. Working solutions of coumarin 334 were prepared at 100 nM in Tris buffer.
7.2.2

Aβ Sample Preparation and Characterization
Unlabeled Aβ (1-40) peptide was purchased from the W.M Keck Foundation

Biotechnology Research Laboratory (Yale University, New Haven CT). Carboxyfluorescein
labeled Aβ (1-40), i.e. FAM-Aβ (1-40), was purchased from Anaspec Inc. (Fremont, CA). Each
Aβ peptide monomer is covalently labeled with a single carboxyfluorescein on the first aspartic
acid (D) on the amine terminus of the peptide chain. Arctic Aβ (1-40) was purchased from
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BioSource. Arctic Aβ (shown below) is a variant of the normal Aβ (1-40) peptide by
replacement of the glutamic acid (E) at position 22 in the peptide chain with Glycine (G). All
peptides were stored with desiccant at -80 °C until used.
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All monomeric peptide solutions were prepared independently in PBS buffer, and the
targeted, total concentration of Aβ used for aggregation studies was 20 to 25 µM [45,118,128].
After the monomeric peptide solutions were prepared, the Aβ monomer concentration of each
solution was determined by HPLC-UV. Monomer preparation and analysis have been described
in detail previously [45,118]. After the concentrations were determined, the FAM-Aβ peptide
was mixed at a mass ratio of 1:4 or 1:1 with either unlabeled Aβ (1-40) or Arctic Aβ (1-40),
respectively, to give a final total monomeric equivalent Aβ concentration between 20 and 25 µM.
The total volume of each mixture was 1 mL. The mixed monomeric Aβ peptides were then
incubated at 37°C and ambient pressure during the aggregation studies.
In order to remove aliquots of sample for analysis during aggregation, the sample was
removed from the incubator and lightly vortexed to homogenize the mixture and suspend any
aggregates that may have settled to the bottom of the centrifuge tube. A 200 µL aliquot of the
sample was removed from the mixture to analyze, and the remaining portion of the mixture was
returned to incubator to continue aggregating. The 200 µL aliquot was buffer exchanged from
PBS buffer into the Tris buffer at pH 7.80 for CE analysis [59]. To perform the buffer exchange,
the sample was placed in a 3000 molecular weight cutoff Microcon filter cartridge and
centrifuged at 14,000 rpm (approximately 20,000 g) at 4° C for 60 min. The retained portion of
the sample was resuspended in Tris buffer. This process was performed until the theoretical
volume % PBS was below 5%, which typically required 3 cycles of centrifuging. Next, the
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Microcon filter was inverted into a clean centrifuge tube and spun at 3000 rpm for 1 min to
collect the Aβ sample. This sample was transferred to a 200 µL thermowell polypropylene tube
(Corning Incorporated; Corning, NY) and put on ice until CE analysis, which was performed
approximately 2 hr after completing the buffer exchange.
To minimize photobleaching of the fluorophore-labeled peptide during sample
preparation and prior to CE analysis, exposure of samples to ambient light was minimized during
the all stages of the sample handling, including incubation, sampling, buffer exchanging and
analysis. This was accomplished by keeping the sample container wrapped in aluminum foil
when possible and reducing the ambient light.
7.2.3

Capillary Electrophoresis with Laser-Induced Fluorescence Anisotropy Detection
Prior to CE-LIFA, samples were characterized by CE-UV [45,118] using a Beckman

Coulter PACE MDQ equipped with a diode array detector. Samples were then analyzed
immediately with a lab-constructed CE-LIFA instrument. The LIFA detector used for this work
was described in detail previously [128] and is based on a design published by [120]. Excitation
was carried out using a polarized diode laser with and excitation wavelength and laser power of
445 nm and 1.63 mW, respectively. For the detection system used in this work, the 490 nm
emission bandpass filter used previously for thioflavin T detection [128] was replaced with a 560
nm emission bandpass filter better suited for detection of emission of the fluorescein label. The
parallel and perpendicular fluorescence emissions were collected simultaneously by two separate
photomultiplier tubes (PMT). The outputs of the PMTs were filtered by 500 Hz low pass RC
filters and collected by a National Instrument PCI-6024E DAQ board at a scan rate of 1000 Hz.
The fast data collection was necessary for detecting peaks from individual Aβ fibrils that
typically have peak widths of 3-15 ms at FWHM [128]. The CE-LIFA data collection was

114

controlled by a program written with LabView Version 5.0, and the data were analyzed using
Origin Pro and Microsoft Excel.
The fluorescent neutral marker (coumarin 334) was injected prior to the Aβ sample
injection. This injection order minimized potential interactions between Aβ and the neutral
marker because all forms of Aβ detected migrated slower than the neutral marker. Injections
conditions are given in the figure captions. The Aβ samples were vortexed prior to every
injection to suspend any aggregates that could have settled to the bottom of the sample vial. The
electrophoretic potential was applied using a Spellman CZE1000R high-voltage power supply
(Hauppauge, NY) at 25.0 kV (417 V/cm). The electrophoretic current was 5-6 µA.
7.2.4

Data Analysis
The dual channels of the detection system allowed the parallel and perpendicular

fluorescence emission relative to the polarization of the laser source to be measured
simultaneously. The measured fluorescence intensities were used to calculate the fluorescence
anisotropy according to Equation 7.1, where r is the fluorescence anisotropy and I║ and I┴ are the
measured parallel and perpendicular fluorescence intensities relative to the polarization of the
excitation source, respectively. The factor G corrects for differences in responses and
sensitivities between the two PMTs. For this work, the voltages applied to both PMTs were
adjusted so that G was as close to 1 as possible. This was done by using a dilute solution of
coumarin 334 (50-100 nM), which is expected to have an FA near 0 because of its small size and
fast rotational diffusion rate. After adjusting the G-factor empirically to as close to 1 as possible,
some day-to-day variability was observed in the coumarin 334 fluorescence anisotropy values.
To correct for this, the average G-factor per day was calculated using Equation 7.2, where the
intensities are those from coumarin 334. This G-factor was used in the Equation 7.1 to calculate
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the fluorescence anisotropy of all the peaks in the electropherograms from that day.
r=

.∥ − 0.1
.∥ 2 20.1

G=

(7.1)

.∥
.1

(7.2)

Fast data collection (1000 Hz) was used because of the narrow peak widths due to
individual, large Aβ aggregates, which produce peaks that are only ~ 10 ms wide [82,106,128].
The fast data collection causes fast random fluctuations in measured signals. These random
fluctuations do not occur equally in both the parallel and perpendicular channels; therefore, the
fluorescence anisotropy can be drastically different from one time point to the next based on
these random fluctuations. To reduce the impact that the random fluctuations could have on the
calculated FA of the narrow (~10 ms) Aβ fibril peaks, the FA was averaged over the FWHM of
the fibrils’ fluorescence peaks. For broad peaks due to coumarin 334 and Aβ monomer and
intermediate peaks, the FA was averaged over 100 ms at the apex of the peak.
7.3

Results and Discussion
Previous studies have demonstrated that CE-LIF with ThT in the separation buffer can be

used successfully for analysis of Aβ peptide aggregation [113] and detection of individual Aβ
aggregates [128]. Our work also explored the potential of this approach with LIFA detection
[128,129]; however, different Aβ aggregates detected with ThT labeling did not exhibit distinct
fluorescence anisotropy values. Another limitation of labeling with ThT is that only some larger
Aβ aggregates will produce enhanced fluorescence [4,12,63]. In this study, the aggregation of
Aβ (1-40) with a covalently attached fluorophore was carried out using CE-LIFA. The objective
of this study was to determine if significant differences in FA could be measured for different
aggregate types by CE-LIFA. The Aβ (1-40) peptide was labeled with carboxyfluorescein on the
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first aspartic acid (D) on the amine terminus of the peptide chain, and all forms of this peptide
should produce a fluorescence signal. A mixture of this labeled peptide with unlabeled Aβ (1-40)
was analyzed by CE-LIFA at different times during the aggregation process.
7.3.1

Aggregation of Aβ (1-40)
Figures 7.1-7.3 present CE-LIF electropherograms for an aggregating mixture of FAM-

Aβ (1-40) and unlabeled Aβ (1-40) mixed at a mass ratio of 1:4 (FAM labeled:unlabeled) at days
0, 4 and 6 during aggregation. Only one data channel (parallel polarization) for the CE-LIFA
experiments is plotted in Figures 7.1, 7.2A and 7.3 for clarity. Corresponding electropherograms
for the same samples by CE-UV are shown in Appendix A (Figure A.5). The main objective of
sampling and analyzing the aggregating Aβ sample at different days was to attempt to detect Aβ
aggregates exhibiting distinct FA values intermediate between monomers and fully-formed
fibrils. Figure 7.1 shows that on day 0, only the neutral marker peak at 64.0 s and a monomer
peak at 94.7 s were observed, as expected. The CE-UV data did not indicate the presence of any
aggregated species (Appendix A: Figure A.5A).

Figure 7.1. CE-LIF electropherogram of a 1:4 mixture of FAM-Aβ (1-40) peptide:Unlabeled Aβ
(1-40) peptide sampled on day 0.The main peaks are the neutral marker (NM) peak coumarin
334 at 64.0 s and the FAM-Aβ monomer peak at 94.7 s.
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Figure 7.2. CE-LIF electropherogram of a 1:4 mixture of FAM-Aβ (1-40) peptide:Unlabeled Aβ
(1-40) peptide sampled on day 4. (A) Single channel data (parallel channel). The neutral marker
(NM)and FAM-Aβ (1-40) monomer peaks are labeled. Sharp peaks following the monomer peak
are due to large Aβ aggregates. In (B) and (C) the perpendicular and parallel channels are plotted
in grey and black, respectively. (B) Expanded view of a broad peak at 112 s thought to be due to
an intermediate sized Aβ aggregate. (C) Expanded views of 3 large Aβ aggregate peaks detected
individually. The x-axes in (C) are 100 ms for each plot.
The FA value for the monomer peak shown in Figure 1 was 0.019, and the FA value for
coumarin 334 was -0.001. The molecular weight of the labeled Aβ monomer, and coumarin 334
are 4689.2 g/mol and 283.3 g/mol, respectively. The measured FA values are consistent with the
relative sizes of the two molecules. Fluorescence anisotropy is capable of discerning size
differences between different fluorescent species in solution based on their rotational diffusion
rates. In general, larger species have smaller rotational diffusion rates and exhibit larger
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fluorescence anisotropy values as indicated by the Perrin Equation shown in Equation 7.3, where
D is the rotational diffusion coefficient, rₒ, is the fundamental anisotropy and τ is the fluorescence
lifetime. The fundamental anisotropy is dependent on the angle between the absorption and
emission transition dipoles of the fluorophore [69].

=


1 2 645

(7.3)

Figure 7.2A shows an electropherogram for the same aggregating mixture sampled on
day 4. In Figure 7.2A, the FAM-Aβ monomer peak is at 94.7 s. The day 4 electropherogram
includes 12 narrow peaks between 100–120 s with an average FWHM = 12 ms. These peaks are
not present in the day 0 sample and are consistent with peaks observed in our earlier studies and
attributed to individual Aβ aggregates [128]. That work used ThT in the separation buffer for
fluorescence detection.
Figure 7.2B shows one of the most interesting features of this electropherogram, a
relatively broad peak (FWHM ~ 2 s) with a migration time of 112 s that was not detected in the
day 0 sample. The broad shape of this peak and its migration relative to the monomer peaks
suggests that this peak could be to an aggregate peak that is small relative to the structures that
can be detected individually as narrow peaks (FWHM =12 ms) [45,118,128]. If this peak is an
aggregated form of Aβ (1-40), it should exhibit a FA value greater than that of the monomer
peak. Both fluorescence channels are plotted in Figure 7.2B (parallel and perpendicular
polarization), and the peak does exhibit fluorescence anisotropy. The average FA value for 5
injections of this sample was 0.063 ± 0.015, while the average value for monomer was 0.018 ±
0.001 (Table 7.1).
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Table 7.1. Summary of fluorescence anisotropy results for Aβ mixtures.
Aβ Samples

Coumarin

Monomer

Intermediate

Fibril

FAM:Unlabeled
(n = 5)

0.000 ± 0.007

0.018 ± 0.001

0.063 ± 0.015

0.100 ± 0.020
(43 peaks)

FAM:Arctic
(n = 3)

0.000 ± 0.002

0.020 ± 0.001

0.095 ±0.002

0.093 ± 0.029
(40 peaks)

FAM:Unlabeled Aβ sample data are averaged from 5 injections
FAM:Arctic Aβ sample data are averaged from 3 injections

Figure 7.3. CE-LIF electropherogram of a 1:4 mixture of FAM-Aβ (1-40) peptide:Unlabeled Aβ
(1-40) peptide sampled on day 6.
This intriguing peak is not present in the electropherogram for the day 6 sample (Figure
7.3). The electropherogram has a monomer peak at 94.4 s and 13 narrow aggregate peaks
between 100-120 s. These peaks are similar in shape to the narrow peaks in Figure 7.2A, but they
are clearly more intense, on average. These data are consistent with the identification of the
broad peak in Figure 7.2A as a relatively small Aβ aggregate, and the narrow peaks in Figures
7.2A and 3 as larger aggregates detected individually. It is not surprising that a small Aβ
aggregate would disappear as the aggregation proceeded towards larger structures. The presence
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of large aggregates that produce narrow peaks would not be expected at day 0. These peaks
increased in number from day 4 (9 peaks averaged from 5 injections) to day 6 (31 peaks
averaged from 3 injections), and their intensities increased – consistent with Aβ fibrils that are
continuing to grow in size and number.
Figure 7.2C shows parts of the electropherogram from the day 4 sample with both
fluorescence channels plotted. Clearly these narrow peaks exhibit significant FA. The average
FA value for all 43 of the narrow peaks detected from 5 injections of the day 4 sample was 0.100
± 0.020 (Table 7.1). These FA data are plotted as a histogram in Figure 7.4A to take advantage
of the additional distribution information provided. The FA values for these narrow peaks are
larger and distinct compared to the values for the monomer peak and peak shown in Figure 7.2B
(Table 7.1). Figure 7.4B is a histogram of the FA of the narrow peaks detected on day 6. The
average FA value for all 63 of the narrow peaks detected from 3 injections of the day 6 sample
was 0.101 ± 0.023, and a Gaussian distribution is observed.
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Figure 7.4. Fluorescence anisotropy histograms of narrow peaks detected from the 1:4 mixture
of FAM-Aβ (1-40) peptide:Unlabeled Aβ (1-40) peptide sampled on days 4 (A) and day 6 (B). In
both (A) and (B), bin = 0.01. In (A), 43 peaks are represented from 5 injections. In (B), 63 peaks
are represented from 3 injections.
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These experiments were repeated with sampling at days 0, 2, 3 and 6. The primary aim of
the increased number of samples taken during the early stages of aggregation was to increase the
probability of detecting the apparently transient peak shown in Figure 7.2B. This peak was not
observed despite the increase in sampling frequency. The CE-LIFA experiments and
corresponding CE-UV experiments did indicate that aggregation to place to form large Aβ
aggregates as expected (data not shown). This result is not unexpected. Other reports in the
literature indicate the appearance of relatively stable Aβ aggregates of intermediate size indicate
that they are short lived, found at low concentration and are not observed in all experiments [83].
At this point it was decided that it would be wise to change to an Aβ aggregation experiment
known to produce higher concentrations of more stable intermediate aggregates.
7.3.2

Aggregation of Mixtures of Aβ (1-40) and Arctic Aβ (1-40)
Arctic Aβ is a variant of wild type Aβ where Glu22 is replaced by Gly. This single amino

acid mutation has been shown to promote and stabilize the formation of smaller soluble Aβ
aggregates, such as oligomers and protofibrils, which are thought to play a pathogenic role in AD
[83,105]. Arctic Aβ has been used to study the structure of these species [83,105,130-133]. To
further investigate whether intermediate Aβ aggregates between monomers and fully-formed
fibrils could be analyzed be CE-LIFA, monomeric FAM-Aβ (1-40) peptide was mixed with
monomeric Arctic Aβ (1-40) at a mass ratio of 1:1 to increase the stability of intermediate
aggregates; thereby increasing the chance of detecting intermediate species. This Aβ mixture was
sampled on days 1, 2, 3, and 6.
Figure 7.5 shows LIF electropherograms from days 2, 3, and 6. The day 1 LIF
electropherogram and CE-UV electropherograms for all 4 days are included in Appexdix A
(Figures A.6A-E). Compared to the experiments shown in Figures 7.1-7.3, the distance from the
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capillary inlet to the detector was increased while using from the same applied potential (417
V/cm) in order to improve the separation resolution.

Figure 7.5. Electropherograms of a 1:1 mixture of FAM-Aβ (1-40) peptide:Arctic Aβ peptide
sampled on day 2 (A), day 3 (B) and day 6 (C). Peak I is hypothesized to be due to a population
of Aβ aggregates that are intermediate in size between monomer and fully-formed fibrils (shown
as individually detected narrow peaks).
The FAM-Aβ monomer peak was detected in each electropherogram shown in Figure 7.5
(labeled FAM Aβ Monomer) while the Arctic Aβ monomer was not detected since it was not
labeled with a fluorophore. The CE-UV data for the day 1 and day 2 samples (Appendix A:
Figure A.6B and A.6C) has peaks for both the Arctic Aβ monomer and FAM-Aβ monomer, at
approximately a 1:1 ratio as expected. Intermediate aggregate peaks similar to that in Figure 7.2
were observed for day 1, day 2 and day 6 samples. The CE-UV electropherograms also included
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peaks consistent with intermediate aggregates [45,118]. Significant numbers of narrow peaks
attributed to larger individual Aβ aggregates are first apparent on day 3 (13 peaks averaged from
3 injections) and increase on day 6 (35 peaks averaged from 3 injections). The average FA value
for all 40 of the narrow peaks detected from 3 injections of the day 3 sample was 0.093 ± 0.029
(Table 7.1). Figure 7.6 shows a FA histogram of the narrow peaks detected on day 3. By day 3,
the peaks for Arctic Aβ monomer and FAM-Aβ monomer were near or below the CE-UV
detection limits though the labeled peptide was still detectable by CE-LIF. Overall these results
are consistent with the expected progression of Aβ aggregation.
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Figure 7.6. . Fluorescence anisotropy histograms of narrow peaks detected from the 1:1 mixture
of FAM-Aβ (1-40) peptide:Arctic Aβ (1-40) peptide sampled on day 3 (A). bin = 0.01. 40 peaks
are represented from 3 injections.
7.3.3

CE-LIF Anisotropy Analysis of Aβ Peptides
The fluorescence anisotropy data are summarized in Table 7.1. There is a clear increase

in the fluorescence anisotropy from monomer to intermediate Aβ peaks and fibrils for both
samples. The smaller fluorescence anisotropy for the monomer compared to the intermediate
peaks and fibrils is understandable based on fluorescence anisotropy theory because the
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monomer is relatively small. The anisotropy of the monomer is greater than that of the coumarin
as expected.
It is interesting that the monomer and fibrils, on average, are similar between the two
samples taking into account the standard deviation, but the intermediate Aβ peaks’ anisotropy
values are quite different. The arctic Aβ was used in this work because of it stabilizing effect on
intermediate Aβ structures. The data suggest that fluorescence anisotropy can be used to
differentiate between intermediates that are potentially different in size and structure.
A relatively high standard deviation of the fibrils’ fluorescence anisotropy values is
observed in Table 7.1 and Figures 7.4 and 7.6.. Wide variability in the fibrils’ fluorescence
anisotropy values is understandable since individual fibrils presumably have vastly different
sizes and shapes, which would be reflected as differences in fluorescence anisotropy. Plotting the
fibrils’ anisotropy values versus peak migration time did not result in any discernable trend (data
not shown).
7.4

Conclusions
In this work, time-course Aβ aggregation studies were investigated by capillary

electrophoresis with laser-induced fluorescence anisotropy detection. By performing the
aggregation with fluorescently-labeled Aβ peptides (FAM-Aβ), several forms of Aβ were
separated and observed in a single electrophoretic run from monomers to fully-formed fibrils.
This data demonstrated that fluorescence anisotropy can be used to differentiate Aβ peaks
separated by capillary electrophoresis.
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CHAPTER 8

CONCLUSIONS AND FUTURE DIRECTIONS
8.1

Conclusions
The general focus of this dissertation is the analysis of amyloid peptides by capillary

electrophoresis (CE) combined with spectroscopic detection. In Chapter 2, a method based on
capillary electrophoresis with UV absorbance detection was developed to quantify the
concentration of Aβ (1-40) monomer. This method is an alternative to previously established
HPLC-UV methods for the same purpose. The advantages of the CE-based method over the
HPLC-based method are that the CE-method has faster analysis times, consumes less sample
material and achieves lower mass detection limits. The CE method was determined to have a
limit of detection of 0.5 µM (19 pg). Chapter 2 also showed that the CE-UV method could be
used to indicate whether an Aβ sample preparation would exhibit accelerated aggregation
kinetics. This was possible because of the ability of the CE-UV method to separate and detect
monomeric and aggregated forms of Aβ (1-40). It is highly significant that open bore CE (i.e. no
stationary phase) can separate Aβ aggregates. This is a nontrivial challenge faced by stationary
phase-based separation techniques, e.g. LC and gel-based methods.
In Chapter 2, the original goal was to analyze Aβ (1-40) preparations of pure monomer. It
was clear from CE results in Chapter 2 that some the preparations contained aggregated forms of
Aβ (1-40). Although this was inadvertent, it opened to door to the experiments presented in
Chapter 3. In Chapter 3, experiments were designed to analyze various monomeric and
aggregated forms of Aβ (1-40) and Aβ (1-42). The CE-UV method described in Chapter 2 was
used in Chapter 3 with the exception that the maximum data scan rate allowed by the instrument
was used in Chapter 3 (32 Hz versus 4 Hz). The data showed that monomeric and aggregated
126

forms Aβ peptides were resolved by CE-UV for preparations of both Aβ (1-40) and Aβ (1-42)
isoforms. By maximizing the data scan rate, additional sharp peaks were observed in aggregate
containing samples. These sharp peaks are believed to be due to fully-formed fibrils, and the
broad aggregate peaks are believed to be due to unresolved Aβ intermediate sized aggregates, i.e.
oligomers or protofibrils. Aβ seeds are often used to promote aggregation through the
elimination of the lag phase associated with the nucleation-dependent growth. Aβ seeds are
sonicated Aβ fibrils, where the sonication process breaks up larger fibrils into smaller Aβ fibril
fragments that can seed further fibril growth. Aβ (1-40) seeds were also prepared and analyzed
by the CE-UV method. Comparing the CE-UV electrophoretic profiles of the Aβ (1-40) seed and
Aβ (1-40) fibril samples, fewer sharp peaks, i.e. fibrils, were observed in the seed sample relative
to the fibril sample.
The observation of additional sharp peaks in aggregate containing sample shown in CEUV data in Chapter 3 was largely due to the increase in the data sampling rate from 4 to 32 Hz. It
was believed that 32 Hz was still not sufficient for detecting individual Aβ fibrils. In an effort to
detect all Aβ fibrils injected into the CE system, a CE-LIFA (laser-induced fluorescence
anisotropy) instrument was constructed using a 1000 Hz data sampling rate. This data is
presented in Chapter 4. Aβ peptides do not exhibit strong native fluorescence; therefore, the
amyloid dye Thioflavin T was used for detecting Aβ fibrils. Thioflavin T was added to the
electrophoresis buffer, and labeling the Aβ fibrils with ThT was performed on-column during
electrophoresis. The basic CE conditions were held a similar to those in Chapters 1 and 2 as
possible. Using the lab-constructed CE-LIFA system, individual Aβ fibrils were resolved and
detected as individual peaks. This was shown for Aβ (1-40) and Aβ (1-42) isoforms. These
results were validated by analyzing the same Aβ samples by bulk measurements using a
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fluorescence plate reader, which is a more common technique used to study Aβ fibrils. The
results from the CE and bulk plate reader experiments were consistent.
Chapter 4 also showed that separating Aβ fibrils in the absence of ThT produced sharp
peaks due to scattered light albeit careful optical design to eliminate elastic scattering from being
detected. Scattered light was also observed in the plate reader study for aggregate-containing
samples. It was clear; however, that using ThT resulted in an increase in signal intensity relative
to not using ThT. This effect was extremely clear in the case of the Aβ (1-42) monomer sample,
which was shown to contain aggregates.
In Chapter 4, LIFA detection was used as a means to characterize individual Aβ fibrils. It
was shown in plots of fluorescence anisotropy versus time that no distinction could be made
between the fluorescence anisotropy values of the background electrophoresis buffer that
contained ThT and the Aβ aggregates, i.e. the fluorescence anisotropy electropherograms looked
like

noise

although

there

were

clearly

peaks

in

the

corresponding

fluorescence

electropherograms. Chapter 5 presented a data treatment method designed to differentiate the
fluorescence anisotropy values of the background signal and peaks due to Aβ fibrils. The basis of
the data treatment method was the addition of an artificial signal that was equally applied to all
fluorescence data points prior to calculating the fluorescence anisotropy. After the data treatment
was applied, there were clear fluorescence anisotropy peaks that correspond in time to the
fluorescence peaks detected for Aβ aggregates. It was found that increasing the amount of
artificial single added to the fluorescence data increased the S/N of the fluorescence anisotropy
peaks, but the S/N eventually plateaus as a function of added artificial signal.
In the initial studies of using ThT in the electrophoresis buffer for the on-column labeling
and detection of individual aggregates, several sharp peaks mimicking those of Aβ were
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observed in the background buffer that included ThT. These peaks were hypothesized to be due
to particulate matter in the electrophoresis buffer that were removed by filtering the buffer
through a 0.02 µm filter. The potential of particulate matter to enhance ThT similarly to Aβ and
produce false positives laid the groundwork for the experiments described in Chapter 6. Chapter
6 describes a spectroscopic investigation of ThT enhancement in the presence of polystyrene
(PS) beads. The study showed that ThT enhancement in the presence of PS beads was similar to
that of Aβ peptides. Moreover, it is clear in Chapter 6 that ThT enhancement is dependent on
both PS bead size and concentration.
In Chapter 7, covalently labeled fluorescent FAM-Aβ (1-40) peptide was mixed with
either normal unlabeled Aβ (1-40) or Arctic Aβ (1-40) to produce aggregates. The aggregating
Aβ mixtures were sampled over time and analyze by CE-LIFA. The progression of Aβ
aggregation was clearly observed from day-to-day CE-LIF data. Aβ monomer, intermediate
aggregates and fully-formed fibrils were separated and detected in a single electrophoretic run
for some of the days of aggregation. It was determined that these Aβ peaks exhibited different
fluorescence anisotropy values.
8.2

Future Directions
Our understanding of amyloid aggregation will continue to depend on developing and

improving separation and detection methods. The lab-constructed CE-LIFA instrument used in
Chapters 4 and 7 demonstrated, for the first time, the separation of monomers, intermediate
aggregates and hundreds of individual fibrils. Moreover, in Chapter 7, the differences in the
fluorescence anisotropy values for different forms of Aβ suggested that fluorescence anisotropy
may be useful to differentiate Aβ based on size. To continue development work using
fluorescence anisotropy as a detection method for Aβ, eliminating scattered light produced from
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Aβ fibrils so that the fluorescence anisotropy can be calculated from a pure fluorescence signal
will be critical. The magnitude of scattering can be seen in Chapter 4. Reducing scattered light
could be accomplished by simply adding multiple notch filters in series.
Eliminating scattered light would be beneficial for fluorescence anisotropy; however, an
interesting study would be to modify to the optics of the LIFA system so that one PMT is
monitoring light scattering and the other PMT is monitoring fluorescence, i.e. the detection
system would not be used to calculate fluorescence anisotropy, but it would provide the
magnitude of the scattering under the fluorescence signal for each aggregate. This could be
accomplished by replacing the polarizing beam splitter cube with a dichroic shortpass filter,
which is essentially a spectral beam splitter. These types of filters are commercially available,
e.g. from Edmunds Optics. By using a dichroic shortpass filter, scattered light would pass
through the filter and be detected by the PMT that is currently being used to detect perpendicular
radiation. This means that the scattering PMT would be scattering at 90° relative to the incidence
of the excitation laser radiation on the capillary. The long wavelength of the fluorescence would
be reflected by the dichroic shortpass filter and be detected in the PMT currently being used to
detect parallel radiation. Another necessary change would be to move the notch filter and
fluorescence bandpass filter so that they are between the dichroic shortpass filter and the PMT
that is detecting fluorescence. Moreover, it would be necessary to include a scattering bandpass
filter between the dichroic shortpass filter and the PMT detecting scattering.
Many researchers are using bulk ThT data to measure amyloid aggregation endpoints and
kinetics. Based on the scattering data in Chapter 4, it would be interesting to perform a bulk ThT
time-course aggregation study on Aβ but without the ThT. No data in the literature was found
that compared bulk scattering to ThT fluorescence of Aβ aggregates in a time-course study.
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The time-course aggregation study of FAM-Aβ and unlabeled Aβ presented in Chapter 7
discussed that 1:4 mixture of FAM-Aβ:unlabeled Aβ monomers does not necessarily result in
aggregates containing a composition of 1:4 FAM-Aβ:unlabeled Aβ. It would be an interesting
study to mix two fluorescently labeled Aβ monomers, which both could absorb radiation from
the same excitation source but each would have a unique emission wavelength that could be
selectively monitored. This may require custom fluorescent labeling because all the
commercially fluorescent Aβ peptides that could be found are fluorescein-based. This means that
the emission from the two dyes would be very similar, which makes spectrally separating the
emissions extremely difficult or impossible. If suitable dyes become commercially available or if
they can be synthesized in lab, changes to the emission optics similar to those described above
with the dichroic filter would allow the independent and simultaneous detection of individual
aggregates for selective wavelengths. Based on the fluorescence intensity detected from each
dye, the ratio of each fluorescently-labeled Aβ incorporated into a single aggregate could be
determined. It would be interesting to determine if a correlation exist between the ratio of the
starting monomers and the ratio of the monomers incorporated into single aggregates.
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APPENDIX A: SUPPLEMENTAL FIGURES

Absorbance/mAU

8

6
M
4

2

0
0

60

120

180

240

300

360

300

360

Migration time/s
(a)

8

Absorbance/mAU

M
6

4
A

2

0
0

60

120

180

240

Migration time/s
(b)

Figure A.1. Aβ (1-40) monomer preparation. Same plot as Figure 2.2 except plotted in time and
showing the entire electrophoretic run (360 s or 5 min).
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Figure A.2. Electropherogram of Aβ (1-40) monomer with UV absorbance detection (190 nm).
The sample was the same as that used for Figure 4.3. The capillary (ID = 50 µm, OD = 366 µm)
had a total length of 63.0 cm. The detection window was 53.0 cm from the inlet end. The neutral
marker (NM) was injected for 2.0 s at 0.3 psi followed by the Aβ injection for 5.0 s at 0.5 psi.
The separation potential was 25.0 kV (397 V/cm). The peaks at 216 s and 264 s are due to the
neutral marker and Aβ (1-40) monomer, respectively. The small peaks near the Aβ monomer
peak are thought to be due to Aβ synthetic impurities.
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Figure A.3. Electropherogram of Aβ (1-42) fibril with UV absorbance detection at 190 nm. The
sample was the same as that used for Figure 4.6. The experimental conditions are the same as in
Figure A.2. The peaks at 200 s and 280–360 s are due to the neutral marker and Aβ (1-42)
aggregates, respectively.
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Figure A.4. Optimizing laser power for maximum S/N of a 2.5 µM FAM-Aβ (1-40) sample.
Seven laser powers tested (values shown in embedded table). The laser power was not tunable.
Each laser power was adjusted with neutral density filter(s). The laser power was measured with
a power meter. The black curve is there to guide the eye.
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Figure A.5. CE-UV electropherograms of a 1:4 mixture of FAM-Aβ (1-40) peptide: Unlableled
Aβ (1-40) peptide sampled on day 0 (A), day 4 (B) and day 6 (C).
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Figure A.6. (A) CE-LIF electropherogram of the FAM-Aβ (1-40) peptide:Arctic Aβ (1-40)
peptide analyzed on day 1 of aggregation. (B-E) CE-UV electropherograms of the sample FAMAβ (1-40) peptide:Arctic Aβ (1-40) peptide mixture shown in (A) analyzed on day 1 (B), day 2
(C), day 3 (D) and day 6 (E).
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